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INTRODUCTION 
 
  The history of Siddha medicine is as old as history of Tamil culture and civilization. 
“Siddha system” is an unique system of medicine because it is both medically and spiritually 
enriched. Siddha heritage is invaluable as it helps to acquire health for physique, peace for 
mind and purity for the soul. Siddha System of medicine is considered the oldest documented 
medical system of the world. Siddhars are those who have attained perfection in yogic 
practices to ultimately reach the stage of immortality. Siddhars are those who have attained 
perfection in yogic practice ultimately reach the stage of immortality. In Siddha system of 
medicine the total number of diseases are said to be 4448 but the sub classification 
methodology and enumeration differ from one source to another. However, the classification 
of the majority of these diseases is either based on clinical symptoms or vitiation of humor. 
Further they have been sub-classified on the basis of the predominant symptoms, affected 
organs and etiological factors. 
 Venpulli is also called ‘Suvetha kuttam’ which is one of the 18 varieties of skin 
disorders, under kuttam noted in Yugi Chinthamani. The Siddhars were further the greatest 
scientists in ancient times. They were men of highly cultured intellectual and spiritual 
faculties combined with super nature powers.  
 People with Venpulli (Vitiligo) develop white spots in the skin that vary in size and 
location. The spots occur when pigment cells, melanocytes, are destroyed and the pigment 
melanin can no longer be produced.  Melanocytes  normally occur throughout the skin, and in 
the hair follicles, mouth, eyes, and some parts of the central nervous system. Regarding 
Venpulli, there are many misgivings about this diseases in the minds of the public 
 It is still a wrong notion of the people that it is contagious and it will lead to Hansen’s 
diseases because of the name Venkuttam and also believe that it is due to sin and karma. 
 So the author decided to use form ‘Venpulli’ instead of Venkuttam for this study. The 
depigmentation disorder affecting 0.5 - 1% of the world population. In India 0.25% - 2.5% of 
populations are affected. These people may have difficulties in finding partners and also in 
making a successful carrier professions. 
The clinical signs of Vitiligo are correlated with Venpulli or Venpadai in Siddha 
system of medicine.  Venpulli is a great handicap in the society why because it is visible and 
one of the cosmetic problem also. People with Venpulli (Vitiligo) develop white spots in the 
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skin that vary in size and location. The spots occur when pigment cells, or melanocytes, are 
destroyed and the pigment melanin can no longer be produced. Considerable number of cases 
visited opd for the treatment of Venpulli at Ayothidoss pandithar hospital. 
In the present study the author has taken the Siddha formulations Yaanai Nerunjil 
Chooranam as internal medicine (Reference: Pathartha Guna Vilakkam) and Pathiyaa  
Lebanam as external medicine (Reference: Agathiyar Vaithiya Pillai Tamil).  These drugs are 
indicated for Venpulli noi and their efficacy is not proven till now. These formulations are 
made by easily available herbs in rural India. Hence the author has chosen the above drugs to 
evaluate its therapeutic efficacy in treating Venpulli Noi. Apart from the trial drugs the 
efficacy of Yogam in the treatment of Venpulli noi is also studied. 
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AIM AND OBJECTIVES 
 
Primary aim and objective:   
· To study the efficacy of “Yaanai Nerunjil Chooranam” (Internal medicine) and 
“Pathiyaa Lebanam” (External medicine) in producing repigmentation and reducing 
the size of the depigmented patches in the treatment of “Venpulli” (Vitiligo). 
Secondary objectives: 
· To study the effectiveness of Yogam (Postures and Pranayamam techniques), along 
with the efficacy of “Yaanai Nerunjil Chooranam” (Internal medicine) and “Pathiyaa 
Lebanam” (External medicine) in the treatment of Venpulli (Vitiligo). 
· To study Venpulli on the basis of Siddha parameters, in order to evaluate the 
pathology. 
· To access the predominance of the disease related to age, sex, socio-economic status, 
habits, family history etc. 
· To correlate the aetiology, clinical features, symptoms and signs of Venpulli in 
Siddha system to Vitiligo in Modern science. 
· To evaluate toxicity of the trial drug in animal models to prove the safety of the drug. 
· To do biochemical analysis of the internal drug.  
· To find out any side effect/adverse effect during the trial.  
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REVIEW OF LITERATURE 
SIDDHA ASPECTS 
VENPULLI 
Synonyms: 
Venkuttam, Suvetha Kuttam, Venthittu, Venpadai. 
Definition: 
 Venpulli is defined as the discoloration of the skin characterized by the presence of 
the de-pigmented patches of irregular shape in the epidermis of skin and sometimes hair also 
involved. 
  Siddhar Yugimuni, mentioned this condition as Suvetha Kuttam in the text 
“Yugimuni Vaithiya Chinthamani – 800” which is one among the Eighteen types of Kuttam.  
“¾ÊôÀ¡¸ ¾ÅÇ¿¢Èõ §À¡ø¦Å ÙòÐî 
º÷Å¡í¸Óõ ¦ÅÙò¾¡ü È¡ýÈ¢ ÕõÒõ 
ÁÊôÀ¡¸ ÁÂ¢÷¦ÅÙò¾¡ Äº¡òÂ Á¡Ìõ 
ÅÃ¢×¾Î ×ûÇí¨¸ì Ì¾í ÌöÂó¾¡ý 
¦¿ÊôÀ¡¸ ¦¿ÕôÒôÀð¼Ð §À¡Ä Òñ½¡ö 
¿¢ÈÁ¢Õó¾¡ Äº¡ò¾¢Â¦Áý§È ÔÃì¸ Ä¡Ìõ 
¦ÅÊôÀ¡¸ §ÁÉ¢¦ÂøÄ¡õ ¦ÅÙòÐ Å£í¸¢ø 
¦ÅñÍ§Å¾ Ìð¼¦Áý§È Å¢ÇõÀ Ä¡§Á.” 
- ä¸¢ ÓÉ¢ ¨Åò¾¢Â º¢ó¾¡Á½¢ 800 
Aetiology:  
Siddha system attributes the aetiology of the disease to heredity, stress and strain, 
malnutrition and venereal exposure. No specific causes were mentioned for Venpulli but 
general descriptions have been given. Extrinsic and intrinsic causes have been attributed to 
the manifestation of Venpulli. 
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1) According to “Yugimuni Vaithiya Chinthamani – 800” the causes for the 18 types of 
Kuttam are mentioned as:  
“Å¢ÇõÀ§Å Á¢Ìó¾¯‰ ½ó¾ý É¡Öõ 
   Á¢Ìó¾ º£¾Çò¾¡Ö ÁÆüº¢ Â¡Öõ 
ÅÇõÀ§Å Áó¾ò¾¡ø Å¡ó¾¢ Â¡Öõ 
   Á¸ò¾¡É ¦Àñ§½¡Î ÁÕÅ Ä¡Öõ 
¸¢ÇõÀ§Å ¸¢§Äºí¸û Á¢Ì¾ Ä¡Öõ 
   ¦¸ÊÂ¡É ×Ãì¸í¸Ç ¨¼¾ Ä¡Öõ 
¾ÇõÀ§Å ÁÂ¢Õ¸ü¸û ¾Å¢Î Áñ¸û 
   º¡¾ò¾¢ü ÀÕ¸Ä¡ø Á¢ÌìÌí Ì‰¼õ 
Ìð¼ó¾¡ý À¾¢¦ÉðÎ ÅÃ§Å ¦¾ýÉ¢ü 
   ÌÕ¿¢ó¨¾ º¢Å¿¢ó¨¾ Á¨È§Â¡÷ ¿¢ó¨¾ 
¾¢ð¼ó¾¡ý §¾Å¨¾¨Âò à„¨½ìÌ §Ã¡¾õ 
   ¦ºôÀÄ¡ü È¢Õ¼Ä¡ü ÀÃ¾¡ Ãò¨¾ 
«ð¼ó¾¡ É¡¨ºÂ¡Ä ¨¼ì¸ Äò¨¾ 
   «À¸Ã¢ò¾ Ä¸¾¢ÀÃ §¾º¢ ¾ý¨É 
Åð¼ó¾¡ý ¨Å¾Ä¡ü ¸üÀ Æ¢ò¾ø 
   Åó¾¢Î§Á À¾¢¦ÉðÎì Ìð¼ó ¾¡§É” 
Excessive heat and cold exposure, lazziness, sleep in day time, unbridled sexual 
indulgence, robbery etc. These habits are supposed to be the factors, which lower the immune 
mechanism of the body (Udal vanmai) and makes the body liable for the disease. 
Excessive intake of food which are hard to digest,  frequent intake of food mixed with 
fragments of stone and hair, prolonged mental depression, intention to spoil others, raping, 
greedy, abusing god and noble people, neglecting refuges and beggars, cursing the elders are 
said to the causes for this condition. 
2) According to “Agathiyar Vaithyam” 
“ÌÂøÅ¡ö Ì‰¼õ ºÂíÌýÁ ¿£Ã¢Æ¢× ÍÃì¸¢Ã¡½¢ 
             ¿£Ã¨¼ôÒ À¡ñÎ ãÄ Å¡ö× 
¸Âø Å¡Ô ÅÕí¸ñ½¢ø Ìò¾¡ö ¸Êó¾ ¾ºÅ¡ö× 
             ¸¡½Å¡¸ Óý ¦ºö¾ ¯Â¢÷¸Ùõ Å¢¨É¾¡§É”. 
Kuttam may be hereditary, apart from all other etiological factors Kuttam is also 
considered to be followed by sins committed in the previous birth (Kanma vinai). 
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3) According to “Siddha Maruthuvam Sirappu” 
 The aetiology and the characters of Venpulli  are clearly explained in the text “Siddha 
Maruthuvam Sirappu” as follows: 
In the affected area, reduction or total loss of skin pigment melanin on the epidermis 
is observed. As the distinct aetiology is not known, there exist certain beliefs and hypothesis 
about the disease. They are: 1.Constant irritation to the skin owing to clothes, rubber, plastics 
or other chemical substances. 2. Some essential metal or mineral deficiency in the food 
4) According to “Thirumoolar Karukkadai Vaithiya Nool” 
“Å¢Â¡¾¢Ôñ ãÅ¡Ú Å¢Çí¸¢Â Ìð¼í§¸û 
ÍÂ¡¾¢ì ¸¢Ãó¾¢ ÍÆý §Á¸ò¾¡Ä¡Úõ 
ÀÂ¡¾¢ ÁñÏÇô ÀÄÅñÊÉ¡ ¦ÄðÎõ 
¿¢Â¡¾¢ ÒØ¿¡Ä¡ö ¿¢ýÈ¾¢ì Ìð¼§Á”. 
Among the Eighteen types of Kuttam six are caused by Kirandhi and Megam. Eight 
types are caused by insects in the soil and the remaining four types are caused by Worms.  
Classification: 
1) According to “Yugimuni Vaithiya Chinthamani – 800” 
In “Yugimuni Vaithiya Chinthamani – 800”, Kuttam is classified into 18 types. 
Suvetha Kuttam (Venpadai) is one among them. It is mentioned as below: 
“Óò¾¡Ìí Ìð¼ó¾¡ý À¾¢¦Éð ÎìÌõ 
ÓÉ¢Â¡É ä ¢¸¿¡ý ¦º¡øÄì §¸Ç¡ö 
      Òò¾¡Ìõ Òñ¼Ã£¸ Ìð¼ò §¾¡Î 
       ¦À¡Õ¸¢ýÈ Å¢ü§À¡¼¸ Ì‰¼ Á¡Ìõ 
      Àò¾¡Ìõ ÀÃÁÌ‰¼õ §¸ºÃ Ì‰¼õ 
           ÀÃ¢Å¡É ¸÷½Ìð¼õ º¢ÌÁ Ìð¼õ 
¸¢ò¾¡Ìí ¸¢Õ‰½Ìð¼ «Ð×õÀ÷ Ìð¼õ 
¦¸ÊÂ¡É Áñ¼ÄÌð ¼ÓÁ¡ ¦Áý§É 
Ìð¼Á¡õ ÀÃôÀÃ¢º Ìð¼ ¦Á¡Î  
ÌÊÄÁ¡õ Å¢¸÷îº£¸ Ìð¼ Á¡Ìõ 
Åð¼Á¡õ ¨ÅÂ¡¾¢ Ìð¼ §Á¡Î 
ÁÕÅÄ¡í ¢¸ËÀÌð¼ï º÷Á §¾Åõ 
¾¢ð¼Á¡ §¾ò¾¢Õì Ìð¼ §Á¡Î 
º¢òÐÁ¡ Ìð¼ïº¡ ¸¡ÚÌð¼õ 
Ðð¼Á¡ï Í§Å¾Ìð¼ó ¾ý§É¡ ¦¼¡ì¸î 
ÍÂõÀ¡É À¾¢¦ÉðÎ Ìð¼ Á¡î§º” 
7 
 
1.Pundarega Kuttam   (Padar thamarai Peru Noi) 
2.Virpotaka Kuttam   (Koppula Peru Noi) 
3.Baama Kuttam   (Sirangu Peru Noi) 
4.Gaja Saruma Kuttam  (Yaanaithol Peru Noi, Yaega Saruma Kuttam) 
5.Karna Kuttam   (Kaathu Peru Noi) 
6.Sigura Kuttam   (Thol Peru Noi) 
7.Krishna Kuttam   (Karu Peru Noi) 
8.Avudhumbara Kuttam  (Atthikkaai Peru Noi) 
9.Mandala Kuttam   (Valaiya Peru Noi) 
10.Abarisa Kuttam   (Vali Peru Noi) 
11.Visarchika Kuttam  (Sori Peru Noi) 
12.Vibaathika Kuttam  (Sempadai, Senkuttam) 
13.Kideeba Kuttam   (Pandrithol Peru Noi) 
14.Sarmathala Kuttam  (Tholvedi Peru Noi) 
15.Thethru Kuttam   (Thadippu Peru Noi) 
16.Sithuma Kuttam   (Naa Peru Noi) 
17.Sathaaru Kuttam   (Purai Peru Noi) 
18.Suvetha kuttam   (Venpadai, Venkuttam, Ven Peru Noi). 
2) According to “Siddha Maruthuvam Sirappu” 
According to “Siddha Maruthuvam Sirappu”, Venpulli has been classified into 4 
types: 
1. Vaatha Venpadai 
2. Pitha Venpadai 
3. Kaba Venpadai 
4. Mega Venpadai. 
3) According to “Siddhar Aruvai Maruthuvam” and “Anubava Vaithiya Deva 
Ragasiyam” 
Venpadai has been classified into 3 types on the basis of Mukkutram. They are, 
  1. Vaatha Venpadai  
    2. Pitha Venpadai  
    3. Kaba Venpadai.  
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4) According to “Athma Rakthamirutha Vaithiya Sarasankiraham” 
     Kuttam is classified into 4 types: 
1. Venkuttam 
2. Senkuttam 
3. Karunkuttam 
4. Peru viyathi. 
5) According to “Pararasa Sekaram” 
Kuttam is classified into 5 types: 
1. Venkuttam 
2. Senkuttam 
3. Karunkuttam 
4. Vishakuttam 
5. Azhukannikuttam 
Clinical features: 
1) According to “Yugimuni Vaithiya Chinthamani – 800” 
 Yugimuni shortly attributed the Venpadai under the headline of Suvetha Kuttam 
which is one of the Eighteen kuttams and he mentioned the clinical features of Suvetha 
kuttam as below: 
“¾ÊôÀ¡¸ ¾ÅÇ¿¢Èõ §À¡ø¦Å ÙòÐî 
º÷Å¡í¸Óõ ¦ÅÙò¾¡ü È¡ýÈ¢ ÕõÒõ 
ÁÊôÀ¡¸ ÁÂ¢÷¦ÅÙò¾¡ Äº¡òÂ Á¡Ìõ 
ÅÃ¢×¾Î ×ûÇí¨¸ì Ì¾í ÌöÂó¾¡ý 
¦¿ÊôÀ¡¸ ¦¿ÕôÒôÀð¼Ð §À¡Ä Òñ½¡ö 
¿¢ÈÁ¢Õó¾¡ Äº¡ò¾¢Â¦Áý§È Ô¨Ãì¸ Ä¡Ìõ 
¦ÅÊôÀ¡¸ §ÁÉ¢¦ÂøÄ¡õ ¦ÅÙòÐ Å£í¸¢ø 
¦ÅñÍ§Å¾ Ìð¼¦Áý§È Å¢ÇõÀ Ä¡§Á.” 
Yugimuni gives a clear definition of Venpadai and he mentioned the conditions which 
will not responded to treatment (Asathiyam) as said below: 
1. Whitish discoloration of the part of the body or entire body. Sometimes hair also turns 
white. 
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2. When white patches occur on the palms or muco-cutaneous junctions like lips, anus 
and genitals, it is said to be rarely curable. 
3. If the hair becomes white, prognosis will be very bad. 
4. Fissured body becomes oedematous. 
2) According to “Siddha Maruthuvam Sirappu” 
In the text ‘Siddha Maruthuvam Sirappu’, Venpadai has been classified into 4 types 
and the clinical features are also described: 
I. Vaatham Venpadai 
II. Pitha Venpadai 
III. Kaba Venpadai 
IV. Mega Venpadai. 
I. Vaatham Venpadai: 
 It is characterized by the presence of depigmented patches, which are dry, rough and 
reddish or somewhat pale-black in color. 
II. Pitha Venpadai: 
 It is characterized by the presence of depigmented patches red in color like the flower 
of  thamarai  (lotus flower), spreading with burning sensation and loss of hairs on that area. 
III. Kaba Venpadai:  
               It is characterized by the presence of depigmented patches white in color like the 
flower of Thumbai (Leucas aspera), spreading with itching sensation and mild elevation of 
the lesion. 
IV. Mega Venpadai: 
 It is followed by venereal diseases. It may develop in 4 to 6 months after the venereal 
exposure. This Venpadai develops initially in the nape and the adjoining spaces. It then 
gradually spreads to involve the shoulder joints and back of the trunk. 
  Clinical features: Depigmented patches are small in number, pale in colour or light 
turmeric in colour or dark colour and margins marked by hyperpigmention. These lesions are 
circumscribed with 2 mm to 3 mm diameter or above. This correct picture of depigmented 
and hyperpigmented skin seems to be more or less a multi eyed filter (sieve like). 
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 Females are more prone to this Mega Venpadai and the treatment takes longer period. 
Therefore drugs to be given for the treatment of Mega noi (Venereal disease) before treating 
Venpadai. 
Siddha Pathology: 
            As per Siddha system, the human body is composed of 96 Thaththuvams (constituent 
principle in nature including Panchaboothams and Three Thodams).  
The Siddha system of Medicine is based on the Thrithodam theory. They are 
Vaatham, Pitham  Kabam; the manifestations of all diseases are the result of derangement of 
these Uyir thathus (Thrithodam).  
These three humours are primary and essential factors of human body. These factors 
exist in 1: ½: ¼ ratio respectively in the normal body and this humoural existence is 
responsible for the proper functioning of the body. Any alteration in the above ratio can cause 
disease in the body like, Vaatham disease, Pitham disease and Kabam disease. 
· According to Siddha literature, equilibrium of Vaatham, Pitham and Kabam is 
responsible for the normal color and texture of skin by the way of equilibrium of 
black, yellow and white colour. 
According to Noi Naadal Noi Mudhlal Naadal thirattu, Pitham kurai kunam and Senneer 
kurai kunam result in loss of color and shining of skin. 
· Pitham is responsible for the yellow/ red colour of skin. Pitham kurai kunam leads to 
Ranjaga kuraivu, Prasaga kuraivu and senneer kuraivu. Decreased Ranjagam, 
Pirasagam, and Senneer results in hypo/ depigmentation of skin. 
· According to Theraiyar Pinikalin Mudhar Kaaranam, “without variation in Vaatham, 
body will not be affected”. Owing to defective food habits, Vaatham gets vitiated and 
affects body fluids, blood and other body parts and alters the complexion. 
‘Vaathamalaathu meni kedaathu’ 
-Theran.  
 
 
Prognosis of the disease: 
 The prognosis of the disease is also mentioned in Siddha literature: 
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1) According to the text “Yugimuni Vaithiya Chinthamani – 800”  
curable types - 10: 
“Ìð¼ó¾¡ý À¾¢¦ÉðÊø º¡ò¾¢ Âó¾¡ý 
  ÜÈì§¸û Å¢ü§À¡¼¸ ÀÃÁü Ìð¼õ 
¸¢ð¼ó¾¡ý §¸îº÷Á Ìð¼ §Á¡Î 
  ¸¢Õ‰½ Ìð¼Á×¾õÀ ÃÌð¼ó ¾¡Ûõ 
¾¢ð¼Á¡ó §¾ò¾¢Õì Ìð¼ §Á¡Î 
  ¦ºÂº¢òÐ Á¡Ìð¼í ¸¢ËÀ Ìð¼õ 
¾ð¼ó¾¡ý Á¢Ìó¾º¡ ¾¡Õ Ìð¼õ 
 ºÁ¸¢Õ‰½ Ìð¼õ º¡ò ¾¢ÂÁ¡ ¦Áý§É” 
1. Virpodaga Kuttam 
2. Baama Kuttam 
3. Gaja Sarma Kuttam 
4. Krishna Kuttam 
5. Avuthumbara Kuttam 
6. Thethru Kuttam 
7. Sithuma Kuttam 
8. Kideepa Kuttam  
9. Satharu Kuttam 
10. Sarmathala Kuttam 
Incurable Types - 8: 
“¬¦ÁýÈ ÀòÐó¾¡ý º¡òÂ Á¡Ìõ 
  «º¡òÂ ÁÐ¾¡¦ÉðÎ «È¢óÐ À¡Õ 
§À¡¦ÁýÈ â÷Åò¾¢ý ¸ýÁò ¾¡Öõ 
  ÒÅ¢¾Éì ÌõÁ¢Ì¸ýÁï ¦ºö¾ À¡Åõ 
À¡¦ÁýÈ ¦ÀÃ¢§Â¡÷¸û º¡Àò ¾¡Öõ 
  À¡¾¸í¸û ÁÉ¾È¢Âô ÀñÏõ §À÷ìÌõ  
§¸¡¦ÁýÈ Ìð¼Á¡õ §Ã¡¸õ ÅóÐ  
  ÜÎ¦ÁýÚ ä¸¢ÓÉ¢ ÜÈ¢§É§É”. 
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1. Pundareega Kuttam 
2. Karna Kuttam 
3. Sigura Kuttam 
4. Mandala Kuttam 
5. Abarisa Kuttam 
6. Visarchiga Kuttam 
7. Vibaathiga Kuttam 
8. Suvetha Kuttam 
2) According to the text “Siddha Maruthuvam Sirappu” 
Curable conditions in Venpadai are: 
· Lesions without any change in hair colour. 
· Lesions without coarse texture. 
· Lesions that are not appearing like white burnt scar. 
Incurable conditions in Venpadai are:  
· Lesions with whitened hair. 
· Lesions  feeling rough. 
· Lesion appearing like white burnt scar. 
· If the lesion first appears on genitalia, anus, palms and lips. 
· Lesions of fast spreading nature. 
Management in Siddha: 
  “Á¢¸¢Ûõ Ì¨ÈÂ¢Ûõ §¿¡ö¦ºöÔõ á§Ä¡÷ 
    ÅÇ¢Ó¾Ä¡ ¦Åñ½¢Â ãýÚ”. 
-¾¢ÕìÌÈû. 
According to Siddha System, the main aim of the treatment is to cure Udarpini 
(physical illness) and manappini (mental illness). Treatment is not only for complete healing 
but also for the prevention and rejuvenation. 
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In Siddha system, the line of treatment consists of 
1. Neekkam (Treatment) 
2. Niraivu (Rejuvenation of well being) 
3. Kaappu (Prevention) 
 
1. Neekkam (Treatment): 
 Siddha system of Medicine is based on Mukkutram Theory and hence the treatment is 
mainly aimed to bring the Three Thodams to equilibrium state and thereby restoring the 
physiological condition of the Seven Thathukkal. 
 The Three Thodams organize, regularize and integrate the bodily structure and their 
functions. They are always kept in a state of balance by thought, word, deed and food. Any 
imbalance will lead to disease. The imbalanced Thodams are balanced by administrating 
purgatives or emetics or application of Anjanam (application on eyes) and followed by the 
appropriate systemic therapy by giving Siddha drugs. It mentioned as below: 
          "Å¢§ÃºÉò¾¡ø Å¡¾ó ¾¡Øõ". 
   The purgatives should be given before starting the trial to normalize the deranged 
thodams to normal. In this study the purgation is induced by giving  karudan kizhangu ennai -
5 ml early morning with hot water. 
  Then the next day onwards the trial drugs Yaanai Nerunjil Choornam (Internally) 
Pathiyaa Lebanam(Externally) were given. 
2. Niraivu (Rejuvenation): 
  Physical, psychological, social and economic rehabilitation and reassurance of 
individuals is known as Niraivu.  
3.  Kaappu (Prevention): 
 As per Siddha science, even at the time of conception some defects may occur in the 
fertilized embryo forming the basic for the manifestation of certain constitutional diseases 
after birth. These are known as Kanma vinaigal. 
 Kanma Neekkam (Expiation): To prevent and expiate the misdeeds of the kanmam, 
planting of trees, establishing gardens, laying roads and pathways, digging wells and ponds 
for public use, constructing temples, donating ornaments to poor children must be done. 
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Dietary Advice: 
In Siddha system of medicine the importance of dietary habits also emphasiszed for 
the diseases management and prevention. This line is well understood in these verses, 
“¯½§Å ÁÕóÐ ÁÕó§¾ ¯½×”. 
“ÁÕó¦¾É §Åñ¼¡Å¡õ Â¡ì¨¸ìÌ «Õó¾¢ÂÐ 
«üÈÐ §À¡üÈ¢ ¯½¢ý”. 
In diseased condition diet restrictions or paththiyam are strictly followed to increase 
the effectiveness of medicine and to reduce the incidence of the diseases.  This is given in the 
following verse,  
      “Àò¾¢Âò¾¢É¡§Ä ÀÄý ¯ñ¼¡Ìõ ÁÕóÐ 
Àò¾¢Âí¸û §À¡É¡ø ÀÄý§À¡Ìõ - Àò¾¢Âò¾¢ø 
Àò¾¢Â§Á ¦ÅüÈ¢¾Õõ ÀñÊ¾÷ìÌ ¬¾Ä¢É¡ø 
        Àò¾¢Â§Á ¯ò¾¢¦ÂýÚ À¡÷” 
                               - §¾¨ÃÂ÷ ¦ÅñÀ¡. 
Dietary and other restrictions for Venpulli patients:    
   Diet restrictions or pathiyam should be strictly followed in Venpulli patients. These 
are prescribed to normalize the deranged Thodam and to increase the potency of the drugs. 
Patients are a 
Patients are strictly advised to follow the dietary and other restrictions: 
· Avoid all non-vegetarian foods except goat’s meat.  
· Avoid food items which are enriched with alcohol.  
· Avoid the Sesban, Brinjal, Kaar arisi, Green plantain, Bitter gourd, Pickles, 
Tamarind.  
· Vitamin C rich fruits and vegetables like lemon, goose-berry, orange, etc. Vitamin 
C must be avoided in diet, since in the formation of melanin, tyrosine plays an 
important role. But in the metabolic pathway of tyrosine a metabolic error 
happens due to increased presence of vitamin C (Ascorbic acid). If this error 
occurs continuously the tyrosine cannot be absorbed by the body and is execrated 
through urine. 
· To avoid substances allergic to the particular individual. 
15 
 
· To take Thiridhoda samapporulkal (elam, manjal, seeragam, kaayam, chukku, 
venthayam, poondu, milagu). 
· To take vegetables and green leafy vegetables 
· To take more germinated grams, dates, figs and powder of fenugreek regularly.  
· Using of soaps and detergents should be avoided. To take neutral value pH soaps 
for bath purpose. 
· To use Nalunguma a Siddha herbal preparation which contains sandanam, vetti 
ver, vilamacham ver, kichili kizhangu, karbogi, paasipayiru instead of soap and 
other detergents for bath. 
Special treatments: 
 In Venpulli, patients are advised to do Pranayamam, Dhyanam and Asanams for speedy 
cure and prevention of recurrences. 
1) Yogasanam (Posture): 
Asanam is defined as keeping the body or part of the body steady and motionless in a 
particular posture for a specific time. Regular practice of asanam maintains both physical and 
mental health. 
The specific asanams which are advised to the Venpulli patients are: 
1. Kiriya Gnayiru Vanakkam, (Kiriya Pose of Sun Salutation)  
2. Meditative postures, 
§ Thamarai Asanam (Padmasanam) 
§ Mandi Uruthi Asanam (Vajrasanam) 
3. Shanthi Asanam (Savasanam). 
 The asanams advised to Venpadai patients with thyroid disorders are: 
1. Meenasanam (Machasanam) 
2. Sarvangasanam. 
2) Pranayamam (breathing technique): 
 It is a form of Kayakalpam method and by practicing this, one can prevent many 
diseases. This is mentioned in the verse as: 
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       "²üÈ¢ þÈì¸¢ þÕ¸¡Öõ âÃ¢ìÌõ  
¸¡ü¨Èô À¢ÊìÌõ ¸½ì¸È¢ Å¡Ã¢ø¨Ä 
    ¸¡ü¨Èô À¢ÊìÌõ ¸½ì¸È¢ Å¡Ç÷ìÌ 
  Üü¨È ¯¨¾ìÌõ ÌÈ¢ÂÐ Å¡§Á". 
- ¾¢ÕÁó¾¢Ãõ. 
 The pranayamam techniques advised for Venpulli patients are: 
1. Mathrika Pranayamam, 
2. Omkhara Pranayamam,  
3. Nithirai Pranayamam.          
 These techniques are very helpful to relieve the stress and strain of the patients. Also it 
increases alertness, memory and maintains a clear mind. 
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           MODERN ASPECTS 
Skin Anatomy 
 The human skin is the outer covering of the body and is continuous with the mucous 
membranes in the region of the mouth, nose, urogenital organs and the anus. In an adult the 
skin surface measures 1.5. to 2 m2 while the thickness of the skin varies from fractions of a 
millimeter to 4 mm. The thickness of the epidermis varies from 0.06-0.9 mm to 0.5 – 0.6 mm. 
The thickness of the subcutaneous fat varies considerably. Some area is devoid of fat while in 
others (on the abdomen and gluteal regions). It is several centimeters thick. The mass of skin 
an adult accounts for approximately 5% while together with the subcutaneous fat for about 10 
to 17.7% of the total body mass. 
 The colour of the skin may change because the amount of the pigment in it varies 
under the effects of external and internal factors. 
 The skin surface is covered with hairs over a great area. The areas devoid of hairs are 
the lips, the palms and soles, the palmar surface of the hand and the plantar surface of the 
toes, the glans penis, the inner surface of the prepuce and the inner surface of the labia 
marjoram and minorum. 
 
 
Anatomy of skin (Cross section) 
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Facts about the skin: 
  The skin and external nucleus membranes separate the human organism from the 
environment and accomplish a variety of functions. Normal functioning of the skin and its 
appendages of high significance for the organism activity as a whole and has a positive 
influence on its general condition. 
Skin Histology  
 The skin develops from two germinative zones. The ectoderm which is represented by 
the epidermis (the most superficial skin layer) and the mesoderm (the middle embryonal 
layer) represented by two layers namely the true skin, or dermis (the middle layer) and the 
subcutaneous fat or hypoderm the deepest skin layer. 
 The boundary between the epidermis and dermis and dermis forms a wavy line 
because of the presence of skin papillar (special out growth on the surface of the true skin). 
The spaces between which are filled with epithelial processes. 
Specialized Epidermal Cells 
There are three types of specialized cells in the epidermis 
· The melanocyte produces pigment (melanin)  
· The Langerhans' cell is the frontline defence of the immune system in the skin  
· The Merkel's cell's function is not clearly known 
Epidermis 
The epidermis is the most superficial layer of the skin and provides the first barrier of 
protection from the invasion of foreign substances into the body. The principal cell of the 
epidermis is called a keratinocyte.  
The epidermis is subdivided into five layers or strata, 
The stratum germinativum , 
The stratum spinosum, 
The stratum granulosum, 
The stratum lucidum and 
The stratum corneum in which a keratinocyte gradually migrates to the surface and is 
sloughed off in a process called desquamation. 
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Stratum germinativum 
The whole of the epidermis germinates from this layer hence the name stratum 
germinativum.These germinal cells are separated from the dermis by a thin layer of basement 
membrane. After a mitotic division a newly formed cell will undergo a progressive 
maturation called keratinization as it migrates to the surface. 
Stratum spinosum 
The cells that divide in the statum germinativum soon begin to accumulate many 
desmosomes on their outer surface which provide the characteristic “prickles” (seen on the 
close-up view) of the stratum spinosum, which is often called the prickle-cell layer.  
 
Stratum granulosum 
The progressive maturation of a keratinocyte is charcterized by the accumulation of 
keratin, called keratinization. The cells of the stratum granulosum  accumlate dense 
basophilic keratohyalin granules (seen on the close-up view). These granules contain lipids, 
which along with the desmosomal connections, help to form a waterproof barrier that 
functions to prevent fluid loss from the body. The cells that divide in the statum 
germinativum soon begin to accumulate many desmosomes on their outer surface which 
provide the characteristic “prickles” (seen on the close-up view) of the stratum spinosum, 
which is often called the prickle-cell layer.  
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 Stratum Lucidum 
Epidermis varies in thickness throughout the body depending mainly on frictional 
forces and is thickest on the palms of the hands and soles of the feet. The stratum lucidum is 
normally only well seen in thick epidermis and represents a transition from the stratum 
granulosum to the stratum corneum. 
Stratum corneum 
As a cell accumulates keratinohyalin granules, it is thought that rupture of lysosomal 
membranes release lysosomal enzymes that eventually cause cell death. The dead and dying 
cells filled with mature keratin form the stratum corneum. The deeper cells of the stratum 
corneum retain their desmosomal junctions, but as they are pushed to the surface by newly 
forming cells of the stratum germinativum, the dead cells gradually break apart and are lost, a 
process called desquamation.  
Dermis 
The dermis assumes the important functions of thermoregulation and supports the 
vasular network to supply the avascular epidermis with nutrients. The dermis is typically 
subdivided into two zones, a papillary dermis and a reticular layer. The dermis contains 
mostly fibroblasts which are responsible for secreting collagen, elastin and ground substance 
that give the support and elasticity of the skin. Also present are immune cells that are 
involved in defence against foreign invaders passing through the epidermis. 
Papillary dermis 
The papillary dermis contains vascular networks that have two important functions. 
The first, to support the avascular epidermis with vital nutrients and secondly to provide a 
network for thermoregulation. The vasculature is organized so that by increasing or 
decreasing blood flow, heat can either be conserved or dissipated. The vasculature 
interdigitates in areas called dermal papillae. The papillary dermis also contains the free 
sensory nerve endings and structures called Meissner’s corpuscles. 
Vascular system of Skin: 
 
 Vascular system of the skin is formed of several networks of blood vessels. Large 
arterial vessels stretch from the fascia through the subcutaneous fat and give off small 
branches to the fat lobules. On the boundary of the dermis and hypoderm, they divide into 
branches which stretch horizontally and anastomose with one another. A deep arterial plexus 
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of skin forms, which gives rise to branches supplying the holes of the sweat glands, the hair 
follicles and the fat lobules. The epidermis is devoid of blood vessels. The most powerful 
network of blood vessels is located in the skin of the face, palms, soles, lips, genitals and in 
the skin around the anus. 
 
Lymphatic system of the Skin: 
  The lymphatic system of the skin forms a superficial and deep network. The 
superficial lymphatic network arises on the papillary layer as blind rounded dilated capillaries 
between which there are numerous anastamosis. The second network of lymph vessels is in 
the lower part of the dermis and already has valves. There is a network of wide loops forming 
lymphatic plexus and deeper parts are continuous with lymph trunks. 
Skin Physiology The skin is the body's largest organ, covering the entire body. In addition 
to serving as a protective shield against heat, light, injury, and infection, the skin also. 
· regulates body temperature. 
· stores water and fat. 
· functions as sensory organ. 
· prevents water loss. 
· Secretion and excretion 
· Absorption 
· gaseous exchange 
FUNCTIONS OF SKIN: 
Sl. 
No FUNCTIONS STRUCTURE 
1 Barrier protection:  
   UV rays Melanocytes 
 Infection & Fluid homeostasis Keratinocytes 
 Protection from trauma Epidermis & dermis 
2 Thermoregulation Blood vessels in superficial & deep dermal plexus 
3 Immuno regulation Langerhans cells &Inflammatory cells of all types 
4 Sense perception  
 Pain, touch,temperature Peripheral nerve trunks 
 Pressure Pacini vater corpuscles 
 Discriminant touch Meissners corpuscles 
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Melanocytes 
Melanocytes are derived from stem cells in the neural crest that normally migrate to 
the epidermis, where they are scattered along the basal layer. Melanocytes produce melanin 
within cytoplasmic packets called melanosomes. These contain greater amounts of melanin in 
darker skinned individuals. The melanin is distributed to keratinocytes via dendrites when 
stimulated by exposure to ultraviolet radiation and other factors.  
Melanin 
Melanin – Dervied from the Greek word Melas, meaning black. 
Melanin is a complex black-brown polymer synthesized from the aminoacid L-
DOPA. 
Melanin is endogenous nonhaemoglobin derived or brown black pigment (formed). 
When the enzyme tyrosinase catalyses the oxidation of tyrosin to dihydroxy phenylalanine 
(DOPA) in melanocytes.  
Melanin layer of skin: 
 
Distribution 
It is widely distributed in the body but peculiarity enough it is limited only to those 
structures which have got an ectodermal origin, for skin, hair, choroid coat of retina and 
substanita nigra of the brain.  It is formed from tyrosine by oxidation metabolism and 
polymarization. 
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Pigmentation of the Skin 
The colour of the skin may be brown or even black according to the amount of 
pigment present. Even in white races most parts of the skin contain brown pigment granules 
in the deepest layers of the germinative zone of the epidermis. In dark races they are more 
abundant and extend through out the whole zone. 
 
Melanin Formation 
 Melanin synthesis is initially catalysed by a copper containing enzyme known as 
tyrosinase.  The broad of melanin synthesis from the oxidation of phenylalanine or tyrosine 
are as follows. 
1. Tyrosine            DOPA             DOPA   quinone 
2. DOPA – quinone               2-Carboxy 2, 3 – dihydro – 5, 6 – dihydroxyindole 
           2 – Carboxy – 2, 3 – dihydro – indole – 5, 6 – quinone          5, 6 Dihydroxyindole. 
3. 5, 6 Dihydroxyindole              Indole - 5, 6 Quinone                  Melanin 
 Melanin produced in the melanocytes is donated via their dendrites to neighbouring 
keratinocytes.  Melanin formation in both human and amphibian skin is augmented by the 
hormone known as intermedin or melanocyte – stimulating hormone (MSH) secreted by the 
pars intermedia of the pituitary gland. Adrenocartico tropic hormone (ACTH) secreted by 
Anterior Pituitary has melanocyte – stimulating activity similar to MSH although to a much 
lower degree. Melatonin extract from bovine pineal gland, causes concentration of melanin 
near the nuclei of melanocytes in frog and as a result of this the skin becomes paler. Its role in 
the human is not known. MSH causes the serum copper to rise and this is accompanied by 
inner case in the melanin formation. Diminished formation of melanin is seen in albinism and 
leucoderma. In melanotic sarcoma, melanin may be found in the urine. 
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Vitiligo 
The name ‘vitiligo’ is derived from the Latin word skin eruption, victim meaning a 
blemish (spoil the beauty of) happens to be a synonym for it. White skin is the literal meaning 
of leucoderma, derma being derived from the greek words, leucas and dermis. Leucas means 
white and dermis means skin. Celeus was the first Roman physician of the 2nd century to coin 
the word vitilligo, because the disease resembles the white patches of a spotted calf (vitelus). 
Vitiligo is characterized by the presence of non-pigmented areas of irregular shape, 
which develop on the epidermis of skin and hair.  
Definition 
Vitiligo is a common skin disorder in which there is focal failure of pigmentation due 
to destruction of melanocytes that is thought to be mediated by immunological mechanism. It 
is characterized by sharply demarcated, milky white patches with Hyperpigmented borders. 
It is quite clear that vitiligo is due to some derangement in the pigment metabolism 
resulting in appearance of white patches in the skin. It is hard to say whether the site of 
derangement is usually general or local, but the main affected part is the skin, which is the 
most exposed part of the body. It can be examined by naked eye and can furnish a lot of 
information about the person and the disease.  
Epidemiology 
Vitiligo is an acquired idiopathic depigmentary condition, which though worldwide in 
distribution is most common in India, Egypt, and other tropical countries.If affects all age 
groups with no predilection to either sex. 
About 0.5 to 1 percent of the world's population, or as many as 65 million people, 
have vitiligo. 
Vitiligo affects 8.8% of population in India. 
It is present in adult life in 25% of patients. 
Gross Anatomical Changes in Vitiligo 
Vitiligo represents an acquired patchy loss of pigments of the skin. There are no gross 
changes seen except irregularly demarcated depigmented patches of varying size, usually 
surrounded by hyper pigmented skin. These are seen distributed symmetrically or 
asymmetrically at various parts of the body. 
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Histopathalogic Changes in Vitiligo 
Marked histological changes do not occur in cases of vitiligo. All the layers of the 
epidermis and dermis appear normal except a few changes which can be seen after special 
stains. 
Absence of melanocytes 
Negative silver stain for melanin 
Negative dopa reaction 
Lymphocytic inflammation may be seen 
Melanophages may be seen. 
In the affected area the basal cells and the keratinzing cells of the other layers of 
epidermis do not contain melanin pigment granules in them.  
At the border of the patches of vitiligo the melanocytes often appear large and posses 
long dendritic process filled with melanin granules. Electron microscopic studies confirm the 
absence of melanocytes in areas of long standing vitiligo. 
There are collections of monomuclear cells at dermo epidermal junction at the border 
between vitilliginous and normal skin. These cells are predominately small lymphocytes. In 
the long standing cases where the skin has become thick and scaly, varying amount of 
keratosis is seen. 
Pathophysiology 
Vitiligo is a multifactorial polygenic disorder with a complex pathogenesis. It is 
related to both genetic and nongenetic factors. Although several theories have been proposed 
about the pathogenesis of vitiligo, the precise cause remains unknown. Generally agreed upon 
principles are an absence of functional melanocytes in vitiligo skin and a loss of 
histochemically recognized melanocytes, owing to their destruction. However, the destruction 
is most likely a slow process resulting in a progressive decrease of melanocytes.  
Theories regarding destruction of melanocytes include autoimmune mechanisms, 
cytotoxic mechanisms, intrinsic melanocyte defects, oxidant-antioxidant mechanisms, and 
neural mechanisms. 
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· Autoimmune and cytotoxic hypotheses: Aberration of immune surveillance results in 
melanocyte dysfunction or destruction.  
· Neural hypothesis: A neurochemical mediator destroys melanocytes or inhibits 
melanin production.  
· Oxidant-antioxidant mechanisms: An intermediate or metabolic product of melanin 
synthesis causes melanocyte destruction.  
· Intrinsic defect of melanocytes: Melanocytes have an inherent abnormality that 
impedes their growth and differentiation in conditions that support normal 
melanocytes. 
Autoimmune destruction of melanocytes: 
The autoimmune theory proposes alteration in humoral and cellular immunity in the 
destruction of melanocytes of vitiligo. 
The most convincing evidence of an autoimmune pathogenesis is the presence of 
circulating antibodies in patients with Vitiligo.The role of humoral immunity is further 
supported by the observation that melanocytes are destroyed in healthy skin engrafted onto 
nude mice injected with vitiligo patient sera.  
In addition to the involvement of humoral immune mechanisms in the pathogenesis of 
vitiligo, strong evidence indicates involvement of cellular immunity in vitiligo. Destruction 
of melanocytes may be directly mediated by autoreactive CD8+ T cells. Activated CD8+ T 
cells have been demonstrated in perilesional vitiligo skin. In addition, melanocyte-specific T 
cells have been detected in peripheral blood of patients with autoimmune vitiligo.  
Thyroid disorders, particularly Hashimoto thyroiditis and Graves disease; other 
endocrinopathies, such as Addison disease and diabetes mellitus; and alopecia 
areata; pernicious anemia; inflammatory bowel disease; psoriasis; and autoimmune 
polyglandular syndrome are all associated with vitiligo. 
Intrinsic defect of melanocytes 
Vitiligo melanocytes may have an intrinsic defect leading to melanocyte death. These 
melanocytes demonstrate various abnormalities, including abnormal, rough endoplasmic 
reticulum and incompetent synthesis and processing of melanocytes. In addition, homing-
receptor dysregulation has also been detected. Early apoptosis of melanocytes has also been 
suggested as a cause of reduced melanocyte survival; however, subsequent investigation 
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found that the relative apoptosis susceptibility of vitiligo melanocytes was comparable with 
that of normal control pigment cells.  
Disturbance in oxidant-antioxidant system in vitiligo  
Oxidant stress may also play an essential role in the pathogenesis of vitiligo. Studies 
suggest that accumulation of free radicals, toxic to melanocytes leads to their destruction. 
Because patients with vitiligo exhibit a characteristic yellow/green or bluish fluorescence in 
clinically affected skin, this led to the discovery that the fluorescence is due to accumulation 
of 2 different oxidized pteridines. The overproduction of pteridines led to the discovery of a 
metabolic defect in tetrahydrobiopterin homeostasis in patients with vitiligo, which results in 
the accumulation of melanocytotoxic hydrogen peroxide. 
Because oxidative stress has been suggested to be the initial pathogenic event in 
melanocyte degeneration, several studies have been conducted to evaluate this theory. Recent 
investigations set out to evaluate the role of oxidative stress by measuring levels of the 
antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT) in lesional and normal 
skin of patients with vitiligo and in the skin of normal control subjects. They concluded 
oxidative stress is increased in vitiligo, as indicated by high levels of SOD and low levels of 
CAT in the skin of vitiligo patients. 
Neural theory 
Case reports describe patients afflicted with a nerve injury who also have vitiligo have 
hypopigmentation or depigmentation in denervated areas. Additionally, segmental vitiligo 
frequently occurs in a dermatomal pattern, which suggests that certain chemical mediators are 
released from nerve endings that affect melanin production. Further, sweating and 
vasoconstriction are increased in depigmented patches of vitiligo, implying an increase in 
adrenergic activity. Finally, increased urinary excretion of homovanillic acid and 
vanilmandelic acid (neurometabolites) has been documented in patients with vitiligo. This 
may be a secondary or primary phenomenon. 
In summary, although the ultimate cause of vitiligo is not completely known, this 
condition does not reflect simple melanocyte loss, but possible immunologic alterations and 
other molecular defects leading to pigment cell destruction; however, melanocytes may be 
present in depigmented skin after years of onset and may still respond to medical therapy 
under appropriate stimulation. 
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Genetics of vitiligo  
Vitiligo is characterized by incomplete penetrance, multiple susceptibility loci, and 
genetic heterogeneity. The inheritance of vitiligo may involve genes associated with the 
biosynthesis of melanin, a response to oxidative stress, and regulation of autoimmunity.  
Human leukocyte antigens (HLAs) may be associated, but not in a consistent manner. 
For example, HLA-DR4 is increased in blacks, HLA-B13 is increased in Moroccan Jews, and 
HLA-B35 is increased in Yemenite Jews. An association with HLA-B13 is described in the 
presence of antithyroid antibodies. 
A genome-wide association study of generalized vitiligo in an isolated European 
founder population identified that the group had significant association with single-nucleotide 
polymorphisms in a 30-kb LD block on band 6q27, in close vicinity to IDDM8, which is a 
linkage and an association signal for type I diabetes mellitus and rheumatoid arthritis. Only 
one gene, SMOC2, is in the region of association, within which SNP rs13208776 attained 
genome-wide significance for association with other autoimmune diseases and vitiligo 
 
Important known causative factors are: 
· Nutritional – defects in copper, proteins and vitamins in diet, digestive upsets like 
amoebiasis, helminthics, chronic diarrhoea, dysentery etc., 
· Endocrines – Association with thyrotoxicosis and diabetes. 
· Trophoneurosis and autonomic imbalance – emotional stress and strain. 
· Infections and toxic products, Enteric fever ill health, focal sepsis. 
· Drugs and chemicals – like quinines, guano furacin, amylphenol, chlorthiazide broad 
spectrum antibiotics and chloroquin. 
Chemicals are known to inhibit melanogenesis, enzymatic actions and several chain 
biochemical reactions. They can also cause interference with nutrition of the tissues. Hence 
tie up of the chemicals and nutrition may provide the answer. Role of food adulterants, 
industrial chemicals and dyes, contaminating water and foods may be guess work at this stage 
but may prove to be ultimate causes. 
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Hereditary Factors 
· Vitiligo has a genetic background.   
· >30% of affected individuals have reported vitiligo in a parent, sibling or child. 
· Vitiligo in identical twins has been reported. 
· Transmission is most likely polygenic with variable expression. 
· The risk of vitiligo for children of affected individual is unknown but may be <10% 
· Familial incidence has been reported in 7.5 to 21% in India and 33 to 40% in western 
countries. 
Psychology of vitiligo Patients 
             White patches of vitiligo can affect emotional and psychological well-being and self-
esteem. People with vitiligo can experience emotional stress, particularly if the condition 
develops on visible areas of the body.  
 The main symptom of vitiligo is the appearance of lesions, with an often distressing 
sense of disfigurement and associated stigma. Social isolation, reduced sense of worth, 
adverse effects on education, occupation, and personal relationships and depressive illness 
can be consequences 
 Although vitiligo is usually not harmful medically, its emotional and psychological 
effects can be devastating. In fact, in India, women with the disease are sometimes 
discriminated against in marriage. Developing vitiligo after marriage can be grounds for 
divorce. This disease attaches a social stigma. Inferiority complex immediately following the 
start of disease, the patient thinks himself inferior to those with whom he was at par or 
excelled for so long. Naturally, at the beginning the individual tries to hide the patches of 
lesion and when fails in this effort, the individual often feels shy of friends and relatives. 
Psychosis: 
As the patient tries to feels shy of the surrounding environment, he may gradually feel 
more and more lonely and withdrawn, ultimately plunging in to a state. 
Anxiety:  
As the disease spreads it may give rise to a state of acute anxiety and insomnia, mixed 
with depression. 
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Pathology: 
Chemically melanin pigment is a group of chromo proteins with coloured prosthetic 
groups, which is derived from the precursor tyrosine in the following way, Tyrosine Tyrinase 
Dihydroxy phenylalanin (DOPA) Melanogenase Melanin (Dopa oxidase). 
Melanin + Protein = Melano protein 
In the skin, the pigment is produced by the melanocytes of their precursor 
melanoblasts. The melanoblasts are supposed to be derived from the cells of neuro 
ectodermal origin during the embryonic life. After birth, these cells migrate to their definitive 
position. The melanocytes appear as clear cells within the basal cell layer of the epidermis 
and show dendritic processes after special staining. These processes come in contact to 
similar process of other melanocytes and epithelial cells through which the melanin pigments 
are donated to the basal cells of epidermis. The dermis of normal skin also shows 
macrophages containing melanin pigments known as melanophores, which are incapable to 
produce the melanin pigments. 
Both the melanocytes and melanoblasts contain the enzyme melanogenase or Dopa 
oxidase, and they are able to convert dihydroxy phyenylalanine into melanin and such cells 
are called DOPA positive. 
In Behl’s practice of Dermatology, it is shortly described. A defect in enzyme 
tyrosinase is held responsible for vitiligo. According to some, it is a metatarin; a substance 
secreted at nerve endings inhibits tyrosinase, thus interfering in pigment formation.                  
DOPA staining shows that melanocytes are deficient. In active cases mononuclear hugging at 
the junction of the lesion and normal skin is a prominent feature. 
Causes of Hypo pigmentation 
Leukoderma can be subdivided in to melanocytopenic and melanopenic disorders. 
Melanocytopenic disorders: Melanocytes are decreased in number or absent. e.g  Vitiligo. 
 
Melanopenic disorders: Absence or reduction in the amount of melanin .  Melanocytes are 
present although not functioning   properly. e.g.  Albinism  
Generalised depigmentation is found mostly in albinos. In this case, the characteristic 
dendritic melanocytes are present in the skin, but they are unable to produce melanin pigment 
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due to defective tyrosinase activity. In albinis, the skin looks milky white, the hairs are pale 
looking and the iris is transparent. This generalized pallor is also noticed in 
panhypopituitiarism, male eunuchoidism and phenyl ketonuria. 
Vitiligo in patients in whom the disease spreads very fast or those having halo-navi or 
malignant melanoma is believed to be based on auto-immune mechanisms, where auto 
antibodies or sensitized lymphocytes are supposed to act on the melanocytes.  
Leucoderma is also commonly seen on the flanks of ladies wearing tight petticoat 
strings where the prolonged pressure is presumed to lead to depigmentation. Sometimes 
vitiligo can be caused by the action of monobenzyl ether of hydroquinone which is present in 
the slippers, gloves (or) other articles made of rubber. Recently vitiligo has also been 
observed to occur from plastic slippers as well as plastic ‘bindis’. 
CLINICAL FEATURES: 
Vitiligo manifests as acquired white or hypopigmented macules or patches. The onset 
is slow and the course insidious but enigmatic. It may continue to increase slowly or come to 
a half and then increase again. It is reported that the malady usually starts and increasing in 
the summer months in northern India. 
The lesions are usually well demarcated, and they are round, oval, or linear in shape. 
The borders may be convex.  
 Lesions enlarge centrifugally over time at an unpredictable rate. Lesions range from 
millimeters to centimeters in size. Initial lesions occur most frequently on the hands, 
forearms, feet, and face, favoring a perioral and periocular distribution.  
Vitiligo lesions may be localized or generalized, with the latter being more common 
than the former.       
  Localized vitiligo is restricted to one general area with a segmental or 
quasidermatomal distribution. Generalized vitiligo implies more than one general area of 
involvement. In this situation, the macules are usually found on both sides of the trunk, either 
symmetrically or asymmetrically arrayed. 
The most common sites of vitiligo involvement are the face, neck, and scalp. Many of 
the most common sites of occurrence are areas subjected to repeated trauma, including the 
following: 
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· Bony prominences  
· Extensor forearm  
· Ventral wrists  
· Dorsal hands  
· Digital phalanges 
Involvement of the mucous membranes is frequently observed in the setting of 
generalized vitiligo. Vitiligo often occurs around body orifices such as the lips, genitals, 
gingiva, areolas, and nipples. 
Body hair (leukotrichia) in vitiliginous macules may be depigmented. Vitiligo of the 
scalp usually appears as a localized patch of white or gray hair, but total depigmentation of 
all scalp hair may occur. Scalp involvement is the most frequent, followed by involvement of 
the eyebrows, pubic hair, and axillary hair, respectively. Leukotrichia may indicate a poor 
prognosis in regard to repigmentation. Spontaneous repigmentation of depigmented hair in 
vitiligo does not occur. 
v Vitiligo is most noticeable in the summer when the normal skin is tanned by the sun. 
The white areas having not protected pigment are easily made red and sore by 
exposure to sun or artificial ultraviolet light. 
v Early lesions may be pale white and ill defined. At this stage, wood’s lamp helps to 
confirm the diagnosis. Patches enlarge slowly and may affect the whole body. 
Patients skin is susceptible to even minor trauma, it heals with depigmentation. 
v At time lesions develop along the distribution of a peripheral nerve, zosteriform 
vitiligo. It is interesting sometimes to see a bunch of hair burning in that area of skin. 
v Occasionaly, vitiligo develops around pigmented moles – ‘Halo naevus’. 
v Haemoglobin content of the blood is low and sometimes intestinal parasites and 
infections can be detected. Patients complaint of easy fatiguability.  
v Vitiligo sometimes disappears spontaneously after months or years but more usually 
the conditions spreads slowly and may eventually involve nearly the whole of the 
skin. 
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Clinical variants 
a. Trichrome vitiligo has an intermediate zone of hypochromia located between the 
achromic center and the peripheral unaffected skin. The natural evolution of the 
hypopigmented areas is progression to full depigmentation. This results in 3 shades of 
color—brown, tan, and white—in the same patient 
b. Zosteriform: Unilateral distribution of lesions, preferably along the course of  
nerves. 
c. Koebner phenomenon is defined as the development of vitiligo in sites of specific 
trauma, such as a cut, burn, or abrasion. Minimum injury is required for Koebner 
phenomenon to occur. 
Clinical classifications of vitiligo 
The classification system is important because of the special significance assigned by 
some authorities to each type of vitiligo. The most widely used classification of vitiligo is 
localized, generalized, and universal types and is based on the distribution, as follows:  
Localized vitiligo  
· Focal: This type is characterized by one or more macules in one area, most commonly 
in the distribution of the trigeminal nerve.  
· Segmental: This type manifests as one or more macules in a dermatomal or 
quasidermatomal pattern. It occurs most commonly in children. More than half the 
patients with segmental vitiligo have patches of white hair or poliosis. This type of 
vitiligo is not associated with thyroid or other autoimmune disorders.  
· Mucosal: Mucous membranes alone are affected. 
Generalized vitiligo  
· Acrofacial: Depigmentation occurs on the distal fingers and periorificial areas.  
· Vulgaris: This is characterized by scattered patches that are widely distributed.  
· Mixed: Acrofacial and vulgaris vitiligo occur in combination, or segmental and 
acrofacial vitiligo and/or vulgaris involvement are noted in combination. 
Universal vitiligo: This is complete or nearly complete depigmentation. It is often 
associated with multiple endocrinopathy syndromes. 
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Classification of vitiligo by progression, prognosis, and treatment  
When progression, prognosis, and treatment are considered, vitiligo can be classified 
into 2 major clinical types: segmental and nonsegmental, as demonstrated in the images 
below. 
· Segmental: This usually has an onset early in life and rapidly spreads in the affected 
area. The course of segmental vitiligo can arrest, and depigmented patches can persist 
unchanged for the life of the patient.  
· Nonsegmental: This type includes all types of vitiligo, except segmental vitiligo.12  
Clinical Criteria for Classification on Vitiligo  
Stage of Clinical Features 
Vitiligo 
Active (V1)    
i)   New lesions developing 
           ii)   Lesions increasing in size 
           iii)  Border ill defined 
Quiescent (V2)  
i)  No new lesions developing 
      ii)  Lesion stationary in size 
     iii)  Border hyperpigmented and well-defined. 
Improving (V3) 
          i)  Lesions decreasing in size 
       ii)  No new lesions developing 
      iii) Border defined and signs of spontaneous regimentation (follicular and 
peripheral) 
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Causes of Localised Hypopigmentation 
Vitiligo Destruction of melanocytes; common; acquired, multiple sharply   
defined nonpigmented patches any where. 
Pityriasis versicolor Superficial fungus infection leading to disturbance in pigment 
production, common multiple pale scaling patches on trunk 
Pityrisis alba Mild patchy eczema of the face in children causing a disturbance 
in pigment production. 
Leprosy One or several paler macules on trunk or limbs that are 
hypoaesthetic. 
White macules of 
affecting tuberous 
sclerosis 
Uncomming development of anomaly of CNS, connective tissue 
and skin; several “maple leaf” shaped hypopigmented macules. 
Postinflammatory 
hypopigmentation 
After inflammatory skin  disease (after eczema or trauma to the 
skin; irregular in shape and in depth of pallor). 
Naevous  anaemicus  Rare developmental solitary white patch uaually on trunk; thought 
to have vascular basis. 
Chemical toxicity May look very much like vitiligo; seen in workers in rubber 
industry exposed to parateriary  benzyltoluence. 
Diagnosis: 
1) The distribution, the age of onset and the hyper pigmented border will suggest the 
diagnosis. 
2) Vitiligo areas are milky white while other lack this milky white colouration. 
3) It is usually apparent. In doubtful and early case, Wood’s lamp is great help in 
diagnosis. 
4) Usually in macularleprosy, seborrhoeides, pityriasis versicolour and nevoid 
condition, its assistance is called for. 
5) In piebaldism the lesions are present at birth, are usually confined to the head and 
trunk and rarely show a hyperpigmented border. 
6) Careful examination of the texture of the unpigmented skin should exclue lichen 
sclerosus and scleroderma. 
7) Post-inflammatory leucoderma, which is frequent in the darker races, shows an 
irregular mottling of hyper pigmented and hypopigmented blotches. 
36 
 
8) Hypomelanosis of the affected skin is commonly seen in pityriasis alba, producing 
slightly scaly areas with rather ill defined edges of children’s faces. 
9) Hypopigmented, slightly scaly macules are seen in pityriasis versicolor.  
10)  Stationary patches are well-defined and have hyperpigmented borders. 
11)  Sensations are normal, so is texture unless the patches have been irritated with 
treatment. 
12)  Absence of scaling, crusting and itching help to eliminate seborrhoeids and 
pityriasis versicolor. 
13)  These areas often fluorescence a golden yellow when examined under a Wood’s 
lamp. The hypomelanotic macules in leprosy are anaesthetic. 
14) Examination of the skin in long wave UVR helps distinguish whether there is total 
depigmenation (as in Vitiligo) or not. It may also detect areas of depigmenation not 
easily seen in ordinary daylight, as well as detecting a lemon-yellow fluorescence 
seen in some cases of pityriasis versicolor. 
Prognosis 
It has improved considerably in recent years because of better understanding of 
etiological factors and advances made in theraphy. Analyses of cases which have failed to 
respond have usually shown the following features: 
1) Poor nutritional state or digestion, use of broad – spectrum antibiotics over long 
periods. Emotional stress and nervous debility. 
2) Presence of vitiligo on resistant sites like the hands and the feet, front of wrists, the 
elbows, the waist, the eyelids and lips. 
3) Depigmented hair in vitiliginous areas. 
Treatment 
In many cases the onset of venpulli and periods of active extension of pigment loss 
occasionally seem to be related to periods of severe physical or emotional stress. So from 
this, it is understood that mental helath is very much important in treatment. 
Therefore before treating the patients with the drug it is necessary to make the patient 
mentally fit. The mental fitness of a patient chiefly depends on his family so that the family 
members aware that it is just depigmentation of the skin and neither it is neither contagious 
nor any dangerous disease. 
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In 6% of those who had perinicious anaemia the haemoglobin content in blood is low. 
So the patients’ nutritional state has to be increased as high as possible. This is very particular 
when venpadai is active and progressively increasing. 
Highly nutritious food like spinach, pomegranate, cheese, butter, milk, almond, 
germinating grams and foods rich in tyrosinase to be added. 
Vit-C (Ascorbic acid) must be avoided in diet, since in the formation of melanin, 
tyrosine, plays an important role. But in the metabolic pathway of tyrosine a metabolic error 
happens due to the presence of vitamin C (Ascorbic acid). If this error happens continuously 
the tyrosine cannot be absorbed by the body and is excreted through urine. 
Treatment:  
The main goal of treating Vitiligo is to improve appearance. The choice of therapy 
depends on the number of white patches; their location, sizes, and how widespread they are; 
and what you prefer in terms of treatment. Each patient responds differently to therapy, and a 
particular treatment may not work for everyone. Current treatment options for Vitiligo 
include medication, surgery, and adjunctive therapies (used along with surgical or medical 
treatments). 
Medical therapies: 
1. Topical steroid therapy: 
2. Psoralen photochemotherapy:  
3. Depigmentation: 
Surgical therapies: 
1. Autologous skin grafts: 
2. Skin grafts using blisters: 
3. Micropigmentation (tattooing): 
4. Autologous melanocyte transplants: 
Diet and restrictions:  
v Occupation 
v Cosmetic things 
v Diet 
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During bathing – the powder of Bengal gram and green gram or any other  herbal 
products can be used. 
If any one above is the reason for allergy it must be avoided. 
v Vinegar, cooking soda, food enriched with alcohol must be avoided. These items may 
promote bleaching of skin pigment. 
v Using soaps and detergents also promote bleaching of skin. 
v Copper and zinc content vegetable such as cooked greengram or Bengal gram at least 
one time a day. 
v The role of copper in skin pigmenation can be well understood in terms of necessity 
of copper for tyrosinase activity. Loss of pigments has been repored in acute zinc 
deficiency. Also reported in vitiligenous skin, zinc and copper contents are decreased. 
v Venpulli is also commonly seen on the flanks of ladies pressure is presumed to lead to 
depigmentation. 
v Avoid  Irritant cosmetic things. 
v  Avoid Rubber slipper, gloves etc.  
At the time of discharge all the fourty patients were advised to attend the out patient 
department for follow up study. 
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PREPARATION AND PROPERTIES OF TRIAL DRUGS 
  INTERNAL MEDICINE: YAANAI NERUNJIL CHOORANAM 
 (Reference: Pathartha guna vilakkam(page no 627-628) 
Ingredients: 
Whole plant of Yaanai Nerunjil 
Method of Purification of Raw drugs: 
The leaves are wiped by a clean, dry cotton cloth. The roots are washed with pure 
water and dried well.    (Reference: Chikicha Rathana Deepam Pg No :28) 
Method of preparation: 
The purified Yaanai Nerunjil Samoolam are dried in the shadow. The dried samoolam 
are grounded into fine powder and then it is sieved by using a fine silk cloth (Vasthrakayam). 
The fine powder is mixed with milk and placed in a cloth which is placed in a vessel 
containing milk with equal amount of water. This is to be closed by another vessel. This 
instrument is subjected to heat (Pittavial method). Then it is dried and then filtered by a 
cotton cloth. The fine powder is stored in a clean, dry air tight glass bottle. 
Dosage:        2-5gm (twice a day) 
Vehicle:       Water 
Duration:     48 days 
EXTERNAL MEDICINE:  PATHIYAA LEBANAM 
                      (Reference: Agasthiyar Vaithiya Pillai Tamil)  
Ingredients: 
 Manjal kadukkai (Terminalia chebula)   -35 gm 
 Kadugu (Brassica juncea)                               -35 gm 
 Vellalari verpattai (Nerium odorum)              -35 gm 
            Veppaver pattai(Azadirachta indica)          -35 gm 
Karbogarasi(Psoralea cordifolia)                -35 gm 
Induppu (sodium chloride impura)             -35 gms 
Method of preparation:                                        
The above said raw drugs are powdered and then it is ground in a Kalvam by adding 
Cow’s urine and made into a paste form. This paste is used externally.                     
  
40 
 
    PROPERTIES OF TRIAL DRUGS 
YAANAI   NERUNJIL  
 
Botanical name:  Pedalium murex 
Family                :Pedaliaceae 
Useful part          :Whole plant 
Organoleptic Characters: 
 Taste         -Thuvarppu ( astrigent) 
 Potency     -Seetham 
 Pirivu        -Inippu(sweet) 
Actions: 
    Refrigerant 
   Diuretic 
Demulcent 
Tonic 
Aphrodisiac 
Astrigent 
General properties: 
       “§Á¸ò¨¾ô §À¡ì¸¢Å¢Îõ ¦ÅñÌð¼ó ¾¡¦É¡Æ¢ìÌó 
§¾¸ò¾¢ü ¸øÄ¨¼ô¨Àò ¾£÷ìÌí¸¡ñ-¿¡¸ò¾¡ó 
§¾¨ÉÂÕõ À¡¨¸ò ¾¢ÕòÐí ¸¢Ç£ ¦Á¡Æ¢§Â! 
Â¡¨É ¦¿Õïº¢ ÄÐ .” 
                              -   «¸ò¾¢Â÷Ì½Å¡¸¼õ 
Chemical Constitutions: 
 Oleic acid, n-hexa-deconic acid, linoleic acid, malvolic acid, palmitic acid, stearic 
acid . Oleic  acid  has  anti-inflammatory  activity,  n-Hexadeconic  acid  (Palmitic  acid)  has  
anti-oxidant, hypocholesterolemic, nematicide  and  pesticide  activities.  Pedalitin  (3,4’,5,6  
tetrahydroxy-7-methoxyflavone),  diosmetin  and  dinatin  isolated  from  the  leaves  of 
Pedalium  murex. (Tayal  and  Dutt,  1939).  
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5,7-  dimethoxy  -2’.  4’.  5’  –  trimethoxyflavone  and tricontanyl  dotriacontanoate  
along  with  lutcolin,  rubusic  acid  and nonacosane-β-D-glucoside  isolated  from  fruits  of 
Pedalium  murex  (Rastogi and Mehrotra, 1992)                                             
KADUKKAI 
English Name  : Chebulic myrobalan. 
Botanical Name  : Terminalia chebula. Retz. 
Family   : Combretaceae 
Part used   : Dry fruit 
Organoleptic characters: 
Taste      : Astringent, sweet, sour, acrid, bitter. 
Potency     : Veppam ( Hot) 
Pirivu  : Inippu( Sweet ) 
Phytochemicals: 
· Chebulinic acid 
· Gallic acid 
Activities: 
· Astringent 
· Laxative 
· Fungicidal 
· Bactericidal 
General Characters: 
“¾¡¨¼ ¸Øò¾ì¸¢ ¾¡Ö ÌÈ¢Â¢Å¢¼ô 
À£¨¼ º¢Ä¢À¾Óü §À¾¢Ó¼õ - ¬¨¼¦Âð¼¡ò 
àÄÁ¢Ê ÒñÅ¡¾ §º¡½¢¸¡ Á¡¨ÄÂ¢Ãñ 
¼¡ÄÁ¢Ê §À¡õÅÃ¢ì¸¡ Â¡ø”. 
     -   «¸ò¾¢Â÷Ì½Å¡¸¼õ 
Uses: 
 It is used in fever, cough, rheumatism, urinary tract diseases, and scorpion stings.13 
CHEMICAL CONSTITUENTS: 
 It has rich source of tannins and other phenolic compounds, some triterpenes and/or 
their glycosides were also reported from T. chebula [1]. For further phytochemical 
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discoveries we investigated this plant and isolated olanolic acid-derived triterpenes.Their 
structures were determined by spectroscopic methods including NMR and HRESIMS 
techniques.                    Ref: http://www.ncbi.nlm.nih.gov/pubmed/17365188 
 
KADUGU 
BOTANICAL NAME : Brassica juncea 
FAMILY   : Brassicaceae 
PARTS USED  : Seed 
ORGANOLEPTIC CHARACTERS: 
Taste  : Kaarpu(pungent) 
Potency : Veppam(heat) 
Pirivu  : Kaarpu(pungent) 
ACTIONS: 
 Emetic 
 Stimulant 
 Rubefacient 
   Vesicant 
 Digestive 
 Diuretic. 
GENERAL PROPERTIES: 
“Áó¾ÁÂì ¸õÅ¡¾õ Å¡ö¿£÷î ÍÆüÈÄê 
ÓóÐ Í¸ôÀ¢Ãº Åí¸éñ¼¡ Á¢óÐÑ¾ý 
Á¡§½!¸¢Ã¡½£ÌýÁ Á¡êÓò §¾¡¼Óõ§À¡õ 
¾¡§É ¸Î¸¢üÌò ¾¡ý.” 
      -   «¸ò¾¢Â÷Ì½Å¡¸¼õ 
CHEMICAL CONSTITUENTS:   
Seed sterols contain 19.2% brassicasterol (9.1% esterified), 23.6% free campesterol 
(34.0% esterified), 57.2% sitosterol (55.2% esterified), 1.7% esterified 5-avenasterol, and 
traces of 7-stigmasterol. It contains the glucosinolate sinigrin (potassium myronate) and the 
enzyme myrosin (myrosinase), sinapic acid, sinapine (sinapic acid choline ester), fixed oils 
(25 to 37%) consisting mainly of glycerides of erucic, eicosenoic, arachidic, nonadecanoic, 
behenic, oleic, and palmitic acids, among others; proteins (e.g., globulins) and mucilage 
(Leung, 1980).     Ref: database vol -6 p-422 
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KARPOGARISI 
BOTANICAL NAME  : Psoralea corlifolia  (Linn) 
FAMILY               :  Fabaceae 
 
ORGANOLEPTIC CHARACTERS :  
                    Suvai         :  Kaippu  
                    Thanmai  :  Veppam 
              Pirivu       :  Kaarppu 
ACTION: 
 Vasodilator activity  
 Laxative 
             Stimulant 
 Anti-staphylococcal activity 
Ref: journal . pharmacetical society of japan[1989,109(12),926-31] 
GENERAL PROPERTIES: 
¦À¡ÐìÌ½õ: 
“¸¡÷§À¡¸  Á¡ÁÃ¢º¢  ¸ñ¼¡ü  ¸ÃôÀ¡ýÒñ 
À£÷ºÌÅ  ¿ïº¢¨Å§À¡õ  À¢ò¾Óñ¼¡õ - À¡÷Á£¾¢ø 
Å¡¾  ¸À¿¨Áîºø  Åý¦º¡È¢º¢  ÃíÌÁÚï 
º£¾  ÁÄ÷ìÌÆÄ¡ö  ¦ºôÒ” 
                                     -   «¸ò¾¢Â÷Ì½Å¡¸¼õ 
CHEMICAL CONSTITUENTS: 
Corlifolinin 
Corylifolin 
Limonene 
Isonerbavachalcone 
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Psorlidin-2’,3’-oxide diacetate  
Isoflavone 
 corylinin 
 along with six known compounds, isopsoralen , psoralen ,  
sophoracoumestan A , neobavaisoflavone , daidzin and uracil . 
Ref: http://www.ncbi.nlm.nih.gov/pubmed/17365188 
VAEPAVAERPPATTAI 
 
BOTANICAL NAME : Azadirachta indica 
FAMILY   : Meliaceae 
PARTS USED  :  Root bark, leaf, flower, unripe fruit, seed, resin, stem bark. 
ORGANOPLEPTIC CHARACTERS:  
 
                Taste   : Kasappu(bitter), Thuvarppu(astringent). 
                Potency : Veppam(heat) 
                Pirivu : Kaarpu(pungent) 
ACTIONS:     
           Antiperiodic, 
Tonic 
Astringent.                                                               
       
CHEMICAL CONSTITUENTS:   
 Azadirachtin was isolated as the principal insecticidal and antifeedant constituent of 
A. indica seeds. In addition, 25 volatile compounds were identified as constituents of crushed 
neem seeds. The major volatile constituent identified, di-n-propyl disulfide, was shown to be 
larvicidal to three species of insects. Furthermore, two new insecticidal compounds, 1-
cinnamoylmelianolone and 1-cinnamoyl-3,11-dihydroxymeliacarpin, were isolated from the 
fruit of M. azedarach. The insecticidal activities of these new compounds, compared with 
those of azadirachtin and several of its derivatives, suggest structure-activity relationships 
and a mode of action that may be useful in the design of synthetic analogs. 
 
ALARIVAERPPATTAI 
BOTANICAL NAME   : Nerium odorum 
FAMILY   : Apocynaceae 
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PARTS USED  : Root bark, flower. 
ORGANPLEPTIC CHARACTERS:  
                  Taste  : Kasappu(bitter). 
                 Potency : Veppam(heat) 
                  Pirivu  : Kaarpu(pungent) 
 
ACTIONS:     
           Emetic, 
Purgative 
Anthelmintic.   
                                                                    
CHEMICAL CONSTITUENTS:    
         Nerium oleander was subjected to methanol extraction and bioassay directed 
fractionation. This led to the isolation of two purified fractions namely, B-1 and B-3. 
Fractions B-1 and B-3 were studied with respect to their actions on the central nervous 
system and behavior pattern in mice. Both fractions were found to produce reduction in 
locomotor activity, rota rod performance and potentiation of hexobarbital sleeping time. 
These fractions also showed analgesic activity. When tested against picrotoxin induced 
convulsions fraction B-1 showed 40% protection, while fraction B-3 exhibited 60% 
protection against bicuculline induced convulsions. These findings suggest that both fractions 
possess a CNS depressant action. 
            
     Ref:http://www.ncbi.nlm.nih.gov/pubmed/17365188 
 
INDHUPPU (SODIUM CHLORIDE IMPURA) 
 
SYNONYM: Chinduram,Sainthavam,Madhiuppu. 
ACTIONS:   
purgative 
carminative 
Stomachic 
digestive 
alleviates Vaatham & 
 kabam, aggravates pitham.  
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GENERAL PROPERTIES:          
    “«ð¼ÌýÁ Áó¾õ «º¢÷¸ÃïÝ÷ º£¾À¢ò¾ó 
     Ðð¼¨ÅÂõ ¿¡ÊôÒñ §¼¡¼í¸û-¦¸ð¼ÁÄì 
     ¸ðÎÅ¢¼ Å¢ó¨¾Âì ¸¡Á¢Â§É¡ö Åý¸ÃôÀ¡ý 
 Å¢ðÎÅ¢¼ Å¢óÐô¨À Å¢û.” 
   -   «¸ò¾¢Â÷Ì½Å¡¸¼õ 
 
CHEMICAL CONCTITUENTS:  
It was estimated, that the human body contains on the average 100g of sodium, 
mainly present together with chloride anions; we can thus assume that the bulk of sodium is 
the form of sodium chloride, a common salt NaCl. An average daily diet contains 3 – 6g of 
Na; in other words around 10g of NaCl2. The consumption of salt varies considerably from 
individual to individual and there is nothing like “recommended daily intake”. 
 
 
 
  COW’S URINE 
ACTIONS: 
   Diuretic 
  Laxative 
 
GENERAL PROPERTIES 
 
“Å¢¼À¡ñÎ §º¡¨ÀÀÄ Å£ì¸ï º¸Ä 
Å¢¼Ó¾¢Ã Á¡¨Ä¦ÂÉ ¦Áò¾ô-Ò¼Å¢¾É¢ü 
§ÀºÄì¸ §½¡Î¾ó¾ô À£¨¼ Â¸ýÈ£Î§Á 
§¸¡ºÄò¾¡ Ä¡Ã½í§¸ Üê.” 
     -Patharthagunasindhamani 
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Chemical description of cow’s urine as per modern concepts  
and cure of diseases accordingly 
Table - Chemical contents of cow’s urine and cure of diseases as per them 
S. 
No. 
Name of 
chemical  
Effect of chemical on diseases  
1. 
Nitrogen N2 
,NH2 
Removes blood abnormalities and toxins, Natural stimulant of urinary 
track, activates kidneys and it is diuretic. 
2. Sulphur S Supports motion in large intestines. Cleanses blood. 
3. Copper Cu Controls built up of unwanted fats 
4. Iron Fe 
Maintains balance and helps in production of red blood cells & 
haemoglobin. Stabilises working power. 
5. 
Urea 
CO(NH2)2 
Affects urine formation and removal. Germicidal. 
6. Potassium K 
Cures hereditary rheumatism. Increases appetite. Removes muscular 
weakness and laziness. 
7. Calcium Ca Blood purifier, bone strengthener, germicidal 
8. Salt NaCl  Decreases acidic contents of blood, germicidal 
9. 
Vitamins 
A,B,C,D,E 
Vitamin B is active ingredient for energetic life and saves from 
nervousness and thirst, strengthens bones and reproductive ingredient 
for energetic life and saves from nervousness and thirst, strengthens 
bones and reproductive power. 
10. Enzymes  Make healthy digestive juices, increase immunity 
The invention relates to an absolutely novel use of cow urine distillate as activity 
enhancer and availability facilitator for bioactive molecules including anti-infective and anti-
cancer agents. The molecules which express any activity in form of either inhibiting or 
promoting a biological function have been referred in this invention as bioactive molecule 
e.g. antibiotics, drugs, nutraceuticals, cardiovascular, hepatoprotective, neuro-tonics etc. The 
present invention has direct implication in drastically reducing the dosage of antibiotics, 
drugs and anti-cancer agent while increasing the efficiency of absorption of bioactive 
molecules. 
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INTERNAL DRUG: YAANAI NERUNJIL 
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INGREDIENTS OF THE EXTERNAL MEDICINE 
 
                   KADUKKAI                              VELLALARI VERPATTAI 
                 
 
 
 
          VEPPA VERPATTAI      KADUGU 
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INDHUPPU                                                KARBOGARISI 
                                   
 
 
 
 
               KOMOOTHIRAM 
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INTERNAL DRUG –YAANAI NERUNJIL CHOORANAM 
 
 
EXTERNAL DRUG – PATHIYAA LEBANAM 
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YOGAM 
 . 
 The term Yogam means “Union”. Siddhars have defined Yogam as an art which 
controls the mind by preventing it from getting distracted through sense and sense organs and 
by uniting it with the divinity after realizing the truth of eternal bliss. Professor Yogi 
Ramaiah has explained this simply as “A perfect scientific art that unites the mind with God 
or the Truth”. 
Yogam is one of the Kayakalpam methods that preserve physical and mental health 
by preventing the approach of grey hair, wrinkling, disease and death. 
Yogam is a precious art that the Siddhars contributed to the Tamils and the Tamil 
medicine, i.e. the Siddha system of medicine, and to the people of the world at large. 
There are people who think only of Yogasanam (postures) whenever we use the term Yogam 
but Yogam consists of eight steps and hence is called Attanga Yogam. 
 The eight steps or stages of Yogam are serially prevented in a verse of 
Thirumathiram, also called Tamil Moovayiram 
“þÂÁ ¿¢ÂÁ§Á ±ñ½¢Ä¡ ¬¾Éõ 
¿ÂÓÚ À¢Ã¡½¡ Â¡ÁõÀ¢Ãò ¾¢Â¡¸¡Ãï 
ºÂÁ¢Ì ¾¡Ã¨½ ¾¢Â¡Éï ºÁ¡¾¢ 
«ÂÓÚõ «ð¼¡í¸ Á¡ÅÐ Á¡§Á” 
ü Iyamam 
ü Niyamam 
ü Asanam 
ü Pranayamam 
ü Prathyaharam 
ü Dharanai 
ü Dhyanam 
ü Samathi 
Asanam: 
 Asanam means posture or pose, that is, the position of our body with reference to 
space. There is another interpretation by Siddhars: A + Samanam – A means athma and 
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Samanam means poise or relaxation. Relaxing athma implies relaxing it from streesful 
conditions of this worldly life. In other words, it means relieving athma from the lure of 
sensual pleasures. As asanam forms a part of Yogam it is also called Yogasanam. 
Definition: 
 Keeping the body or part of the body steady and motionless in a particular posture for 
a specific time is Asanam. 
Yogam techniques to be observed by the Venpulli patients: 
· Kiriya Gnayiru Vanakkam (Kiraiya Pose of Sun Salutation) 
· Meditative postures 
o Thamarai Asanam (Padmasanam) 
o Mandi Uruthi Asanam (Vajrasanam) 
· Paranayamam 
o Mathrika Pranayamam  
o Omkhara Pranayamam  
o Nithirai Pranayamam 
· Shanthi Asanam (Savasanam) 
1.Kiriya Gnayiru Vanakkam (Kiriya Pose of Sun salutation): 
The practice of Gnayiru vanakkam can give a patient a complete exercise regimen. 
One round of Sun salutation consists of twelve postures. 
The Twelve Postures 
Posture 1: Vanakka Muthirai (Pranamasanam - Salutation posture)   
  Stand erect with feet together. Join the palms together in front of the 
chest. Concentrate on standing straight, steady and in a prayerful attitude 
Posture 2 : Hastauttanasanam (Raised arm posture)  
Inhaling stretch both arms above the head, palms facing upward. 
Arch the back and stretch the whole body. This posture stretches the chest 
and the abdomen and lifts the Pranan (energy) upward to the upper parts of 
the body propelled by inhalation. 
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Posture 3: Padahastasanam (Hand to foot posture)   
Exhaling bend the body forward and down, keeping the spine straight. 
Avoid collapsing the chest or "over-rounding" the upper back. Keep the legs 
straight and perpendicular to the ground. The knees may be allowed to bend a 
little if needed. The Pranan is channeled to the lower regions of the body 
propelled by exhalation. 
Posture 4: Ashwa Sanchalanasanam (Equestrian posture)  
On your next inhalation, extend the left leg back and drop the knee 
to the ground. The right knee is bent and kept between the hands and the 
right foot placed flat on the ground. Lift the spine and open the chest. 
Concentrate at the eyebrow center. 
Posture 5: Malai Asanam ( Parvatasanam - Mountain posture)  
On exhalation bring the right leg back to join with the left leg. 
Simultaneously raise the buttocks and lower the head between the arms, so 
that the body forms a triangle with the floor. Try to place the heels flat on 
the ground. Focus awareness at the neck area. This posture strengthens the 
nerves and muscles in the arms and legs, stretches the calf muscles and 
Achilles' tendons and makes the spine straight and taut.  
Posture 6: Ettu Anga Vanakka Muthirai (Ashtanga 
Namaskaram - Salutation with eight limbs)  
Exhaling gently drop both knees to the ground and slowly 
slide the body down at an angle as you bring the chest and chin to 
the ground. All eight limbs - toes, knees, chest, hands and chin - touch the floor. The buttocks 
are kept up. Hold the breath.  
Posture 7: Pambu Asanam (Bhujangasanam - Cobra posture)  
On inhalation, lower the hips while pushing the chest 
forward and upward with the hands, until the spine is fully arched 
and the head is facing up. The knees and lower abdomen remain 
above the floor. Focus the awareness at the base of spine and feel 
the tension from the forward pull. 
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Posture 8: Malai Asanam (Parvatasanam - Mountain posture)  
 Exhale and get back to posture 5. 
 
 
Posture 9: Ashwa Sanchalanasanam (Equestrian posture)  
Inhale and swing the right leg forward between the hands. The left 
leg remains back. Resume posture 4 
Posture 10: Padahastasanam (Hand to foot posture)  
Exhaling, bring the left foot forward. Join both legs and resume 
posture 3 
Posture 11 : Hastauttanasanam (Raised arm posture)  
Inhale, raise the trunk up and bend backward. Resume posture 2. 
 
Posture 12: Vanakka Muthirai (Pranamasana - Salutation posture)  
Straighten the body and bring the hands in front of the chest. 
Resume posture 1.  
After performing Gnayiru Vanakkam, relaxation in Shavasanam is must.  
Benifits: 
· Tones up the digestive system by the alternate stretching and compression of 
abdominal organs. It activates digestion and gets rid of constipation and dyspepsia 
· Strengthens abdominal muscles. 
· Thoroughly ventilates the lungs, and oxygenates the blood. 
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· Acts as detoxifying agent, by getting rid of enormous quantity of carbon dioxide and 
other toxic gases. 
· Tones up the nervous system and improves memory. 
· Promotes sleep and calms anxiety. 
· Normalizes the activity of the endocrine glands - especially the thyroid gland. 
· Refreshes the skin. Prevents Skin disorders. 
· In women, stimulates the breasts to help firmness normally. Restores any lost 
elasticity, through stimulation of glands and the strengthening of pectoral muscles. 
· Suppresses menstrual irregularity and assists in easy childbirth. 
· Prevents loss of hair and graying. 
· Helps reduce fat. 
· Reduces abnormal prominence of the Adam's apple. 
· Eliminates unpleasant smells from the body. 
· Lends grace and ease of movements to the body. 
· Revives and maintains the spirit of youthfulness. 
· Broadens chest and beautifies arms. 
· Makes the spine and waist flexible. 
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· It invigorates the whole body by exercising each and every part of the body.it helps to 
burn out the the excessive calorie. 
· It helps to exercise the lungs and chest. 
· This facilitates the easy flow of air in and out. 
2. Meditative postures:                                                             
2 a. Thamarai Asanam (Padmasanam) 
English name: Lotus Pose 
The term Padmam or Thamarai means lotus. The 
beginners in asanams should get trained in this asanam first, 
because this forms a basic asanam for many other asanams.  
This asanam is one of the meditative postures. 
 
Technique: 
 (1).Put the right leg on the left thigh, keeping the right heel pressing down the lower 
abdomen or (2).Put the left leg on the right thigh, keeping the left heel pressing down the 
lower abdomen. This posture is called pathi thamarai asanam (ardha padmasanam – half-lotus 
pose) 
 Beginners in Thamarai Asanam better practice half-lotus pose for some days. First 
day they can practice (1) and the subsequent day (2) as explained above, and this can be 
continued alternatively for some days and then lotus pose in its full form can be practiced as 
follows: 
First do as explained in (1) and follow the steps as explained in (2) above. i.e., 
combine (1) and (2). Now place left hand with palm facing upward on the lap and then right 
hand similarly over the left(Pambu or Bairava Mutthirai) or place the hands on the knees, 
with palms facing upwards and keep the thumbs and the index fingers touching each other in 
the form of a circle and keep the other three fingers extended (Gnana mutthirai). 
The vertebral column should be kept erect and head straight with eyes closed or open 
depending upon the meditation technique. This is Poorana Padmasanam (complete lotus 
pose) 
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To begin with, this Asanam can be practiced for 1 to 3 minutes and the duration can 
be increased according to our need in the course of time. 
Relaxing the Asanam: 
From the summit or the final completed stage of asanam, the asanam should be 
relaxed step by step in the reverse order. First, the left leg followed by the right leg should be 
taken away from the thighs to reach sukhasanam and then stand up and finally to the zero 
stage. 
The counterpose for thid asanam is 
shavasanan or poorana shanthi asanam. 
Benefits: 
· Calms the brain 
· Mental concentration is increased 
· Stretches the ankles and knees  
· Joints, especially the knee joints are 
strengthened 
· Prevents joint disorders in old age 
· Increases digestive function 
· Produces clarity of the mind and briskness. 
· Stimulates the pelvis, spine, abdomen, and bladder 
· Eases menstrual discomfort and sciatica  
· Traditional texts say that Padmasanam destroys all diseases and awakens kundalini.  
· Padmasanam helps to get rid of flab around abdomen, thighs and buttocks. 
· The thigh and calf muscles become stronger. 
· The pose helps attain a straight posture. 
· Padmasanam ensures the required blood supply to the abdomino-genital and pelvic 
areas. 
· All muscles, tendons and ligaments are flexed and extended during Padmasanam. 
They are then relaxed when you relax. 
· The erect spine attained in this posture prevents compression of the abdominal 
viscera. 
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2. b. Mandi Uruthi Asanam (Vajrasanam): 
This is one of the meditative postures and this Asanam can be done even immediately 
after taking food 
English name: Kneeling pose of firmness 
Technique: 
 Kneel down from the 1st stage of attention position. Expand the heels and sit on the V 
–shaped gap between. See that the right great toe overlaps the left one like a pair of scissors 
while expanding the heels. Maintain the neck and the spinal column in an erect position. 
  
Benefits: 
· Increases digestive power 
· Relieves constipation 
· Produces good appitite 
· Strengthens shoulders, knee joints, ankle joints and hip joints 
· Refreshes the soft parts of the abdomen 
· Strengthens the spinal cord and spinal column 
· Maintains  good bloodsupply to thyroid and parathyroid glands 
· Vajrasanam alters the flow of blood and nervous impulses in the pelvic region and 
strengthens the pelvic muscles.  
· It is a preventative measure against hernia and also helps to relieve piles.  
· It increases the efficiency of the entire digestive system, relieving stomach ailments 
such as hyperacidity and peptic ulcer.  
· It reduces the blood flow to the genitals and massages the nerve fibers which feed 
them, making it useful in the treatment of dilated testicles and hydrocele in men.  
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· It is a very important meditation posture because the body becomes upright and 
straight with no effort. It is the best meditation asana for people suffering from 
sciatica and sacral infections.  
· it is the best stretch for quadriceps muscle groups.  
3. Shanthi Asanam (Savasanam): 
English Name: corpse pose 
 This posture is so named in the summit of this posture, one observes a motionless 
state (except breathing) like that of deadbody. 
 
 
Technique: 
 Lie down on the back on a nice bedspread spread out on a floor with an even surface. 
With palms facing upwards on the sides half a foot apart fromthe body. Leaving half a foot 
gap in between the heels, leep the legs in a relaxed manner.by allowing the head to turn freely 
to left to right side, keep the head and neck in a relaxed manner. Keep the eyes gently closed. 
Maintain normal breathing. Keeping the whole body from head to foot in a relaxed manner. 
Observe this asanam for 15 to 30 minutes or even more, if necessary. 
Benefits: 
· Relieves physical and mental tiredness 
· One must do this asanam lastly after performing all other asanams and may maintain 
this till the physical and mental tiredness resulting from performing a number of 
asanams get relieved 
· If hard physical labourers do this asanam as soon as they return home from work, it 
refreshes the body and relieves tiredness. 
· Sound sleep ensues if one observes this asanam for about 10 minutes before retiring to 
bed. Calms the brain and helps relieve stress and mild depression  
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· Relaxes the body  
· Reduces headache, fatigue, and insomnia 
· Helps to lower blood pressure 
· Allows the body time to process information at the end of a class.  
4. Pranayamam: 
The perfect and scientific art of controlling one’s breathing is called Pranayamam. It 
is also called Vaasi or Vaasiyogam. By bringing to control the breathing that goes normally, 
automatically and in a regular rhythm and fixing  the duration and amount of breathing 
differently as described by Siddhars, different types of Pranayamam are devised.   
Pranayamam is one of the rejuvenation techniques which prolong one’s lifetime. This 
is indicated by Thirumoolar as follows: 
“²üÈ¢ þÈì¸¢ þÕ¸¡Öõ âÃ¢ìÌõ  
¸¡ü¨È À¢ÊìÌõ ¸½ì¸È¢ Å¡Ã¢ø¨Ä 
¸¡ü¨È À¢ÊìÌõ ¸½ì¸È¢ Å¡Ç÷ìÌì 
Üü¨È ¯¨¾ìÌõ ÌÈ¢ÂÐ Å¡§Á” 
²üÈ¢ þÈì¸¢ denotes the act of increasing or decreasing the quantity of air inspired 
during respiration. þÕ¸¡Öõ âÃ¢ìÌõ denotes saturating the two lungs with the vital air by 
inspiring through the nostrils. In this ¸¡ü¨È À¢ÊìÌõ ¸½ì¸È¢ Å¡Ç÷ is the one who is 
engaged in the practice of Pranayamam. ÜüÚ means Yaman, the one who takes the life 
from the body. Üü¨È ¯¨¾ìÌõ ÌÈ¢ means that Pranayamam is the means of preventing 
Yaman from approaching the one who practices it. 
Benefits: 
· Pranayamam not only useful in the treatment of diseases of lungs and respiratory tract 
but proves beneficial as a main or supportive therapy in the treatment of diseases of 
skin, nervous system incluing brain, and diseases of the mind. 
· It is useful in developing body resistance and also in increasing the memory and 
mental concentration. 
· It removes bad odour and renders sattviga gunam (good characters) predominant 
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4. a. Mathrika Pranayamam: 
Technique: 
 Sit in Sukhasanam or Padmasanam observing Pambu mutthirai. Inhale through both 
the nostrils slowly and steadily as much as possible raising the shoulders simultaneously at 
the same pace.  Without holding the breath, start exhaling in a similar manner simultaneously 
depressing the shoulders at the same pace. This is counted as ‘one’ and this process may be 
repeated 30 to 50 times both morning and evening before food. This Pranayamam can be 
done in the afternoon and night too. After getting well trained in this, one can do this more 
effectively by involving the muscles of abdomen and chest. This technique is called Mathrika 
Pranayamam. 
 Timing is very important in this Pranayamam. One must see to it that the duration of 
exhalation is equal to that of inhalation (i.e., expiratory phase = inspiratory phase) 
 
Benififs: 
· Ensures increased supply of Pranic energy to lungs 
· Purifies blood 
· Increases efficiency of  exercise 
· Increases appitite and power of digestion 
· Prevents/cures skin and nervous diseases 
· Proves useful as a supportive therapy in the diseases of lungs 
· Increases memory power 
· Produces briskness 
4. b. Nithirai Pranayamam: 
English Name :( Sleeping Pranayamam) 
Technique:  
1. Sit on a bedspread or a smooth mat in sukhasanam or padmasanam with Pambu 
Muthirai (Bairava Muthirai) or Chin Muthirai.  
2. Close your eyes and concentrate on your breathing. 
3. Through both nostrils breath in slowly, steadily and gradually to the maximum at the 
same time calculating the total time taken for this Poorakam (inspiration) by counting 
inwardly as 1, 2. 3 ….at the same pace throughout. 
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4. As soon as the Poorakam is over, start rechakam (expiration) observing the same 
technique explained in 3 but see to it that the time taken for expiration is only half the 
time taken for inspiration.  
5. Repeat the technique 30 to 40 times. 
N.B: The above description is based on the teachings of Yogi S. A. A. Ramiah 
Benefits:  
· Induces sleep.  
· Relieves stress and other symptoms like headache, heaviness of head, tiredness.  
4. c. Omkhara pranayamam: 
Technique: 
1. Sit on a bedspread or a smooth mat in sukhasanam or padmasanam with Pambu 
Muthirai (Bairava Muthirai) or Chin Muthirai. 
2. Close your eyes and concentrate on your breathing. 
3. Through both nostrils breath in slowly, steadily and gradually to the maximum at the 
same time  chanting the manthiram AUM in a such a way that the sound ‘A’ (i.e 
Akaram) occupies the 50% of the time taken for inspiration and ‘U’(i.e Ukaram) 20% 
and ‘M’ (i.e Makaram) the remaining 30% of the time taken in order. 
4. Repeat the process again and again for 30 to 40 times 
Benefits:  
· Relieves stress.  
· Ensures sound sleep.  
· Increases memory power and concentration.  
· Increases exercise tolerance.  
· Nourishes the nervous system.  
· Purifies blood.  
Conduct of the study: 
The trial drug Yaanai Nerunjil Chooranam (Internally) and Pathiyaa Lebanam 
(Externally) are given for 48 days .10 IP patients are given Yogam treatment along with their 
internal medicine. The remaining 30 Out-Patients didn’t receive Yogam treatment. The 
results are compared at the end of the study. The results are, 
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10 In-Patients, Who received Yogam treatment along with trial drugs showed good 
prognosis when compared to the Out- Patients who didn’t receive any Yogam treatment.  
All the 10 In-Patients developed repigmentation in the lesions. 
Among 30 Out-Patients, 25 patients developed repigmentation in the lesions and the 
remaining 5 Out-Patients didn’t develop any repigmentation. 
Discussion: 
Hence Yogam treatment along with the trial drugs is more effective in the treatment 
of Venpulli when compared to the treatment with the trial drugs alone. 
Result: 
Yogam treatment proved to be effective in producing the repigmentation in Venpulli 
in this clinical trial. 
 
 
 
65 
 
MATERIALS AND METHODS 
              The study on Venpulli was carried out in the inpatient and Out patient 
department of Sirappu  Maruthuvam in Ayothidoss Pandhithar Hospital ,National 
Institute of Siddha ,Chennai-47. 
 The disease ‘’Venpulli’’ has been dealt in  the Siddha Maruthuvam Sirappu .one 
among the 18 types of Kuttam .Patients were selected according to the clinical features  
STUDY DESIGN : 
A Pilot clinical trial  
STUDY PLACE:   
OPD and IPD of Ayothidoss Pandithar Hospital,  
National Institute of Siddha, Tambaram Sanatorium, Chennai-47. 
STUDY PERIOD:  
12 months 
SAMLE:  
 Patients having Venpulli noi reporting at Ayothidoss Pandithar Hospital, National 
Institute of Siddha 
SAMPLE SIZE:  
40 patients (30 OP +10 IP).  
Out of the above, 10 patients were given Yogam treatment along with trial 
medicines and the remaining were given medicines only. 
TRIAL DRUGS: 
Internal medicine :    Yaanai Nerunjil Choornam  
                                     (Reference: Pathartha guna vilakkam(page no 627-628) 
Dosage:     2-5gm (twice a day) 
Vehicle:       Water 
Duration:     48 days 
 
External medicine:    Paththiyaa Lebanam  
(Reference: Agathiyar vaithiya pillai tamil, Page no 78) 
Dosage :     Q.S 
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STANDARD OPERATING PROCEDURE:  
Source of raw drugs: 
The required raw drugs for the preparation of Yannai Nerunjil Choornam and 
Pathiyaa Lebanam were purchased from a well reputed country shop and the purchased 
drugs were authenticated by the faculty members in charge of Gunapadam laboratory at 
National Institute of Siddha. 
Method of Purification of Raw drugs: 
The whole plant is wiped by a clean, dry, cotton cloth. 
Internal drug:    
 Yaanai Nerunjil Choornam 
Ingredients: 
Yaanai Nerunjil Samoolam 
Method of preparation: 
The purified Yaanai Nerunjil Samoolam are dried in the shadow. The dried 
samoolam are grinted into fine powder and then it is sieved by using a fine silk cloth 
(Vasthrakayam). The fine powder is mixed with milk and placed in a cloth which is 
placed in vessel containing milk and that was closed by another vessel. This instrument 
is subjected to heat (Pittavial method). Then it is dried and then filtered by a cotton cloth. 
The fine powder is stored in a clean, dry air tight glass bottle. 
External drug:  
 Paththiyaa Lebanam 
Ingredients: 
 Manjal kadukkai (Terminalia chebula)   -35 gm 
 Kadugu (Brassica juncea)                               -35 gm 
 Vellalari verpattai (Nerium odorum)              -35 gm 
            Veppaver pattai(Azadirachta indica)          -35 gm 
Karbogarasi(Psoralea cordifolia)                -35 gm 
Induppu (Sodium chloride impura)             -35 gm 
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Method of preparation:                                        
The above said raw drugs are powdered and then it is grinded in a Kalvam by 
adding cow urine and made as a paste form. This paste used as externally.   
 
                   Ref : Agasthiyar Vaithiya Pillai Tamil  
Drug Storage: 
The trial drugs Yaannai Nerungil Choornam is stored in clean and dry glass 
bottles and Pathiyaa Lebanam is stored in clean and dry glass bottles. 
Dispensing: 
        The Choornam is given in packets and Lebanam is given in packets. 
YOGAM TECHNIQUES ADVISED FOR THE TRIAL: 
· Gnayiru Vanakkam (Sun salutation)  
· Meditative postures 
o Padmasanam 
o Vajrasanasm 
o savasanam 
· Pranayamam (Mathrika Pranayamam and Omkhara Pranayamam, Nithirai 
Pranayamam-SOS) 
Reference:  
1) Yogam by Dr.R.S.Ramaswamy, --Siddha Maruthuvam Special areas-- 
Published by Tamil Valarchi Kazhagam, Chennai -5. 
2) Yogasana –A comprehensive description about the Yogasana--- Published by 
Morarji Desai National Institute of Yoga 1st Edition (2008)     
3) Pranayama - A comprehensive description about the Pranayama--- Published 
by Morarji Desai National Institute of Yoga 1st Edition (2008)     
4) Yogic Management of Respiratory Disorders--- Published by Morarji Desai 
National Institute of Yoga 1st Edition (2008)    1st Edition (2010)     
 
SUBJECT SELECTION: 
Patients reporting with symptoms Venpulli were screened by screening Proforma 
then they will be enrolled for the study. 
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INCLUSION CRITERIA 
1. Age:  between 18 - 60 years.  
2. Sex: Both male and female 
3. depigmented patches without any structural changes in any part of the body. 
4. Patient willing to sign the informed consent stating that he/she will 
consciously stick to the treatment during 48days but can opt out of the trial of 
his/her own conscious discretion 
5. Willing laboratory investigations whenever required. 
6. Willing for photograph whenever required with his consent. 
 
EXCLUSION CRITERIA: 
1. Albinism 
2. Thyroid disorders 
3. Leprosy 
4. STD 
5. Burns 
6. Pregnancy and Lactation 
7. Cardiac diseases 
8. Patients with any other serious systemic illness. 
 
WITHDRAWAL CRITERIA 
· Intolerance to the drug and development of adverse reactions during drug trial. 
· Poor patient compliance & defaulters. 
· Patient turned unwilling to continue in the course of clinical trial. 
 
TESTS AND ASSESMENTS 
A. Clinical assessment  
B. Laboratory investigations 
C. Siddha system examination 
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A. CLINICAL ASSESSMENT: 
§ Site 
§ Repigmentation  
§ Number of lesions 
§ Colour change  
§ Appearance of new lesions 
§ Size and shape of the lesions 
§ Borders 
§ Erythema 
§ Repigmentation of Hair 
§ Itching 
 
Clinical Assessment of the Lesions: 
 
Parameter - + ++ +++ ++++ 
Change in 
colour 
No change Yellowish tint Slight contrast 
between lesion 
color and 
surrounding 
skin color 
No contrast 
between lesion 
color and 
surrounding 
skin color 
100% 
remission 
in all 
treated 
lesions 
Change in size No change Up to 5 mm 
reduction in 
diameter 
Up to 10 mm 
reduction in 
diameter 
More than 10 
mm reduction 
in diameter 
 
Folliculocentric 
Repigmentation 
No 
Repigmentation 
Up to 5 mm 
perifollicular 
Repigmentation 
Up to 10 mm 
perifollicular 
Repigmentation 
More than 10 
mm 
perifollicular 
Repigmentation 
 
 
- No response; +, mild response; ++, moderate response; +++, marked response; ++++, complete 
response. 
 
Ref: Journal of European Academy of Dermatology and Venerelogy 
(JEADV) 
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B. LABORATORY INVESTIGATIONS: 
Blood 
 Hb  
 Total RBC Count 
 ESR  
 Blood sugar 
     
Kidney Function Tests 
 Urea 
 Creatinine 
 
 Liver Function Tests 
 
 Serum total bilirubin 
 Direct bilirubin 
  Indirect bilirubin 
  Serum Alkaline phosphatases 
 SGOT 
 SGPT 
 
  Thyroid Profile:             
 T3 
  T4 
 TSH  
 
Urine 
 Urine sugar 
 Albumin 
     Deposits 
 
MOTION 
 Ova 
 Cyst
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SIDDHA SYSTEM EXAMINATION: 
                       1. Naadi 
                       2. Parisam 
                       3. Naa  
                       4.Niram 
                       5. Mozhi  
                       6. Vizhi 
                       7. Malam 
                       8. Moothiram 
                                 Neikkuri : 
                             Neerkkuri: 
 
DATA COLLECTION FORMS: 
Required information was collected from each patient by using the following 
forms. 
 
FORMS 
 
FORM I          : Screening and Selection Proforma  
FORM lI    : History taking Proforma  
FORM llI     : Clinical Assessment Proforma 
FORM lll                : Laboratory Investigation Proforma  
FORM IV       : Informed Consent Form 
FORM V     : Withdrawal Form 
FORM VI     : Patient Information Sheet 
FORM VII    : Dietary advice Form  
FORM VIII            :Adverse Reaction Form 
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PATIENT SCREENING 
 
INCLUSION CRITERIA 
EXCLUSION CRITERIA 
 ADVICED TO CONTINUE IN OPD 
MEDICINE 
STUDY DESIGN 
       STUDY NUMBER 
     HISTORY TAKING 
LAB INVESTIGATION 
 TRIAL DRUG  
CLINICAL ASSESSMENT 
OUTCOME 
INFORM ABOUT STUDY AND 
TRIAL DRUG 
INFORMED CONSENT 
FORM 
ADVERSE EFFECT 
TREATED IN OPD 
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 STUDY ENROLLMENT  
In this study Patients reporting at the OPD with the clinical symptoms of 
depigmentation, itching, burning sensation etc were examined clinically for enrolling in 
the study based on the inclusion and exclusion criteria.  
The patients who are going to be enrolled would be informed (Form IV) about 
the study, trial drug, possible outcomes and the objectives of the study in the language 
and terms understandable to them. 
After ascertaining the patient’s willingness, informed consent were obtained in 
writing from them in the consent form (Form IV). All these patients were given unique 
registration card in which patients’ Registration number of the study, Address, Phone 
number and Doctors phone number etc. will be given, so as to report easily should any 
complications arise. 
Complete clinical history, complaints and duration, examination findings -- all 
were recorded in the prescribed Proformas in the history and clinical assessment forms 
separately. Screening Form- I will be filled up: Form – II, Form – III and Form - IV will 
be used for recording the patients’ history, clinical examination of symptoms and signs 
and laboratory investigations respectively. Patients will be advised to take the trial drug 
and appropriate dietary advice (Form VII).  
CONDUCT OF THE STUDY: 
Purgation: 
On the first day of the treatment Purgation with Karudan Kizhangu Ennai - 5 ml, 
early morning with hot water was given for balancing the deranged Udal Thathukkal.  
Treatment: 
The next day onwards the trial drugs Yaanai Nerunjil Chooranam (Internal) 
And Paththiyaa Lebanam (External) are given for 48 days without any break.  Out 
patients are requested to visit once in 7 days in the OPD of Ayothidoss Pandithar 
Hospital of National Institute of Siddha.  At each and every visit clinical assessment is is  
noted in the prescribed Proforma. For In patients the trail drugs are given for 48 days and 
the clinical assessment is done daily. 10 IP patients will be given Yogam treatment along 
with trial medicines. Laboratory investigations are done on the first day, and 48th  day of 
the trial. For IP patients, who are not in a situation to stay in the hospital for a long time, 
are advised to attend the OPD for further follow- up. Siddha investigations like Neer kuri 
and Nei kuri will be done and it will be recorded the Proforma, Photographs of Neer kuri 
and Nei kuri will also be taken on first day, and 48th day. After the end of the treatment, 
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the patient was advised to visit the OPD for another two months for observing any 
recurrence of this disease and follow up. Defaulters were not  allowed to continue the 
trail and withdrawn from the study.  
DATA ANALYSIS: 
After enrolling the patient in the study, a separate file for each patient was opened 
and all forms were kept in the file. Study No. and Patient No. was entered on the top of 
file for easy identification. Whenever study patient visits OPD during the study period, 
the respective patient file will be taken and necessary recordings will be made at the 
assessment form or other suitable form. The screening forms will be filed separately. The 
recorded Datas were monitored by Head of the Department and All datas were analysed 
with the help by Senior Research Officer (Statistics) for logical errors and 
incompleteness of data to avoid any bias. Then final report was generated. No 
modification in the results is permitted for unbiased reports. 
GRADING: 
  GRADE 1        :Turning to normal skin. 
  GRADE 2       :Repigmentation in /Reduction in size of all lesions. 
  GRADE 3 :Repigmentation in/Reduction in size of selected lesions. 
  GRADE 4       :Static-remains the same-(no further lesions formed). 
  GRADE 5       :New lesions appearing. 
OUTCOME 
Primary Outcome:      
The therapeutic efficacy of trail drugs were assessed - repigmentation by 
appearance of dots and reduction in the size of the lesion  
Secondary Outcome:   
The effect of Yogam in the treatment of Venpulli is assessed  -
repigmentation by appearance of dots and reduction in the size of the lesion  
ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT:  
If the trial patient develops any adverse reactions, he/she was immediately 
withdrawn from the trial and proper management  given in OPD of National Institute of 
Siddha and the same were informed to the Pharmacovigilance committee of NIS. 
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ETHICAL ISSUES 
 
1. To prevent any infection, while collecting blood sample from the patient, only 
disposable syringes, disposable gloves, with proper sterilization of lab 
equipments were used.                        
2. No other external or internal medicines will be used other than the trial drug, for 
treating Venpulli. There were no infringement on the rights of patient.    
3. The data collected from the patients were kept confidential. The patients were 
informed about the diagnosis, treatment and follow-up.  
4. After getting written consent of the patient only (through consent form in their 
understandable language) they will be enrolled in the study.  
5. Treatment would be provided free of cost.  
6. Any serious adverse reactions happened they were referred to the OPD of 
National Institute of Siddha for alternative treatment.  
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RESULTS   AND   OBSERVATION  
 
            1. Family History   
2. Gender distribution 
3. Age Distribution 
4. Kaalam distribution 
5. Occupational Status 
6. Seasonal variations 
7. Thinai 
8. Socio-economic Status 
9. Yakkai Illakanam 
10. Gunam 
11. Dietary Habits 
12. Udal kattugal 
13. Distribution of Mukkutram 
14. Envagai Thervugal 
15. Neerkkuri  
16. Neikkuri 
17. Modern classification 
18. Change in colour after treatment 
19. Reduction in size after treatment  
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1. FAMILY HISTORY: 
Sl. No 
 
Criteria 
 
No of Cases Percentage 
1 
 
Family History (+ve) 
 
3 7.5% 
2 
 
Family History (-ve) 
 
37 92.5% 
 
 
 
 
 
 
 
 
 
 
Observation 
 
 90% of the patients showed negative family history. 
  
7.5%
92.5%
Family History
Family History (+ve)
Family History (-ve)
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2.  GENDER DISTRIBUTION: 
Gender No of  Out Patients No. of  In Patients Total Percentage 
Male 15 5 20 50 
Female 15 5 20 50 
Total 30 10 40 100 
 
 
               
 
Inference:  
                  Among 40 cases, 50% were Male, 50% cases were Female. 
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3.  AGE DISTRIBUTION: 
Age in 
Years 
No. of  Out Patients No. of  In Patients 
Total Percentage 
Male Female Total Male Female Total 
18 to 20 2 1 3    3 7.5 
21 to 30 5 7 12 2 1 3 15 37.5 
31 to 40 6 5 11 2 2 4 15 37.5 
41to 50 2 1 3 0   3 7.5 
51to 60  1 1 1 2 3 4 10 
Total 30 10 40 100 
 
 
 Inference:  
Among 40 cases,7.5 % of the cases belonged to the age group of 18-20 years, 37.5% 
of cases 21-30 years37.5%of cases 31-40 years, and 7.5% of cases 41-50 years,10%of cases 
51-60years. 
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4.  KAALAM DISTRIBUTION (According to Age) 
 
In Siddha literature human life has been divided into three periods as follows 
1 Vaatham 
2 Pitham 
3 Kabam 
The duration of each period is said to be 33 years 
Sl No Kaalam No of Cases Percentage 
1 Vaatha Kaalam (1-33 Years) 18 45% 
2 Pitha  Kaalam (34-66 years) 22 55% 
3 Kaba Kaalam (67-100 years) 0 0% 
 
 
 
 
 
 
 
Observation 
18cases( 45%) reported in Vaatha Kaalam, 22Cases (55%) reported in Pitha Kaalam and 
none of the cases reported in Kaba Kaalam.  
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KAALAM DISTRIBUTION
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5.  OCCUPATIONAL STATUS: 
 
Occupation 
No of  Out Patients No of  In Patients 
Total Percentage 
Male Fema Total Male Female Total 
Student 3 2 5 1      0 1 6 15 
Teacher 0 0      0 0 1 1 1 2.5 
Home maker 0 10 10 0 2      2 12 30 
     Driver 1 0 1 1 0 1 2 5 
Supervisor 0 0 0 1 0 1 1 2.5 
Engineer 3 0 3 1 1 2 5 12.5 
Business 0 0 0 1 0 1 1 2.5 
Electrician 1        0 1 0 0 0      1 2.5 
Tailor 0 2 2 0 1 1 3 7.5 
Cashier 1 1 1 0 0 0 1 2.5 
      Typist 0 0 1 0 0 0 1 2.5 
Printer 1 0 0      0       0      0  1          2.5 
Designer 1 0 1 0 0 0 1 2.5 
Manager 2       0  2      0      0 0 2 5 
Salesman 1 0 1 0 0 0 1 2.5 
Mechanic 1 0 1 0 0 0 1 2.5 
Total   30   10 40 100 
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5. OCCUPATIONAL STATUS: 
 
 
 
 
Observation: 
 The majority of patients in this study were home makers ,and students.  
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       6.  SEASONAL VARIATIONS 
Season 
No. of  Out Patients No. of  In Patients 
Total Percentage 
Male Female Total Male Female Total 
Kaar 5 4 9 3 2 5 14 35 
Koothir - - - - - - -  
Munpani - - - - - - -  
Pinpani - - - - - - -  
Elavenil - - - - - - -  
Muthuvenil 10 11 21 2 3 5 26 65 
Total 30 10 40 100 
 
 
Inference:    
In Siddha system, a year is divided into 6 Paruva Kaalangal (Seasons).Out of 40 cases, 
14patients (35%) were admitted in Kaar Kaalam, 26 patients (65%) were admitted in Koothir 
Kaalam. 
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6.  THINAI: 
Thinai 
No. of  Out Patients No. of In Patients 
Total Percentage 
Male Female Total Male Female Total 
Kurinji - - - - - - - - 
Mullai - - - - - - - - 
Marutham 2 1 3 - - - 3 7.5 
Neithal 13 14 27 5 5 10 37 92.5 
Paalai - - - - - - - - 
Total 30 10 40 100 
 
 
THINAI      
 
           
Inference:  
Among the 40 patients, 3 (7.5%) were from Marutham and 37 (92.5%) were from 
Neithal thinai. 
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7.   SOCIO - ECONOMIC STATUS: 
Socio economic 
status 
No. of  Out Patients No. of In Patients  
Total 
 
Percentage 
Male Female Total Male Female Total 
Low income 4 I 5 2 1 3 8 20 
Middle income 20 5 25 5 2 7 32 80 
High income  -  - - - - - 
Total 30 10 40 100 
 
 
      
Inference:  
            Out of 40 cases 20% of cases were poor, 80% cases were from middle class. 
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8.  YAAKAI ILAKKANAM 
 
 
Sl. No Yaakai Ilakkanam No. of Cases Percentage 
1 Vaatha Udal 0 0.00% 
2 Pitha Udal 0 0.00% 
3 Kaba Udal 0 0.00% 
4 Thontha Udal 40 100.00% 
 
Observation 
 
 
All the patients (100%) had ThonthaUdal. 
 
 
 
9.  GUNAM (QUALITY AND CHARACTERS) 
 
 
 
Sl. No Gunam No of Cases Percentage 
1 Sathuva Gunam 0 0.00% 
2 Rajo Gunam 36 90% 
3 Thamo Gunam 4 10% 
 
 
Observation 
 
 
90% of the patients had “Rajo Gunam” and the remaining 10% “Thamo Gunam 
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10.  DIETARY HABITS: 
 
 
 
 
 
Inference: 
           Out of 40 cases ,5% of cases were Vegetarians and 95% cases were Non-vegetarians. 
Dietary habits No of  Out Patients No of In Patients Total Percentage 
Male Female Total Male Female Total 
Vegetarian 2  2 -  0 2 5 
Non-vegetarian 13 15 28 5 5 10 38  
Total 30 10 40 100 
5%
95%
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11. UDAL KATTUGAL 
The Seven Udal Kattugal which constitute our body structure and help to maintain the normal 
physiological functions get changed in Pathological conditions. 
 
Sl. No UdarKattugal No of Cases Percentage 
1 Saaram 40 100.00% 
2 Senneer 40 100.00% 
3 Oon 0 0.00% 
4 Kozhuppu 0 0.00% 
5 Enbu 0 0.00% 
6 Moolai 0 0.00% 
7 Sukkilam/Suronitham 0 0.00% 
 
Among 40 patients, Saaram and Seneer were affected in all the cases. 
12.  DISTRIBUTION OF MUKKUTRAM 
The derangement of Vatham, Pitham and Kabam in venpulli are as follows 
 
VATHAM 
 
Sl. No Classification of Vatham No of Cases Percentage 
1 Pranan 0 0.00% 
2 Abanan 0 0.00% 
3 Udhanan 0 0.00% 
4 Samanan 40 100.00% 
5 Viyanan 40 100.00% 
6 Nagan 0 0.00% 
7 Koorman 0 0.00% 
8 Kirukaran 0 0.00% 
9 Devathathan 0 0.0% 
10 Dananjayan 0 0.00% 
 
Samanan and Viyanan was found to be affected in all the 40 patients.  
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PITHAM 
 
Sl. 
No 
Classification of Pitham No. of Cases Percentage 
1 Anarpitham 0 0.00% 
2 Ranjakam 40 100.00% 
3 Sathakam 0 0.00% 
4 Alosakam 0 0.00% 
5 Prasakam 40 100.00% 
 
Prasakam was affected in all the cases patients. Ranjakam too was affected in 40% of 
the patients. 
 
KABAM 
 
 
Sl. No Classification of Kabam No of Cases Percentage 
1 Avalambagam 0 0.00% 
2 Kilethagam 0 0.00% 
3 Pothagam 0 0.00% 
4 Tharpagam 0 0.00% 
5 Santhigam 0 0.00.% 
 
 
No changes reported in kabam in all patients. 
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13.  EN VAGAI THERVUGAL 
 
 
Sl. 
No En Vagai Thervugal No. of Cases Percentage 
1 Naa 0 0.00% 
2 Niram 40 100.00% 
3 Mozhi 0 0.00% 
4 Vizhi 0 0.00% 
5 Sparisam 40 100.00% 
6 Malam 0 0.00% 
7 Moothiram 0 0.00% 
8 Naadi   
 a. Vathapitham 21 52.50% 
 b. Pithavatham 19 47.50% 
                                                                                                                                                            
 
In En vagaithervugal, Niram and Sparisam were found affected in all the 40 cases. 
The Naadinadai seen in venpulli patients were Vathapitham 52.50 %, Pithavatham 47.50 %. 
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14.  NEERKKURI: 
 
Niram 
No. of  Out Patients No. of  In Patients Total Percentage 
Male Female Total Male Female Total 
Straw 8 2 10 8 2 10 12 30 
Yellow 9 4 13 2 3 5 15 37.5 
Pale yellow 6 5 11 3 1 4 13 32.5 
Total 34 10 40 100 
 
 
 
 
 
Inference: 
Out of 40 cases, colour of the urine for 30% of the patients were straw coloured, 37.50% 
were yellow coloured, 32.50% were Pale yellow coloured. 
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15.  NEIKKURI: 
Neikkuri 
No of  Out Patients No of  In Patients  
Total 
 
Percentage Male Female Total Male Female Total 
Vaatham 8 2 10 3 0 3 13 32.5 
Pitham 6 3 9 1 1 2 11 27.5 
Kabam 9 2 11 3 2 5 16 40 
Total 30 10 40 100 
 
 
                  
Inference:  
 Out of 40 cases 30% of patients showed Vaatham type of neikkuri pattern, 30% of 
patients showed Pitham type of neikkuri pattern and 40% of patients showed Kabam type of 
neikkuri pattern. 
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16.  MODERN CLASSIFICATION: 
 
 
Inference: 
Out of 40 cases generalised Vitiligo was seen in 30% cases, localized Vitiligo in 
67.5% cases, segmental Vitiligo in 2.5% cases. 
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No of  Out Patients No of  In Patients 
Total Percentage Male Female Total Male Female Total 
Generalised 1 1 2 6 4 10 12 30 
Localised 21 6 27 - - - 27 67.5 
Segmental 1 - 1 
 
- 
 
- 
 
- 1 2.5 
Total 30 10 
40 
 
100 
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17.  CHANGE IN COLOUR AFER TREATMENT: 
            
                       
 
Inference:   Among 40 cases no colour change was seen in 5 (12.5%) cases, yellowish tint 
colour change was seen in 16 (40%) cases, slight contrast between lesion colour and 
surrounding skin colour was seen in 12 (30%) cases, no contrast between lesion colour and 
surrounding skin colour was seen in 7 (17.5%) cases,  
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Change in colour 
No. of  Out Patients No. of  In Patients  
Total 
 
Percentage Male Female Total Male Female Total 
No change 4 1 5    5 12.5 
Yellowish tint 13 1 14 1 1 2 16 40 
Slight contrast 
between lesion 
colour and 
surrounding skin 
colour 
5 3 8 3 1 4 12 30 
No contrast 
between lesion 
colour and 
surrounding skin 
colour 
1 2 3 3 1 4 7 17.5 
Total 30 10 40 100 
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18.  REDUCTION IN SIZE AFTER TREATMENT: 
 
 
       
Inference:    Among 40 cases no reduction in size was seen in 8 (20%) cases, mild reduction 
was seen in 25 (62.5%) cases, considerable reduction was seen in 7 (17.5%) cases. 
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No. of  Out Patients No. of  In Patients  
Total 
 
Percentage Male Female Total Male Female Total 
No reduction 1 1 2 5 1 6 8 20 
Mild reduction 16 5 21 2 2 4 25 62.5 
Considerable 
reduction 6 1 7 
- 
 
- 
 
- 7 17.5 
Complete 
reduction 
- 
 
- 
 
- 
 
- - - - - 
Total 30 10 40 100 
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19. REPIGMENTATION PATTERN AFTER TREATMENT 
 
 
 Inference: 
Among 40 cases no repigmentation was seen in 5 (12.5%) cases, repigmentation in 
minimal numbers of patches was seen in 19 (47.5%) cases, repigmentation in more numbers 
of  patches was seen in 11 (27.5%) cases, repigmentation in all patches colour was seen in 5 
(12.5%) cases 
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Change in colour 
No. of  Out Patients No. of  In Patients  
Total 
 
Percentage Male Female Total Male Female Total 
No change 4 1 5    5 12.5 
Repigmentation 
in minimal 
numbers of 
patches  
4 8 12 5 3 8 20 50 
Repigmentation 
in more numbers 
of patches 
4 3 7 3 2 5 12 30 
Repigmentation 
in all patches 
1 2 3 
   
3 7.5 
Total 30 10 40 100 
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20.  COMPARISON: 
Repigmentation 
Trial drugs 
alone 
percentage 
Trial drugs+ 
Yogam 
percentage 
No repigmentation 5 16.66 0 0 
Repigmentation 
development 
25 83.33 10 100 
Total 30 100 10 100 
       
Inference: 
Among 10 In-Patients, all of the 10 patients developed repigmentation in the lesions. 
Among 30 Out-Patients, 25 patients developed repigmentation in the lesions and the 
remaining 5 Out-Patients didn’t develop any repigmentation. 
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21.  RESULTS AFTER TREATMENT 
 
 
   Inference: 
Among 40 cases no improvement was seen in 5 (12.5%) cases, mild improvement 
was seen in 28 (70%) cases moderate improvement was seen in 7 (17.5%)  
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Moderate Mild N o improvement
Improvement 
No. of  Out Patients No. of  In Patients 
Total Percentage 
Male Female Total Male Female Total 
Good (Grade 1) - - - - - - - - 
Moderate (Grade 
2) 3 1 4 2 1 3 7 17.5 
Mild (Grade 3) 16 5 21 5 2 7 28 70 
No (Grade 4) 2 3 5 - 
 
- 
-- 
- 5 12.5 
Deteriorated 
(Grade 5) 
- - - - - - - - 
Total 30 10 40 100 
 
 
BEFORE TREATMENT 
PATIENT’S NAME  : Mr.R.SUDHAKARAN 38/M (IP.NO.4973) 
SITE OF THE LESION : LEFT SIDE OF THE NECK 
 
AFTER TREATMENT 
 
 
 
 
    BEFORE TREATMENT 
 PATIENT’S NAME :Mrs.R. KAMATCHI 41/F (OP.NO.78437) 
SITE OF THE LESION :BACK OF THE LEFT ELBOW JOINT 
 
 
AFTER TREATMENT 
 
 
 
   
 BEFORE TREATMENT 
PATIENT’S NAME :Mrs.S. VANATHI SRI 37/F    (OP.NO.C40748) 
SITE OF THE LESION :RIGHT SIDE OF THE FOREHEAD 
 
 
               AFTER TREATMENT 
 
 
 
 
 
 
BEFORE TREATMENT  
PATIENT’S NAME:Mr.R. SATHEESH KUMAR25/M (OP.NO.58672) 
SITE OF THE LESION :CHEST REGION 
 
AFTER TREATMENT 
 
S.NO OP & IP NO NAME AGE SEX DOA TIME PERIOD DOD DAYS RESULT
1 C78264 J.RADHAKRISHNAN 48 M 22.7.12 5 YEARS 10.9.12 48 NO
2 C40748 S.VANATHISRI 37 F 24.7.12 15 YEARS 2.10.12 48 MLD
3 C58672 S.SATHISHKUMAR 25 M 27.7.12 7 YEARS 25.10.12 48 MODERATE
4 C62577 A.JAYAKUMAR 25 M 27.7.12 20 YEARS 22.9.12 48 MILD
5 W2115 B.KAVITHA 39 F 27.7.12 7 YEARS 24.9.12 48 MILD
6 C67074 M.SARAVANAKUMAR 30 M 28.7.12 3 YEARS 30.10.12 48 MILD
7 C26240 RAJESH KANNA 34 M 28.7.12 12 YEARS 18.9.12 48 NO
8 C72874 P.KUMARI 51 F 28.7.12 15 YEARS 18.9.12 48 MILD
9 B85008 RANJITHKUMAR 31 M 28.7.12 11 YEARS 18.9.12 48 MILD
10 C80290 S.RANGANATHAN 46 M 29.7.12 13 YEARS 1.10.12 48 NO
11 C26766 JOTHILAKSHMI 23 F 29.7.12 1 1/2 MONTHS 6.10.12 48 MILD
12 C69625 M.DURAIBABU 33 M 25.7.12 3 YEARS 3.10.12 48 MILD
13 C72769 P.REVATHY 22 F 2.8.12 7 YEARS 20.11.12 48 MILD
14 C51835 B.SHANKARI 35 F 3.8.12 5 YEARS 21.11.12 48 NO
15 C3326 VIJAYALAKSHMI 29 F 5.8.12 5 YEARS 23.11.12 48 NO
16 C20487 K.NAGAMMAL 33 F 5.8.12 15 YEARS 23.11.12 48 MILD
17 C78437 R.KAMATCHI 41 F 6.8.12 5 YEARS 2.11.12 48 GOOD
18 C78792 S.USHA 24 F 13.8.12 7 YEARS 3.10.12 48 MILD
19 C87874 V.SUDHARSAN 23 M 3.8.12 10 MONTHS 2.10.12 48 MODERATE
20 C88480 V.AMUDHA 30 F 18.8.12 9 YEARS 27.10.12 48 MILD
21 C760521 J.JOSHWA JAYASEELAN RAFIL 18 M 18.8.12 4 YEARS 27.10.12 48 MODERATE
22 C77212 B.REVATHY 24 F 19.8.12 2 YEARS 28.10.12 48 MILD
23 C73596 A.GOKULAKANNAN 18 M 20.8.12 3  YEARS 26.10.12 48 MILD
24 B13375 MURUGAMMAL 39 F 22.8.12 10 YEARS 28.10.12 48 MILD
25 C19651 S.VIJAYAKUMAR 37 M 23.8.12 3 YEARS 29.10.12 48 MILD
26 C54015 T.KANNAN 29 M 25.8.12 15 YEARS 24.10.12 48 MILD
27 C93640 S.PRIYA 20 F 1.9.12 2 YEARS 22.10.12 48 MILD
28 C95201 P.SASIKUMAR ROW 37 M 6.9.12 7 MONTH 2.11.12 48 MILD
29 C94503 S.MAHALAKSHMI 26 F 11.9.12 21 YEARS 1.11.12 48 MILD
30 C94449 P.BASKARAN 37 M 14.9.12 2 MONTHS 4.11.12 48 MLD
31 40021 R.RUKMANI 55 F 25.7.12 2 YEARS 16.9.12 48 MLD
32 4973 K.SUDHAKARAN 38 M 27.7.12 5 YEARS 16.9.12 48 MODERATE
33 B90639 E.DHANALAKSHMI 36 F 28.7.12 7 YEARS 28.9.12 48 MILD
34 4012 V.SAROJA 55 F 28.7.12 2 MONTHS 20.8.12 48 MILD
35 4977 G.KANNAN 35 M 28.7.12 2 MONTHS 13.9.12 48 MODERATE
36 5032 M.JULION 54 M 16.8.12 12 YEARS 7.9.12 48 MODERATE
37 4127 R.GNANASUNDARI 30 F 27.8.12 2 YEARS 10.9.12 48 MILD
38 5095 V.SATHISHKUMAR 21 M 3.9.12 3 YEARS 23.10.12 48 GOOD
39 84807 R.MATHANRAJ 26 M 13.9.12 3 MONTHS 3.11.12 48 MILD
40 4196 S.NEELA 40 F 20.9.12 1 YEAR 10.11.12 48 MILD
OP AND IP CASES CLINICAL IMPROVEMENT
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INVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
 
 
 
 
S.No 
 
 
 
OP/IP 
No 
 
 
NAME 
 
 
AGE/SEX 
 
 
Hb (gm/dl) 
 
TOTAL RBC 
COUNT 
(million/cu.mm) 
 
ESR (mm/hour) 
BT AT BT AT BT AT 
1. 
2. 
3. 
4. 
5 
6 
7 
8 
9 
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11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
C78264 
C40748 
C58672 
C62577 
W2115 
C67074 
C26240 
C72874 
B85008 
C80290 
C26766 
C69625 
C72769 
C51835 
C3326 
C20487 
C78437 
C78792 
C87874 
C88480 
R.Radhakrishnan 
S.Vanathisri 
S.Sathishkumar 
A.Jayakumar 
B.Kavitha 
M.Saravanakumar 
Rajeshkumar 
P.kumari 
Ranjithkumar 
S.Ranganathan 
Jothilaksmi 
M.Duraibabu 
P.Revathy 
B.Shankari 
B.Vijayalaksmi 
K.Nagammal 
R.Kamatchi 
Usha 
V.Sudharsan 
V.Amudha 
48/M 
37/F 
25/M 
25/M 
39/F 
30/M 
34/M 
51/F 
31/M 
46/M 
23/F 
33/M 
22/F 
35/F 
29/F 
33/F 
41/F 
24/F 
23/M 
30/F 
13.7 
14.4 
14.1 
15.2 
10.9 
16.09 
10.8 
13.9 
15.1 
14.9 
14.2 
15 
12.7 
13.7 
14 
13.6 
11.7 
12.2 
16.3 
12.7 
14.1 
11.9 
15.3 
16 
13 
15.8 
10.4 
14.6 
13.3 
15 
14.8 
12.9 
11.3 
13.7 
11.5 
14 
10.9 
11.6 
15.5 
10.5 
4.8 
4.6 
4.7 
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4.2 
5.3 
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5.7 
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4.9 
5.2 
4.3 
5.1 
4.3 
4.5 
4.5 
3.9 
5.3 
5.1 
8/16 
10/22 
4/8 
2/4 
52/100 
2/4 
12/22 
8/20 
6/14 
2/6 
2/4 
2/6 
4/20 
2/4 
20/42 
4/8 
2/4 
20/40 
2/4 
2/6 
 2/12 
4/8 
2/4 
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2/4 
6/14 
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                                       INVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
 
 
S.No 
 
 
 
OP/IP 
No 
 
 
NAME 
 
 
AGE/ 
SEX 
 
 
Hb (gm/dl) 
 
TOTAL 
RBC 
COUNT 
(million/cu.
mm) 
 
ESR 
(mm/hour) 
BT AT BT AT BT AT 
21 
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28 
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32 
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34 
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39 
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C760521 
C77212 
C73596 
B13375 
C19651 
C54015 
C93640 
C95201 
C94503 
C94449 
40021 
4973 
B90639 
4012 
4977 
5032 
4127 
5095 
C84807 
4196 
J.Joshwa jayaseelan rafil 
B.Revathy 
A.gokulakannan 
Murugammal 
S.Vijayakumar 
 T.Kannan 
S.Priya 
P.Sasikumar row 
S.Mahalakshmi 
P.Baskaran 
R.Rukmani 
K.Sudhakaran 
E.Dhanalakshmi 
V.Saroja 
G.Kannan 
M.Julion 
R.Gnanasundari 
V.Sathishkumar 
R.Mathanraj 
S.Neela 
18/M 
24/F 
18/M 
39/F 
37/M 
29/M 
20/F 
37/M 
26/F 
37/M 
55/F 
38/M 
36/F 
55/F 
35/M 
54/M 
30/F 
21/M 
26/M 
40/F 
17.3 
13.4 
17 
13.4 
15 
17.2 
14.4 
13.1 
12.2 
17.5 
13.6 
14.2 
11.5 
12.8 
13.8 
16.7 
13.0 
16.2 
17.2 
12.8 
15 
11 
17.5 
13.5 
14.3 
16 
13.9 
12.0 
12.5 
17.3 
13.5 
15.7 
11.3 
13.7 
14.3 
15.8 
13.2 
13.9 
16.9 
12.6 
5.9 
4.6 
5.5 
4.1 
4.6 
5.7 
5.0 
4.4 
4.1 
5.9 
4.8 
4.6 
5.0 
4.0 
4.8 
5.0 
4.3 
4.5 
5.7 
4.3 
5.5 
4.6 
5.7 
4.0 
5.0 
5.5 
4.9 
4.8 
4.5 
5.9 
4.7 
5.0 
5.1 
4.4 
5.0 
4.8 
4.4 
4.8 
5.6 
4.3 
2/4 
4/16 
2/4 
6/12 
2/4 
2/4 
2/4 
2/10 
4/12 
2/4 
2/8 
2/4 
22/46 
10/28 
2/4 
2/4 
2/6 
2/4 
2/4 
6/12 
2/4 
2/6 
2/4 
6/12 
2/6 
2/4 
2/4 
12/26 
4/8 
2/4 
6/20 
2/4 
6/14 
8/22 
6/18 
4/8 
4/8 
2/4 
2/4 
4/8 
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LABORATORYINVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
 
 
 
S.N
o 
 
 
 
OP/IP No 
 
 
NAME 
 
 
AGE/ 
SEX 
 
BLOOD (mg/dl)  
UREA  
(mg/dl) 
 
CREATININ
E (mg/dl) 
FASTING 
(mg/dl) 
POST 
PRANDIA
L(mg/dl) 
BT AT BT AT BT AT BT AT 
1. 
2. 
3. 
4. 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
C78264 
C40748 
C58672 
C62577 
W2115 
C67074 
C26240 
C72874 
B85008 
C80290 
C26766 
C69625 
C72769 
C51835 
C3326 
C20487 
C78437 
C78792 
C87874 
C88480 
R.Radhakrishnan 
S.Vanathisri 
S.Sathishkumar 
A.Jayakumar 
B.Kavitha 
M.Saravanakumar 
Rajeshkumar 
P.kumari 
Ranjithkumar 
S.Ranganathan 
Jothilaksmi 
M.Duraibabu 
P.Revathy 
B.Shankari 
B.Vijayalaksmi 
K.Nagammal 
R.Kamatchi 
Usha 
V.Sudharsan 
V.Amudha 
48/M 
37/F 
25/M 
25/M 
39/F 
30/M 
34/M 
51/F 
31/M 
46/M 
23/F 
33/M 
22/F 
35/F 
29/F 
33/F 
41/F 
24/F 
23/M 
30/F 
111 
72 
91 
81 
71 
92 
83 
81 
77 
83 
93 
85 
92 
92 
74 
92 
81 
78 
82 
76 
97 
90 
93 
91 
72 
96 
91 
101 
96 
100 
97 
106 
94 
85 
83 
94 
101 
90 
95 
95 
120 
94 
108 
100 
98 
105 
103 
98 
98 
93 
126 
100 
111 
112 
92 
105 
136 
80 
98 
98 
112 
90 
112 
111 
100 
111 
106 
110 
116 
114 
113 
123 
117 
97 
101 
110 
121 
104 
116 
108 
17 
23 
23 
20 
14 
17 
14 
17 
19 
26 
14 
22 
17 
15 
14 
20 
16 
24 
21 
19 
17 
18 
22 
19 
18 
14 
18 
14 
19 
23 
22 
23 
14 
22 
14 
20 
17 
19 
14 
16 
0.7 
0.8 
0.8 
0.6 
0.5 
0.6 
0.5 
0.6 
0.6 
0.7 
0.4 
0.6 
0.7 
0.4 
0.5 
0.6 
0.5 
0.8 
0.6 
0.5 
0.8 
0.6 
0.8 
0.5 
0.8 
0.5 
0.5 
0.4 
0.6 
0.7 
0.7 
0.7 
0.4 
0.7 
0.4 
0.6 
0.6 
0.7 
0.5 
0.5 
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 LABORATORYINVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
 
 
 
S. 
No 
 
 
 
OP/IP No 
 
 
NAME 
 
 
AGE/ 
SEX 
 
BLOOD (mg/dl)  
UREA  
(mg/dl) 
 
CREATININ
E (mg/dl) 
FASTING 
(mg/dl) 
POST 
PRANDIAL
(mg/dl) 
BT AT BT AT BT AT BT AT 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
 
C760521 
C77212 
C73596 
B13375 
C19651 
C54015 
C93640 
C95201 
C94503 
C94449 
40021 
4973 
B90639 
4012 
4977 
5032 
4127 
5095 
C84807 
4196 
J.Joshwa jayaseelan rafil 
B.Revathy 
A.gokulakannan 
Murugammal 
S.Vijayakumar 
 T.Kannan 
S.Priya 
P.Sasikumar row 
S.Mahalakshmi 
P.Baskaran 
R.Rukmani 
K.Sudhakaran 
E.Dhanalakshmi 
V.Saroja 
G.Kannan 
M.Julion 
R.Gnanasundari 
V.Sathishkumar 
R.Mathanraj 
S.Neela 
18/M 
24/F 
18/M 
39/F 
37/M 
29/M 
20/F 
37/M 
26/F 
37/M 
55/F 
38/M 
36/F 
55/F 
35/M 
54/M 
30/F 
21/M 
26/M 
40/F 
91 
107 
102 
72 
83 
89 
78 
91 
87 
80 
98 
83 
80 
79 
96 
78 
82 
100 
79 
91 
92 
87 
80 
90 
98 
90 
82 
89 
80 
90 
92 
93 
95 
82 
100 
80 
90 
99 
90 
87 
105 
119 
117 
108 
93 
106 
100 
127 
127 
103 
106 
125 
99 
102 
113 
100 
104 
115 
112 
110 
105 
117 
90 
103 
120 
108 
112 
107 
110 
105 
101 
141 
107 
100 
120 
97 
104 
118 
102 
103 
20 
28 
14 
14 
20 
14 
21 
19 
14 
13 
20 
19 
20 
19 
23 
21 
16 
15 
14 
14 
20 
21 
17 
17 
21 
16 
20 
17 
17 
16 
14 
37 
19 
16 
26 
19 
19 
15 
16 
17 
0.6 
0.8 
0.4 
0.4 
0.6 
0.4 
0.8 
0.5 
0.4 
0.4 
0.6 
0.6 
0.7 
0.6 
0.7 
0.6 
0.5 
0.4 
0.4 
0.4 
0.6 
0.6 
0.7 
0.7 
0.7 
0.6 
0.8 
0.6 
0.7 
0.7 
0.4 
0.9 
0.6 
0.5 
0.7 
0.8 
0.6 
0.5 
0.7 
0.7 
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LABORATORYINVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 
 
 
OP/IP No 
 
 
NAME 
 
 
AGE/SEX 
 
 
SGOT (IU/L) 
 
SGPT (IU/L) 
BT AT 
AT 
BT AT 
AT 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
C78264 
C40748 
C58672 
C62577 
W2115 
C67074 
C26240 
C72874 
B85008 
C80290 
C26766 
C69625 
C72769 
C51835 
C3326 
C20487 
C78437 
C78792 
C87874 
C88480 
R.Radhakrishnan 
S.Vanathisri 
S.Sathishkumar 
A.Jayakumar 
B.Kavitha 
M.Saravanakumar 
Rajeshkumar 
P.kumari 
Ranjithkumar 
S.Ranganathan 
Jothilaksmi 
M.Duraibabu 
P.Revathy 
B.Shankari 
B.Vijayalaksmi 
K.Nagammal 
R.Kamatchi 
Usha 
V.Sudharsan 
V.Amudha 
48/M 
37/F 
25/M 
25/M 
39/F 
30/M 
34/M 
51/F 
31/M 
46/M 
23/F 
33/M 
22/F 
35/F 
29/F 
33/F 
41/F 
24/F 
23/M 
30/F 
23 
8 
14 
18 
73 
18 
10 
27 
33 
20 
20 
26 
11 
29 
22 
14 
17 
12 
22 
14 
23 
10 
18 
17 
38 
12 
19 
26 
22 
14 
14 
17 
11 
35 
11 
16 
10 
27 
13 
22 
25 
9 
17 
19 
94 
22 
12 
28 
36 
21 
18 
27 
12 
30 
24 
19 
19 
15 
31 
16 
25 
12 
20 
19 
33 
14 
21 
28 
24 
16 
15 
19 
12 
29 
12 
22 
12 
21 
14 
24 
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S.No 
 
 
 
OP/IP No 
 
 
NAME 
 
 
AGE/
SEX 
 
 
SGOT (IU/L) 
 
SGPT (IU/L) 
BT AT 
AT 
BT AT 
AT 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
C760521 
C77212 
C73596 
B13375 
C19651 
C54015 
C93640 
C95201 
C94503 
C94449 
40021 
4973 
B90639 
4012 
4977 
5032 
4127 
5095 
C84807 
4196 
J.Joshwa jayaseelan rafil 
B.Revathy 
A.gokulakannan 
Murugammal 
S.Vijayakumar 
 T.Kannan 
S.Priya 
P.Sasikumar row 
S.Mahalakshmi 
P.Baskaran 
R.Rukmani 
K.Sudhakaran 
E.Dhanalakshmi 
V.Saroja 
G.Kannan 
M.Julion 
R.Gnanasundari 
V.Sathishkumar 
R.Mathanraj 
S.Neela 
18/M 
24/F 
18/M 
39/F 
37/M 
29/M 
20/F 
37/M 
26/F 
37/M 
55/F 
38/M 
36/F 
55/F 
35/M 
54/M 
30/F 
21/M 
26/M 
40/F 
19 
34 
15 
16 
35 
34 
20 
19 
36 
44 
28 
22 
21 
26 
12 
22 
20 
17 
15 
19 
22 
11 
20 
25 
26 
34 
19 
13 
29 
27 
16 
24 
13 
24 
15 
30 
27 
31 
28 
33 
20 
36 
16 
17 
47 
45 
19 
21 
30 
36 
29 
23 
24 
32 
13 
23 
21 
19 
16 
20 
24 
12 
22 
20 
27 
34 
19 
14 
20 
21 
18 
26 
15 
29 
17 
27 
25 
28 
23 
27 
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LABORATORY INVESTIGATIONS BEFORE AND AFTER TREATMENT 
 
 
 
  
 
 
 
 
 
OP/IP 
No 
 
 
NAME 
 
 
AGE/ 
SEX 
 
 
URINE 
SUGAR  
(F) 
 
URINE 
SUGAR 
(PP) 
 
ALBUMIN 
 
               DEPOSITS 
 
Epithelial cells Pus cells 
BT AT BT AT BT AT BT AT BT AT 
1. 
2. 
3. 
4. 
5. 
6. 
  7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
 
C78264 
C40748 
C58672 
C62577 
W2115 
C67074 
C26240 
C72874 
B85008 
C80290 
C26766 
C69625  
C72769 
C51835 
C3326 
C20487 
C78437 
C78792 
C87874 
C88480 
R.Radhakrishnan 
S.Vanathisri 
S.Sathishkumar 
A.Jayakumar 
B.Kavitha  
M.Saravanakumar 
Rajeshkumar 
P.kumari 
Ranjithkumar 
S.Ranganathan 
Jothilaksmi 
M.Duraibabu 
P.Revathy 
B.Shankari 
B.Vijayalaksmi 
K.Nagammal 
R.Kamatchi 
Usha 
V.Sudharsan 
V.Amudha 
48/M 
37/F 
25/M 
25/M 
39/F 
30/M 
34/M 
51/F 
31/M 
46/M 
23/F 
33/M 
22/F 
35/F 
29/F 
33/F 
41/F 
24/F 
23/M 
30/F 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
nil 
nil 
nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
Nil 
Nil 
nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
Nil 
Nil 
nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
Nil 
Nil 
Nil 
1-3 
1-2 
2-4 
4-5 
1-2 
1-2 
2-4 
1-2 
1-2 
1-2 
1-2 
1-2 
2-4 
4-8 
3-6 
2-4 
5-6 
1-2 
2-4 
4-5 
 
2-4 
1-2 
1-2 
3-4 
2-4 
1-2 
2-4 
1-2 
2-4 
2-4 
2-4 
6-8 
3-6 
3-6 
4-8 
2-4 
2-3 
2-3 
1-2 
2-4 
1-2 
1-2 
1-2 
2-4 
2-4 
2-4 
1-2 
1-2 
1-2 
2-4 
1-2 
1-2 
1-2 
1-2 
6-8 
3-6 
2-4 
3-4 
1-2 
2-4 
4-8 
2-4 
1-2 
2-4 
2-4 
3-6 
1-2 
1-2 
2-4 
1-2 
2-4 
1-2 
4-8 
1-2 
3-6 
2-4 
2-4 
1-3 
1-2 
2-4 
3-6 
S. 
No 
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S. 
No 
 
 
 
OP/IP No 
 
 
NAME 
 
 
AGE/ 
SEX 
 
 
URINE 
SUGAR 
(F) 
 
URINE 
SUGAR 
(PP) 
 
ALBUMIN 
 
               
DEPOSITS 
 
Epithelial 
cells 
Pus cells 
BT AT BT AT BT AT BT AT BT AT 
21. 
  22. 
23. 
24. 
25. 
26. 
  27. 
28. 
29. 
30. 
31. 
32. 
33. 
34. 
35. 
36. 
37. 
38. 
39. 
40. 
 
C760521 
C77212 
C73596 
B13375 
C19651 
C54015 
C93640 
C95201 
C94503 
C94449 
IP 40021 
IP 4973 
IP 90639 
IP 4012 
IP 4977 
IP 5032 
IP 4127 
IP 5095 
IP 4807 
IP 4196 
J.Joshwa jayaseelan rafil 
B.Revathy 
A.gokulakannan 
Murugammal 
S.Vijayakumar 
 T.Kannan 
S.Priya 
P.Sasikumar row 
S.Mahalakshmi 
P.Baskaran 
R.Rukmani 
K.Sudhakaran 
E.Dhanalakshmi 
V.Saroja 
G.Kannan 
M.Julion 
R.Gnanasundari 
V.Sathishkumar 
R.Mathanraj 
S.Neela 
18/M 
24/F 
18/M 
39/F 
37/M 
29/M 
20/F 
37/M 
26/F 
37/M 
55/F 
38/M 
36/F 
55/F 
35/M 
54/M 
30/F 
21/M 
26/M 
40/F 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
nil 
nil 
nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
nil 
 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
Nil 
Nil 
nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
Nil 
Nil 
nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
Nil 
nil 
Nil 
Nil 
Nil 
1-3 
1-2 
2-4 
4-5 
1-2 
1-2 
2-4 
1-2 
1-2 
1-2 
1-2 
1-2 
2-4 
4-8 
3-6 
2-4 
5-6 
1-2 
2-4 
4-5 
 
2-4 
1-2 
1-2 
3-4 
2-4 
1-2 
2-4 
1-2 
2-4 
2-4 
2-4 
6-8 
3-6 
3-6 
4-8 
2-4 
2-3 
2-3 
1-2 
2-4 
 
1-2 
1-2 
2-4 
2-4 
2-4 
1-2 
1-2 
1-2 
2-4 
1-2 
1-2 
1-2 
1-2 
6-8 
3-6 
2-4 
3-4 
1-2 
2-4 
4-8 
2-4 
1-2 
2-4 
2-4 
3-6 
1-2 
1-2 
2-4 
1-2 
2-4 
1-2 
4-8 
1-2 
3-6 
2-4 
2-4 
1-3 
1-2 
2-4 
3-6 
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DISCUSSION 
  Yugi Vaidya Chinthamani describes Venpulli  as Suvetha Kuttam, which is one among 
the Eighteen types of Kuttam. As the term ‘Kuttam’ bears social stigma, the disease is called as 
Venpulli instead of Venkuttam.  
 The clinical entity of Venpulli is more or less similar to that of Vitiligo in modern 
medicine. It is an acquired idiopathic depigmentary condition and is characterized by completely 
depigmented macules and patches of varying sizes and shapes. Besides loss of colour there is no 
other structural change. It is also a non-contagious disease.  
 The author has collected information largely from the literatures and text books like 
Siddha Maruthuvam - Sirappu, Yugi Vaithya Chinthamani, Gurunaadi Nool, Dhanvanthiri 
Vaidhiyam and Agathiyar Kanma Kaandam in which the Siddha methods of diagnosis have been 
dealt with.  
The trial drugs for this study were prepared by the Author in the Gunapadam practical 
laboratory of National Institute of Siddha, under the supervision of the members of the teaching 
faculty and guided by the Head of the Department of Sirappu Maruthuvam of the National 
Institute of Siddha, Chennai - 47.  
In Siddha system, before starting the treatment it is necessary to bring the Mukkutram to 
equilibrium. By giving purgation we can normalize the deranged Vatham.  
                                  “Å¢§ÃºÉò¾¡ø Å¡¾õ ¾¡Øõ” 
          Purgation with Karudan Kizhlangu Ennai - 5ml with hot water at early morning was 
given for balancing the deranged Mukkutram a day before treatment for all the patients.  
The trial drugs Yaanai Nerungil Chooranam (Internal) and Pathiyaa Lebanam (External) 
were given for 48 days. Out-Patients were asked to visit the hospital once in days. For Out-
Patients the drugs were given for 48 days and the clinical assessment was done on 0th day, 8th 
day, 15th day, 22th day 29th day, 36th day, 43rdday,49thday. 
 For In-Patients the drugs were given for 48 days and the clinical assessment was done 
daily. 10 In-Patients were given Yogam treatment along with their trial drugs. The results were  
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compared at the end of the study. For In-Patients, who are not in a situation to stay in the hospital 
for a long time, were advised to attend the Out-Patient Department of Sirappu Maruthuvam for 
further follow- up. 
Patients were instructed to take the medicines regularly and apply the external medicine 
twice a day and to expose the affected parts to sunlight in the morning. It was ensured that the 
diet restrictions imposed were followed properly by the patients. 
After the treatment, the patients were advised to visit the Out-Patient ward of Department 
of Sirappu Maruthuvam for another 2 months for follow-up.  
 40 patients of both genders were recruited for this study. Among the 40 cases 20(50%) 
were males and 20 (50%) were females. Generally Venpulli affects both the sexes, this study 
shows equal number of males and females affected. 
 3 (7.5%) patients were in the age group between 18 -20 years, 15 (37.5%) patients 
between 21 and 30 years, 15 (37.5%) patients between 31 and 40 years, 3 (7.5%) patients 
between 41 and 50 years, 4 (10%) patients between 51 - 60. Venpulli affects people of all the age 
groups. In this study most of the cases were reported in the middle age group ie (21 to 40years) 
 38 (95.5%) patients were non vegetarians and only 2 (5%) were vegetarians. According 
to Siddha literature, non- vegetarian foods are one of the precipitating factors for skin diseases. 
This present study also emphasizes the same.  
 14 (35%) cases were admitted to trial in Kaar Kaalam, 26 (65%) cases were admitted in 
Munpani Kaalam. 
           Among the 40 patients, 3 (7.5%) were from Marutham and 37 (92.5 %) were from Neithal 
thinai. 
          In this study maximum patients were coming from in and around Chennai which belongs 
to Neithal thinai. According to Siddha literature skin diseases are more prevalent in Neithal 
thinai. In Siddha literature, Marutha nilam is mentioned as the land which is free of diseases 
among the five lands. Venpulli occurs in Marutham irrespective of the nature of the land but its 
prevalence is low. 
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        Viyanan (Depigmentation / hypopigmentation of the skin) and Samanan were affected in 
all the cases (100%).  
Praasakam and Ranjagam were affected in all the 40 (100 %) patients. Ranjagam is 
responsible for the colour of blood. Praasakam is responsible for the complexion of the skin. 
Hence the defect in Ranjagam and Praasakam may lead to the causative factor for this disease.  
No changes were reported in kabam in all the 40 patients. 
Saaram and Senneer were affected in all the 40 (100 %) cases. Saaram and Senneer are 
responsible for the colour of the skin. Decreased Senneer (Senneer Kurai Kunam) results in 
Hypopigmentation of the skin. Decreased Saaram is the cause for the depressive psychology in 
patients. 
Niram was affected in all the 40 (100 %) cases. In Venpulli, the colour of skin changes 
into white.  
Laboratory investigations were done before and end of the trail. Photographs were also 
taken before, during and after the trail. 
Laboratory investigations were done before treatment (0th day), and after treatment (49th 
day) of the trial for both the Out-Patients and the In-Patients to find out any abnormal changes in 
laboratory parameters (CBC, RFT, LFT) 
The colour of the patches and the surrounded skin were observed in all the 40 patients 
after the trial period. Among 40 cases no change in the colour of the lesion was seen in 5 
(12.5%) cases, yellowish tint colour change was seen in 16 (40%) cases, slight contrast between 
lesion colour and surrounding skin colour was seen in 12 (30%) cases, no contrast between 
lesion colour and surrounding skin colour was seen in 7 (17.5%) cases,  
Among 40 cases no reduction in size was seen in 8 (20%) cases, mild reduction was seen 
in 25 (62.5%) cases, considerable reduction was seen in 7 (17.5%) cases.  
Among 40 cases no repigmentation was seen in 5 (12.5%) cases, repigmentation in 
minimal numbers of patches was seen in 20(50%) cases, repigmentation in more numbers of 
patches was seen in 12 (30%) cases, repigmentation in all the patches were seen in 3 (7.5%) 
cases. 10 In-Patients, who received Yogam treatment along with trial drugs showed good 
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prognosis when compared to the patients treated without Yogam. All the 10 patients developed 
repigmentation in the lesions. 
Among 30 Out-Patients, 25 patients developed repigmentation in the lesions and the 
remaining 5 Out-Patients didn’t develop any repigmentation. 
It was also observed during this trial that no new lesions were formed and there was no 
increase in any existing lesion was found in all the 40 patients. 
Among 40 cases no improvement was seen in 5 (12.5%) cases, mild improvement was 
seen in 28 (70%) cases, moderate improvement was seen in 7 (17.5%) cases.  
Patients who had chronic lesions showed mild improvement only. Patients who had 
lesions recently (approximately 1-5 years) showed considerable improvement. 
The acute toxicity study was conducted for the trial drug Yaanai Nerungil Chooranam in 
National Institute of Siddha and it showed no abnormal results. Hence the safety of the trial drug 
was also proved. 
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SUMMARY 
Various literatures dealing with Venpulli were collected from Siddha and Modern text 
books. 
Preclinical analysis in toxicological and biochemical aspects were conducted for the trial 
drug Yaanai Nerunjil Chooranam.  
40 patients of both the sexes and in the age group between 18 to 60 were selected for the 
study. 10 cases in the In-Patient ward were given Yogam therapy along with the trial drugs for 
48 days. 30 cases were treated in the Out-Patient Department for 48 days only with the trial 
drugs. 
All the details about the study and the drugs were informed to the patients in their 
vernacular language and consent forms duly signed by them were obtained from them.  Before 
starting the treatment, the blood samples of the selected patients were subjected to investigation 
and photographs of the lesions were taken. 
A day before starting the treatment purgation was given by administering Karudan 
Kizhangu Ennai - 5ml with hot water in the early morning to bring the Thirithodam to 
equilibrium. 
From the second day onwards Yaanai Nerunjil Chooranam -2gm (twice a day) along with 
hot water was given internally and Pathiyaa Lebanam with Cow’s urine for external use were 
given to the patients. 
Diet restrictions were strictly imposed during the treatment period.  Every 7th day, the 
patients were assessed for clinical improvement and adverse effects. at the end of the treatment 
(49th day) the laboratory investigations were repeated. The photographs of the lesions were taken 
whenever necessary. Photographs were also taken before, during and after the trial. The 
improvement was assessed. 
During the course of treatment there were no adverse effects or unwanted drug reactions 
in GIT, RS, CVS and Excretory systems. There were no symptoms such as nausea, oral ulcers, 
abdominal discomfort, dyspnoea, cough, palpitations, raised blood pressure, dysuria/oliguria and 
pedal edema.  
It is Concluded that “Yaanai Nerunjil Chooranam - internally” and “Pathiyaa Lebanam- 
externally” are effective in producing repigmentation and reducing the size of the depigmented 
patches in the treatment of “Venpulli” (Vitiligo). 
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CONCLUSION 
 
The clinical study reveals that the trial drug showed Grade 2 – moderate improvement 
in 17.5% of the cases, Grade 3 – mild improvement in 70% of the cases, Grade 4 – no 
improvement in 12.5% cases. 
Yogam treatment along with the trial drugs showed good prognosis when compared to 
patients treated only with trial drugs. Hence the study reveals the importance of Yogam in 
treating Venpulli.  
Clinically, no adverse effects were reported during the trial and the laboratory 
investigations were also within normal limits. So, the drug is assumed to be safe for humans. 
Acute toxicity study in animal models reveals that the trial drug Yaanai Nerunjil 
Chooranam” is safe.  The safety of the trial drug was also proved from this study.  
Because of the encouraging clinical results, it could be concluded that “Yaanai 
Nerunjil Chooranam - internally” and “Pathiyaa Lebanam externally” are effective in 
producing repigmentation and reducing the size of the de-pigmented patches in the treatment 
of “ Venpulli” (Vitiligo). 
113 
 
QUALITATIVE ANALYSIS 
SL.NO EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample Brown in colour  
2. Solubility:  
a. A little of the sample is 
shaken well with distilled 
water. 
b. A little of the sample is 
Shaken well with con. Hcl 
 Con. H2SO4. 
 
Completely soluble 
 
 
 
Completely soluble 
 
 
 
 
 
Absence of Silicate 
3. Action of Heat: 
A small amount of the sample is 
taken in a dry test tube and 
heated gartly at first and then 
Strong. 
 
 
White fumes not 
evolved 
 
Brown fumes not 
evolved 
 
 
Absence of 
Carbonate.                        
 
Absence of Nitrate. 
4. Flame  Test: 
A small amount of the sample is 
made into a paste with con. Hcl 
in a watch glass and introduced 
into non-luminous part of the 
Bunsen flame. 
 
White flame  is 
appeared 
 
 
 
Absence of Copper. 
5 Ash Test: 
A filter paper is soaked into a 
mixture of sample and cobalt 
nitrate solution and introduced 
into the Bunsen flame and 
ignited 
 No Yellow colour 
flame. 
 
Absence of Sodium. 
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Preparation of the extract 
 
5 gm   of  Yaanai Nerunjil Chooranam was weighed accurately and placed in a 
250 ml clean beaker. Then 50 ml distilled water was added and dissolved well. Then  
it is boiled well for about 10 minutes. It was cooled and filtered in a 100 ml 
volumetric flask and then it was made up to 100 ml with distilled water. This fluid 
was taken for analysis. 
 
  
SL.NO EXPERIMENT OBSERVATION INFERENCE 
TEST FOR ACID RADICALS 
1. Test For Sulphate: 
a. 2 ml of the above prepared 
extract is taken in a test tube to 
this added 2ml of 4% ammonium 
oxalate solution 
b. 2ml of the above prepared 
extract is added with 2 ml of dil-
Hcl is added until the 
effervescence ceases off. Then 2ml 
of Barium chloride solution is 
added 
Cloudy appearance 
present 
 
 
 
A white precipitate 
insoluble in con. Hcl is 
obtained 
Absence of Sulphate. 
 
 
 
Sulphate is not 
confirmed.                    
2. Test For Chloride: 
2 ml of the above prepared 
extract is added with dil. HNO3 till 
the effervescence ceases. Then 2 
ml of silver nitrate  solution  is 
added. 
Cloudy appearance 
present 
 
Absence of Chloride. 
 
3. Test For Phosphate: 
2 ml of the extract is treated with 
2ml of ammonium molybdate 
solution and 2 ml of con. HNO3 
 Cloudy yellow 
appearance present 
Absence of 
 Phosphate.        
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4. Test For Carbonate: 
2m1 of the extract is treated with 
2m1 magnesium sulphate solution 
No cloudy appearance 
Absence  of 
Carbonate. 
5 Test For Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated H2SO4   and viewed 
the test tube vertically down. 
 
 
Brown gas is not 
evolved 
 
 
 
Absence of Nitrate. 
 
 
 
6. Test For Sulphide: 
1 gm of the substance is 
treated with 2m1 of con. Hcl. 
 
No Rotten egg 
smelling gas evolved 
 
 
Absence of 
Sulphide. 
 
7. 
 
 
 
 
Test For Fluoride&Oxalate 
     2 m1 of The Extract Is Added 
With 2m1of Acetic Acid and 2 m1 
calcium Chloride solution and 
heated. 
 
No Cloudy appearance. 
 
 
Absence of  Fluoride 
& Oxalate 
 
8.  
 
 
 
Test For Nitrite: 
   3drops of extract is placed on a 
filter paper,on that 2 drops of 
acetic Acid and 2 drops of 
benzidine solution is placed. 
 
No characteristic 
changes 
 
 
Absence of nitrite. 
9. 
 
 
 
Test For Borate: 
    2 pinches of the substance is 
made into paste by using sulphuric 
acid and alcohol (95%) and 
introduced into the blue flame. 
 
 
Bluish green colour 
flame not appeared.. 
 
Absence of borate. 
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II. TEST FOR BASIC RADICALS 
1 Test For Lead: 
2 m1of the extract is added with 
2m1of potassium iodide solution. 
 
 No Yellow precipitate 
is obtained 
 
 Absence of Lead. 
2. Test for Copper: 
a. One pinch of substance is 
made into paste with con. Hcl 
in a watch glass and  introduced 
into the non-luminous part of the 
flame. 
b. 2 ml of extract is added with 
excess of ammonia solution. 
 
No Blue colour flame  
precipitate 
 
 
 
No Blue colour 
precipitate  
 
Absence of Copper. 
 
 
 
 
Absence of Copper. 
3. Test For Aluminium:         
Take the 2m1of the extract sodium 
hydroxide is added in drops to 
excess. 
 
No characteristic 
changes 
 
 
Absence of 
Aluminium. 
 
4. Test  For  Iron: (Ferrous) 
  To  the 2 ml of extract 2m1                                         
ammonium thiocyanate solution                                
and 2m1of con.HNO3 is added 
 
 
Blood red colour 
Appearance 
 
 
Presence of Iron. 
 
 5. Test For Zinc: 
    To 2m1 of the extract sodium 
hydroxide solution is added in 
drops to excess. 
 
White precipitate is not 
Formed 
 
 
Absence of Zinc. 
 
6. Test For Calcium: 
   2m1 of the extract is added with 
2m1 of 4% ammonium oxalate 
Solution. 
 
Cloudy appearance 
and white precipitate                       
is obtained 
 
Absence of Calcium. 
 
7. Test For Magnesium: 
    To 2ml of extract sodium                                   
hydroxide solution is added in 
drops to excess. 
 
White precipitate is not 
obtained. 
 
Absence of 
Magnesium. 
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8. Test For Ammonium: 
   To 2ml of extract few ml of 
Nessler's reagent and excess of 
sodium hydroxide solution are 
added. 
 
 
No Brown colour 
appeared. 
 
 
 
Absence  of 
Ammonium. 
9. Test For Potassium: 
   A pinch of substance is treated 
with 2ml of sodium nitrite solution 
and then treated with 2m1 of 
cobalt nitrate in 30% glacial acetic 
acid. 
 
No Yellowish 
precipitate is 
obtained 
 
 
 
Absence of 
Potassium. 
 
10. Test For Sodium:                        
   2 pinches of the substance is 
made into paste by using HCL 
and introduced into the blue flame 
of Bunsen burner. 
 
 
 
 No Yellow colour  
Flame appeared. 
 
 
 Absence of Sodium. 
 
 
11. Test For Mercury: 
   2m1 of the extract is treated with 
2ml of sodium hydroxide solution. 
 
 
 
 
 Yellow precipitate                           
is obtained 
 
 
 
 
Absence of Mercury. 
 
 
 
12. 
 
Test For Arsenic:                     
  2m1 of the extract is treated with 
2m1 of sodium hydroxide 
solution. 
 
 
 
 
 
No brownish red 
Precipitate is obtained 
 
 
 
 
Absence of Arsenic. 
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III. MISCELLANEOUS 
1. Test for Starch: 
2ml of extract is treated with weak 
iodine solution. 
 
No blue colour 
developed 
 
Absence of Strarch. 
 
2. Test For Reducing Sugar: 
  5. ml of Benedict's qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boil it for   2 minutes. The 
colour changes are noted. 
 
 
Brick red colour 
developed 
 
 
Presence of 
Reducing sugar. 
3. Test For The Alkaloids: 
a. 2m1 of the extract is treated 
with 2ml of potassium Iodide 
solution.                                                   
b. 2m1 of extract is treated with  
2ml of picric acid. 
c. 2m1 of the extract is treated with 
2ml of phosphotungstic acid. 
 
 Red colour 
developed 
 
Trace Yellow colour 
developed 
                                
White precipitate 
developed 
Presence of 
Alkaloid. 
 
 
Trace of Alkaloid 
present. 
 
Presence of Alkaloid 
 
4. Test for Tannic Acid:   
   2ml of extract is treated with  
2ml of ferric chloride solution. 
 
No black precipitate 
is obtained 
 
Absence of Tannic 
acid 
 
5. Test for Unsaturated Compound: 
   To the 2ml of extract 2ml of 
Potassium Permanganate solution is 
added. 
 
Potassium 
Permanganate is  
decolourised 
 
Presence of 
Unsaturated 
Compound. 
6. Test For Amino Acid: 
2 drops of the extract is placed on a 
filter paper and dried well and 2 ml 
of biuret reagent is added. 
 
 
No Violet colour 
developed 
 
Absence of Amino 
acids. 
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7. Test For type of Compound: 
  
     2ml of the extract is treated with  
2 ml of ferric chloride solution. 
  
 
No Green colour 
developed 
 
No Red colour 
developed 
 
 
 
No Violet colour 
developed 
 
 
 
No blue colour 
 developed 
 
Absence of oxy 
quinole epinephrine 
and pyro catechol. 
 
Anti pyrine, 
Aliphatic          amino 
acids and Meconic 
acid are absent. 
 
Apomorphine, 
Salicylate and 
Resorcinol are 
absent. 
 
Morphine, Phenol 
cresol and hydro 
quinone are absent 
 
 
 
RESULT: 
The bio-chemical analysis of Yaanai Nerunjil Chooranam had shown the presence of  
Reducing Sugar ,Iron, Unsaturated compound and Alkaloids. 
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NATIONAL INSTITUTE OF SIDDHA 
ACUTE TOXICITY STUDY OF YAANAI NERUNJIL CHOORANAM 
[WHO guidelines, 1993] 
Principle: 
    Acute toxicity was carried out in Swiss albino mice with a single exposure of 10 
times of the recommended therapeutic dose of test compound the study duration will be 14 days. 
Animal species  : Swiss albino mice 
Age / Weight / Size  :  6 weeks.  Mice-20-25 gms. 
Gender   :   Both male and female 
Number of Animals   : Mice: 10 
Acclimatization Period : 7 Days 
Clinical dose   : 4.0 gms/day 
 
S. No Group No of mice 
1 Vehicle control (saline) 10  (5 male, 5 female) 
 
2 
Toxic dose 
10X (X-therapeutic dose)-
72mg 
10  (5 male, 5 female) 
 
Test Animals  
       Test animals were obtained from the animal laboratory of the King institute, 
Chennai and stocked at National institute of Siddha, Chennai. All the animals were kept under 
standard environmental condition (27+ or – 2 degree c).The animals had free access to water and 
standard pellet diet (Sai Durga foods pvt.ltd, Bangalore).The principles of laboratory animal care 
were followed and the  Institutional ethical committee approved the use of animals and the study 
design. (1248/ac/09/CPCSEA/February/ 2012) 
 
 Route of administration: 
  Oral route was selected, because it is the normal route of clinical administration. 
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Test substance and vehicle 
        Yaanai Nerunjil Chooranam is Brown in colour.  The test substance is insoluble in 
water, in order to obtain and ensure the uniformity in drug distribution the drug is dissolved by 
aqueous Tween 80 solution (10%).  
Administration of doses 
            Yaanai Nerunjil Chooranam was suspended in aqueous Tween 80 solution (10%), 
with uniform mixing and it was administered to the groups in a single oral dose. The control 
groups were received equal volume of the vehicle. The animals were weighed before giving the 
drug. The dose level was calculated according to body weight, and surface area. Since the 
clinical dose was 4.0gms\day it was converted to animal dose (0.0072gm).In acute toxicity study, 
as per WHO guidelines the toxic dose (10X-0.072gm) was administered. The principle of 
laboratory animal care was followed. 
Observations 
  Observations were made and recorded systematically and continuously observed 
as per the guideline after substance administration. The animals were monitored for behavioural 
parameters like 
1. Awareness 
- Alertness 
- Visual placing 
- Stereotype 
- Passivity 
2. Mood 
-  Grooming 
-  Restlessness 
-  Irritability 
-  Fearfulness 
3. Motor activity 
- Spontaneous activity 
- Reactivity 
- Touch response 
- Pain response.  
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Animals were observed for body weight and mortality for 14 days. If animals died during 
the period of study, the animals were sacrificed.  At the end of the 14th day all animals were 
sacrificed and necropsy was done. 
Body Weight 
  Individual weight of animals was determined before the test substance was 
administered and daily for 14 days. Weight changes were calculated and recorded. At the end of 
the test, surviving animals were weighed and sacrificed. 
Results:   
Yaanai Nerunjil Chooranam at the dose 0.072gm/animal did not exhibit any mortality in 
mice. No behaviour changes were noted for the first 4 hours and for the next 24 hours and 
throughout the study period of 14 days. No weight reduction was noted before and after the acute 
study duration. Reflexes were found to be normal before and after the study. All other 
observations were found to be normal before and after the study. In Necropsy, the organs of the 
animal such as, Liver, Heart, Lungs, Pancreas, Spleen, Stomach, Intestine, Kidney, Urinary 
bladder, Uterus all appeared normal. 
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NATIONAL INSTITUTE OF SIDDHA - AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE- DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON YAANAI NERUNJIL CHOORANAM 
(Internal) AND PATHIYAA LEBANAM (External)  FOR THE TREATMENT OF  
VENPULLI (VITILIGO) 
                 FORM l - SCREENING & SELECTION PROFORMA 
1.OP NO: .......................    2. NAME:  ………………………………………….   
3. AGE: ………   4.GENDER: …… 5. OCCUPATION: ……………6.INCOME:    
7. ADDRESS:    ……………………………………     
…………………………………… 
…………………………………… 
8. CONTACT NO:    ……………………………………              
INCLUSION CRITERIA 
· Age :18-60 Yrs          Yes/ No                                                                              
  
· Sex : Both male and female                                                                    Yes/ No                                                                                   
· Patients having symptoms of  Depigmented patches without any structural                                                                                                                              
changes           Yes / No                                                                   
· Patients  are willing to give blood and urine for laboratory investigations     Yes / No                                                     
· Patient willing to sign the informed consent stating that he/she will conscientiously  
stick to the treatment during 48days but can opt out of the trial of his/her                                                                              
      own conscious discretion                          Yes / No                                                 
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EXCLUSION CRITERIA       
1. Hypertension    Yes /No   
2. Diabetes mellitus     Yes /No  
3. Albinism      Yes /No  
4. Leprosy      Yes /No  
5. STD      Yes /No  
6. Depigmentation due to burns  Yes /No  
7. Pregnancy and Lactation   Yes/No  
8. Cardiac diseases     Yes /No  
9. HIV      Yes /No  
10. Patients with any other serious illness.  Yes /No 
  
ADMITTED TO TRIAL  
 YES    NO  
     If yes              OPD                    IPD 
 
 
  
Date:        
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                           Signature of the HOD  
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NATIONAL INSTITUTE OF SIDDHA-AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON YAANAI NERUNJIL   CHOORANAM 
(Internal) AND PATHIYAA LEBANAM (External) FOR THE TREATMENT OF  
VENPULLI (VITILIGO) 
FORM l A - HISTORY PROFORMA ON ENROLLMENT 
1. SERIAL NO OF THE CASE: …………………   2.OP / IP NO: ..........................  
 3. NAME: …………………………… 4. AGE: …………       5.GENDER: .................                           
6. COMPLAINTS & DURATION:   
   
                                                                                                                                                                                   
7. HABITS OF 
SMOKING, YES / NO If yes, specify duration    ---------- yrs 
TOBACCO, YES / NO  If yes, specify duration    ---------- yrs 
ALCOHOL, YES / NO  If yes, specify duration    ---------- yrs               
8. DRUG HISTORY: 
 
9. FAMILY HISTORY:    Whether this problem runs in family?  1. Yes                 2.No         
    If yes, mention the relationship of affected person(s) 
                                               1._________________  2._________________                             
10.DIETARY HABIT:         1.Vegetarian            2.Non-vegetarian 
11. MENSTRUAL HISTORY: 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD   
126 
 
NATIONAL INSTITUTE OF SIDDHA - AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON  YAANAI NERUNJIL   CHOORANAM 
(Internal) AND PATHIYAA LEBANAM (External) FOR THE TREATMENT OF  
VENPULLI (VITILIGO) 
CLINICAL ASSESSMENT ON ENROLLMENT - FORM l1 
1.OP NO:  ------------ 2.IP NO: ---------------    3.BED NO: ------     4.SI NO:   ------ 
5. NAME: ----------------------        6. AGE:   ---------              7.GENDER:    ------ 
8. DATE OF INITIAL ASSESSMENT:     ----------------------             
9. GENERAL EXAMINATION: 
1. Body weight [Kg]    :                      
2. Height [cm]                        :                        
3. Body Temperature [F]       :   
4. Blood Pressure (mmHg)  :      
5. Pulse Rate /min.        : 
6. Heart Rate / min.         : 
7. Respiratory Rate /min.  :   
                                                                                   Yes            No   
8. Pallor  :   
9. Jaundice  :   
10. Clubbing  : 
11. Cyanosis  : 
12. Pedal Oedema : 
13. Lymphadenopathy           :                                        
14. Jugular venous pulsation  :   
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11. SYSTEMIC EXAMINATION: 
Nervous system   -----------------------               cardiovascular system ---------------------- 
 
Uro-genital system -----------------------                Respiratory system ---------------------- 
 
Endocrine system   -----------------------                Gastro intestinal system ------------------- 
11. SIDDHA SYSTEM OF EXAMINATION  
1. THEGI (TYPE OF BODY CONSTITUTION): 
1. Vatha udal          2. Pitha udal        3.Kaba udal         4. Thontha udal         ------------------------ 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji            2. Mullai             3. Marutham            4. Neithal            5. Paalai 
3. KAALAM: 
1. Kaar kaalam             2. Koothir kaalam                  3. Munpani kaalam 
4. Pinpani kaalam             5. Ilavenil kaalam             6. Muthuvenil kaalam  
4. GUNAM:             1. Sathuvam              2. Rasatham               3. Thamasam 
5. PORIPULANGAL (SENSORY ORGANS):          
 Before Treatment After Treatment 
Mei    
Vai   
Kann   
Sevi   
Mooku   
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 6. KANMENDRIYAM (MOTOR ORGANS) 
7. KOSANGAL (SHEATH):          
Before Treatment After Treatment 
AnnamayaKosam Normal  /Affected Normal  /Affected 
Pranamayakosam  Normal  /Affected Normal  /Affected 
Manomayakosam  Normal  /Affected Normal  /Affected 
Vignanamayakosam  Normal  /Affected Normal  /Affected 
Ananthamayakosam  Normal  /Affected Normal  /Affected 
 
  
 Before treatment  After treatment 
Kai    
Kaal    
Vai      
Eruvai   
Karuvai    
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8. UYIR THAATHUKKAL: [THREE HUMORS] (VALI, AZHAL,IYAM) 
A) VALI 
 0th day 8th day 15th day 22nd day 29th day 36th day 43rd day 49th day 
Praanan         
Abaanan         
Samaanan         
Udhaanan         
Viyaanan         
Naagan         
Koorman         
Kirukaran         
Devathathan         
Dhananjeyan         
B) AZHAL 
 0th day 8th day 15th day 22nd day 29th day 36th day 43rd day 49th day 
Analakam         
Ranjakam          
Saathakam          
Prasakam          
Aalosakam         
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C) IYAM 
 0th day 8th day 15th day 22nd day 29th day 36th day 43rd day 49th day 
Avalambagam         
Kilethagam         
Pothagam         
Tharpagam         
Santhigam         
9.SEVEN UDAL DHATHUS: (7 SOMATIC COMPONENTS)  
 Before Treatment After Treatment 
Saaram Normal  /Affected Normal  /Affected 
Senneer  Normal  /Affected Normal  /Affected 
Oon Normal  /Affected Normal  /Affected 
Kozhuppu Normal  /Affected Normal  /Affected 
Enbu Normal  /Affected Normal  /Affected 
Moolai  Normal  /Affected Normal  /Affected 
Sukkilam/Suronitham  Normal  /Affected Normal  /Affected 
 
SIDDHA SYSTEM OF EXAMINATION 
1. ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION] 
 I. NAADI: [PULSE PERCEPTION] 
Nadi Nadai 0th  
day 
8th 
Day 
15th  
Day 
22th  
day 
29th  
day 
36th  
day 
43th  
Day 
49th  
day 
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II .SPARISAM: 
III. NAA:[TONGUE] 
IV.NIRAM: [COMPLEXION]   
V.MOZHI: [VOICE] 
 
 
VI.VIZHI: [EYES]  
 
Sparisam 0th  
Day 
8th 
Day 
15th  
Day 
22th  
day 
29th  
day 
36th  
day 
43th  
Day 
49th  
day 
         
Naa 0th  
Day 
8th 
Day 
15th  
Day 
22th  
day 
29th  
day 
36th  
day 
43th  
Day 
49th  
day 
         
Niram 0th  
Day 
8th 
Day 
15th  
Day 
22th  
day 
29th  
day 
36th  
day 
43th  
Day 
49th  
day 
         
Mozhi 0th  
Day 
8th 
day 
15th  
day 
22th  
day 
29th  
day 
36th  
day 
43th  
day 
49th  
day 
High Pitched         
Medium Pitched         
Low Pitched         
Vizhi 0th  
Day 
8th 
day 
15th  
day 
22th  
day 
29th  
day 
36th  
day 
43th  
Day 
49th  
day 
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VII. MALAM: [BOWEL HABITS / STOOLS] 
malam     Before treatment After treatment 
Niram   
                          Irugal   
Ilagal   
Others   
 
VIII. URINE EXAMINATION 
  
NEIKURI Before Treatment After Treatment 
Serpentine fashion   
Annular/Ringed fashion   
Pearl beaded fashion      
Mixed fashion   
Other fashion   
 
NEERKURI Before Treatment After Treatment 
Niram[Colour]     
                              
Manam[Odour] 
  
Edai[Sp.gra]                               
 
 
Nurai[Froth]   
Enjal[Deposits]   
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NATIONAL INSTITUTE OF SIDDHA -AYOTHIDOSS PANDITHAR HOSPITAL 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON  YAANAI NERUNJIL CHOORANAM (Internal) 
AND PATHIYAA LEBANAM (External)  FOR THE TREATMENT OF  VENPULLI (VITILIGO) 
        FORM ll A -  CLINICAL ASSESSMENT DURING & AFTER TRIAL 
1. OP/ IP NO: ………… 2. SL. NO: ……3.NAME: ………………………………………                   
4. AGE: ………                    5. GENDER: …...  6. DATE OF RECRUITMENT: …………….. 
 0
th day 8th day 15th day 22th day 
Site     
Size of the lesions     
Number of lesions     
Borders     
Itching     
Depigmentation of Hair     
New lesions appearance     
Repigmentation of Hair     
Colour change     
Repigmentation Centrifugal 
                            Centripetal 
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 29
th day 36th day 43th day 49th day 
Site     
Size of the lesions     
Number of lesions     
Borders     
Itching     
Depigmentation of Hair     
New lesions appearance     
Repigmentation of Hair     
Colour change     
Repigmentation Centrifugal 
                            Centripetal 
    
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                             Signature of the HOD 
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              NATIONAL INSTITUTE OF SIDDHA- AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON  YAANAI NERUNJI  CHOORANAM 
(Internal) AND PATHIYAA LEBANAM (External) FOR THE TREATMENT OF  
VENPULLI (VITILIGO) 
                     FORM-III - LABORATORY INVESTIGATIONS 
a) Blood Investigation 
Blood Investigations Normal Values Before trmt (Date) After trmt (Date) 
Hb( gm/dl) M:1215/W:11.5-14   
 
T.WBC (cells/Cu.mm) 
4000-11000   
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 20-40   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
T.RBC(million cells/Cu.mm) M:4.0-5.5 
  W:3.5-4.5 
 
 
 
 
  ESR(mm/hour) ½ hr. M:6-12 
W:7-18 
  
  1 hr.   
Blood glucose 
(mg/dl) 
Fasting    70-110   
PP    80-140   
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RFT (mg/dl) 
Blood urea    16-50   
Serum 
creatinine    0.6-1.2   
LFT (mg/dl) 
Total bilirubin    0.2-1.2   
Direct bilirubin    0.1-1.2   
Indirect 
bilirubin 
   0.2-0.7   
SGOT     0-40   
SGPT     0-35   
Alkaline 
phosphatase 
   80-290   
b) SPECIFIC TESTS 
 
c) URINE INVESTIGATION 
 
Urine investigation Before treatment After treatment 
Albumin   
Fasting sugar   
PP sugar   
d) MOTION EXAMINATION 
 
 
 
 Before treatment After treatment 
Ova   
Cyst   
Date:                         
Station:                     
signature of the investigator: 
Signature of the Lecturer:                                                                          Signature of the HOD 
 
THYROID 
PROFILE   
 
T3   80-200ng/dl   
T4 5-12ug/dl   
TSH 0.4-6.2uU/ml   
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NATIONAL INSTITUTE OF SIDDHA- AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON  YAANAI NERUNJIL CHOORANAM 
(Internal) AND PATHIYAA LEBANAM (External)  FOR THE TREATMENT OF  
VENPULLI (VITILIGO) 
FORM IV B - WITHDRAWAL FORM 
1. SERIAL NO OF THE CASE: …………………   
2.OP / IP NO: ......................................    
3. NAME: ……………………………    4.AGE: …………       5.GENDER: .................                          
6. DATE OF TRIAL COMMENCEMENT: ………………... 
7. DATE OF WITHDRAWAL FROM TRIAL: …………….. 
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:              Yes/ No 
Irregular treatment:                          Yes/ No 
Shift of locality:                                    Yes/No 
Increase in severity of symptoms:    Yes/No 
Development of severe adverse drug reactions:  Yes/No 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA- AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON  YAANAI NERUNJIL    CHOORANAM 
(Internal) AND PATHIYAA LEBANAM (External)     FOR THE TREATMENT OF  
VENPULLI (VITILIGO) 
FORM IV –C (DRUG COMPLIANCE FORM) 
SERIAL NO:  
OP/IP NO: 
NAME:        
AGE/ GENDER:                                  
DRUG NAME:  Yaana Nerunjil Chooranam 
OPD: 
On 1st     day-Date:    Drugs issued: 21(Gms) Drugs returned:  (Gms) 
On 8th   day-Date:     Drugs issued: 21(Gms) Drugs returned:   (Gms) 
On 15th day-Date:         Drugs issued: 21(Gms) Drugs returned:   (Gms) 
On 22nd day-Date:         Drugs issued: 21(Gms) Drugs returned:   (Gms) 
On 29th day-Date:          Drugs issued: 21(Gms) Drugs returned:   (Gms) 
On 36th day-Date:          Drugs issued: 21(Gms) Drugs returned:   (Gms) 
On 43rd day-Date:          Drugs issued: 21(Gms) Drugs returned:   (Gms)  
IPD: 
Day        Date Morning Evening Day       Date Morning Evening 
Day 1    Day 2    
Day 3    Day 4    
Day 5    Day 6    
Day 7    Day 8    
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Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD  
Day 9    Day 10    
Day 11    Day 12    
Day 13    Day 14    
Day 15    Day 16    
Day 17    Day 18    
Day 19    Day 20    
Day 21    Day 22    
Day 23    Day 24    
Day 25    Day 26    
Day 27    Day 28    
Day 29    Day 30    
Day 31    Day 32    
Day 33    Day 34    
Day 35    Day 36    
Day 37    Day 38    
Day 39    Day 40    
Day 41    Day 42    
Day 43    Day 44    
Day 45    Day 46    
Day 47    Day 48    
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NATIONAL INSTITUTE OF SIDDHA- AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON  YAANAI NERUNJIL    CHOORANAM 
(Internal) AND PATHIYAA LEBANAM (External)     FOR THE TREATMENT OF  
VENPULLI (VITILIGO) 
FORM IV E - ADVERSE REACTION FORM 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                             AGE:                                          GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF OCCURRENCE OF THE ADVERSE REACTION:   TIME: 
DESCRIPTION OF ADVERSE REACTION: 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                            Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON YAANAI NERUNJIL CHOORNAM 
(YAANAI NERUNJIL CHOORNAM )AND PATHIYAA LEBANAM (EXTERNAL 
MEDICINE ) FOR THE TREATMENT OF VENPULLI(VITILLIGO) 
FORM IV D - DIETARY ADVICE FORM 
§º÷ì¸ ÜÊÂ ¯½×¸û: 
¸¡ö¸û: 
ÓÕí¨¸À¢ïÍ, (Unripe drumstick) 
«Å¨ÃÀ¢ïÍ, (Unripe Dolichos bean) 
À¢Ãñ¨¼ (Edible Stemmed Vine) 
£¸¨Ã¸û: 
            ¸Ã¢º¡¨Ä (trailing eclipta [Eclipta prostrate]) 
            ¦À¡ýÉ¡í¸ñ½¢ (Sessile plant [Alternanthera sessilis] ) 
            Á½ò¾ì¸¡Ç¢ (black nightshade) 
            ÓÕí¨¸ £¸¨Ã (Leaves of Drumstick [Moringa oleifera] ) 
            Àº¨Ä £¸¨ Ã(Indian Spinach[Basella alba]) 
            º¢Ú¸£¨Ã(Tropical Amaranth [Amaranthus polygonoides]) 
            ¸È¢§ÅôÀ¢¨Ä (Curry leaf [Murraya koenigii] ) 
        ¦¸¡ò¾ÁøÄ¢ (Coriander) 
         Ò¾¢É¡ (Pudina). 
ÀÆí¸û: 
Á¡Ð¨Ç (Pomegranate) 
¬ôÀ¢û (Apple) 
Å¡¨Æ (Banana) 
§ÀÃ£î¨º (Dates) 
«ò¾¢ (Fig)              
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¾¢Ã¡ð¨º (Grapes) 
¦¸¡öÂ¡ (Guava)                
¿¡Åø  (Jambul [Syzygium cumini] )  
ºô§À¡ð¼¡ (Sapodilla) 
¯Ä÷ ¾¢Ã¡ð¨º (Dried Grapes). 
¾¡É¢Âí¸û  
Ó¨Ç ¸ðÊÂ ÀÂ¢÷ Å¨¸¸û (Sprouts)  
§º¡Â¡À£ýŠ ( soya bean) 
  ¦Åó¾Âõ (Fengu greek). 
«¨ºÅõ: 
¦ÅûÇ¡ðÎ¸È¢ (Meat) 
ÁüÈ¨Å: 
À¨É ¦ÅøÄõ (Palm Jaggery) 
À¡ø (Milk)  
¾Å¢÷ì¸ §ÅñÊÂ¨Å¸û:       
§¸¡Æ¢ì¸È¢, Á£ý, ¿ñÎ, ¸ÕÅ¡Î (Chicken, Fish, Crab,Dry fish ) 
§Å÷ì¸¼¨Ä (Groundnut) 
±ûÙ (Seasame) 
ÀôÀ¡Ç¢ (Papaya) 
«ýÉ¡º¢ (Pineapple) 
¿ø¦Äñ¦½ö (Gingely oil) 
ÒÇ¢ôÒ (Sour) 
±ÖÁ¢î¨º (Lemon) 
¾ì¸¡Ç¢ (Tomato) 
°Ú¸¡ö (Pickle) 
Ò¨¸Â¢¨Ä (Tobacco) 
ÁÐ «ÕóÐ¾ø (Alcohol). 
ÁÕòÐÅ «È¢×¨Ã:  
¯¼Ä¢ø §¿¡Â¡ø À¡¾¢ì¸ôÀð¼ þ¼í¸Ç¢ø ¦¸¡Îì¸ôÀð¼  §ÄÀÉõ  ¾¼Å¢ 10 Ó¾ø 15 
¿¢Á¢¼í¸û þÇõ ÝÃ¢Â ¦ÅÂ¢ø «ó¾ þ¼í¸Ç¢ø (¸¡¨Ä 6 Ó¾ø 8 Á½¢ìÌû) ÀÎÁ¡Ú ¿¢ü¸ §ÅñÎõ. 
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            NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON YAANAI NERUNJIL CHOORNAM 
(YAANAI NERUNJIL CHOORNAM )AND PATHIYAA LEBANAM (EXTERNAL 
MEDICINE ) FOR THE TREATMENT OF VENPULLI(VITILLIGO) 
FORM IVA-CERTIFICATE OF CONSENT 
“I have read the foregoing information, or it has been read to me. I have had the opportunity 
to ask questions about it and any questions I have asked have been answered to my satisfaction.  
            I   consent voluntarily to participate in this study and understand that I have the   right to 
withdraw from the study at any time without in any way it affecting my further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date: 
Signature of the participant 
In case of illiterate participant 
  “I have witnessed the accurate reading of the consent form to the potential participant, and 
the individual has had the opportunity to ask questions. I confirm that the individual has given consent 
freely.”                                                   
 
Date: 
 
 Signature of a witness                                            Left thumb Impression of the Participant     
(Selected by the participant bearing no connection with the survey team)       
Date:    
Station:                                                                                  
Signature of participant:                                                 
Signature of the Investigator: 
 Signature of the Lecturer:                                                            Signature of the HOD 
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
«§Â¡ò¾¢¾¡Š ÀñÊ¾÷ ÁÕòÐÅÁ¨É ¦ºý¨É 
¦ÅñÒûÇ¢ §¿¡öì¸¡É º¢ò¾ ÁÕóÐ¸Ç¢ý (Â¡¨É ¦¿Õïº¢ø ÝÃ½õ ÁüÚõ Àò¾¢Â¡ 
§ÄÀÉõ) ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø  ÀÊÅõ. 
´ôÒ¾ø  ÀÊÅõ 
¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð 
¿¡ý þó¾ ¬ö¨Å ÌÈ¢ò¾ «¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢ìÌ  ÒÃ¢Ôõ 
Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É ¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
  
§¾¾¢ :                                                     ¨¸¦Â¡ôÀõ: 
þ¼õ:                                                      ¦ÀÂ÷     : 
                                  
§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
 
¿¡ý §ÁüÜÈ¢Â  ¾¸Åø  ÀÊÅò¨¾ ÀÊòÐ «øÄÐ ÀÊì¸ §¸ðÎ ¦¸¡ñ§¼ý. 
­Ð ¦¾¡¼÷À¡É Å¢Çì¸í¸¨ÇÔõ §¸ðÎ ¦¾Ã¢óÐ ¦¸¡ñ§¼ý.±ó¾ Å¢¾ 
ÅüÒÚò¾Ä¢ýÈ¢ ±ý ¦º¡ó¾ Å¢ÕôÀò¾¢ý §ÀÃ¢ø ±ý¨É ­ó¾ ¬Ã¡öîº¢ìÌ 
¯ðÀÎò¾ ±ý ÓØÁÉ§¾¡Îõ ÍÂ¿¢¨É§Å¡Îõ ºõÁ¾õ ¦¾Ã¢Å¢ì¸¢§Èý. ±ÉìÌ 
Å¢ÕôÀÁ¢øÄ¡¾ Àðºò¾¢ø ­ó¾ ¬Ã¡öîº¢Â¢ø ­ÕóÐ ±ý¨É ±ô§À¡Ð 
§ÅñÎÁ¡É¡Öõ Å¢ÎÅ¢òÐ ¦¸¡ûÙõ ¯Ã¢¨Á¨Â ¦ÀüÚû§Çý ±ýÀ¨¾Ôõ «È¢§Åý 
¿¡ý ±ýÛ¨¼Â Í¾ó¾¢ÃÁ¡¸ §¾÷× ¦ºöÔõ ¯Ã¢¨Á¨Âì ¦¸¡ñÎ ¦ÅñÒûÇ¢ 
§¿¡öì¸¡É Â¡¨É ¦¿Õïº¢ø ÝÃ½õ (¯û ÁÕóÐ) ÁüÚõ Àò¾¢Â¡ §ÄÀÉõ 
(¦ÅÇ¢ ÁÕóÐ) 
ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢üÌ ±ý¨É 
¯ðÀÎò¾ ´ôÒ¾ø «Ç¢ì¸¢§Èý. 
§¾¾¢  :                                                       ¨¸¦Â¡ôÀõ   : 
­¼õ  :                                                         ¦ÀÂ÷           : 
§¾¾¢   :                                     º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ  : 
­¼õ  :                                                        ¦ÀÂ÷            : 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON YAANAI NERUNJIL CHOORNAM 
(YAANAI NERUNJIL CHOORNAM )AND PATHIYAA LEBANAM (EXTERNAL 
MEDICINE ) FOR THE TREATMENT OF VENPULLI(VITILLIGO) 
FORM IV – PATIENT INFORMATION SHEET 
Name of the principal Investigator: Dr.A.Suganya   
Name of the institute:    National Institute of Siddha, 
                                         Tambaram Sanatorium, 
                                          Chennai-47. 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL. 
I,Dr.A.Suganya studying MD(Siddha) at National Institute of Siddha,Tambaram 
Sanatorium is doing a trial on the study Venpulli (Vitiligo). Vitiligo is a  common persistent skin 
disease  occurring through  the world                                                                                                                             
In this regard, I am in a need to ask you a few questions. I will maintain confidentiality of your 
comments and data obtained. There will be no risk of disclosing your identity and no physical, 
psychological or professional risk is involved by taking part in this study. 
Taking part in this study is voluntary. No compensation will be paid to you for taking 
part in this study. 
           You can choose not to take part. You can choose not to answer a specific question. There 
is no specific benefit for you if you take part in the study. However, taking part in the study may 
be of benefit to the community, as it may help us to understand the problem of defaulters and 
potential solutions. 
             If you agree to be a participant in this study, you will be included in the study primarily 
by signing the consent form and then you will be given the internal medicine Yaanai Nerunjil 
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Choornam(Internal medicine-2gm BD with water for 48 days) and Pathiyaa Lebanam(External 
medicine) if you wish to stay in the In Patient ward Yogam Treatment will be provided to you 
assuring that you will not be definitely hurt during the course of treatment. 
  The information I am collecting in this study will remain confidential. I will ask you few 
questions through a questionnaire. I will not write your name on this form. I will use a code 
instead.  
The questionnaire will take approximately 20 minutes of your time. 
If you wish to find out more about this study before taking part, you can ask me all the 
questions you want or contact Dr. A.Suganya…PG Scholar cum principal investigator of this 
study, attached to National Institute of Siddha,Chennai-47. You can also contact the Member-
secretary of Ethics committee, National Institute Siddha,Chennai 600047, Tel No : 91-44-
22380789, for rights and participation in the study.  
§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ,  
«§Â¡ò¾¢¾¡Š ÀñÊ¾÷ ÁÕòÐÅÁ¨É ¦ºý¨É  
 
¦ÅñÒûÇ¢ §¿¡öì¸¡É º¢ò¾ ÁÕóÐ¸Ç¢ý Â¡¨É ¦¿Õïº¢ø ÝÃ½õÁüÚõ Àò¾¢Â¡ 
§ÄÀÉõ) ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø  ÀÊÅõ. 
 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷:ÁÕòÐÅ÷: ................................... 
 ¿¢ÚÅÉò¾¢ý ¦ÀÂ÷           :§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
                              ¾¡õÀÃõ º¡Éð§¼¡Ã¢Âõ 
                              ¦ºý¨É 47 
 §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ø Àð¼ §ÁüÀÊôÒ ÀÂ¢ýÚ ÅÕõ ¿¡ý ............................ 
¦ÅñÀ¨¼ ±ýÛõ §¾¡¨ÄÀ¡¾¢ìÌõ §¿¡Â¢ø ÁÕòÐÅ ¬Ã¡öîº¢Â¢ø ®ÎÀðÎû§Çý.               
¦ÅñÀ¨¼ ±ýÛõ §¿¡Â¡ÉÐ §Áø §¾¡Ä¢ø ¿¢Èõ ¦¸¡ÎìÌõ Å¢Ä þõÁ¢¸û 
Ì¨ÈÅ¾¡ø ¯ñ¼¡¸¢ÈÐ§¾¡Ä¢ø Ð½¢, ÃôÀ÷, À¢Ç¡ŠÊì, Ó¾Ä¢Â¨Å¸Ç¡ø ²üÀÎõ ¦¾¡¼÷ó¾ 
¯Ã¡ö×¸Ç¡Öõ º¢Ä Ãº¡ÂÉ ¦À¡Õû¸Ç¡Öõ ²üÀÎ¸¢ÈÐ.¯¼ÖìÌ «ò¾¢Â¡Åº¢ÂÁ¡É º¢Ä 
¯§Ä¡¸î ºòÐ¸û «øÄÐ ¾¡Ð ¯ôÒ¸û Ì¨Èó¾ ºò¾üÈ  ¯½×¸Ç¡Öõ ¯ñ¼¡¸Ä¡õ. ­Ð 
ÀÃÅ ÜÊÂ §¿¡ö «øÄ. 
­ó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç §¸ð¸×õ, §¾¨ÅÂ¡É ¬öÅ¸ 
ÀÃ¢§º¡¾¨ÉìÌ ¾í¸¨Ç ¯ðÀÎò¾×õ ¯û§Çý. 
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­Ð ºõÀó¾Á¡É ¾í¸ÇÐ «¨ÉòÐ Å¢ÅÃí¸Ùõ Ã¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ ±É 
¯Ú¾¢«Ç¢ì¸¢§Èý. 
­¾¢ø ÀÂ½ôÀÊ Ó¾Ä¢Â ±ó¾ ¯¾Å¢ò ¦¾¡¨¸Ôõ ÅÆí¸ô À¼ Á¡ð¼¡Ð. 
­ó¾ ¬Ã¡öîº¢Â¢ý §À¡Ð ¯¼ÖìÌ §ÅÚ À¡¾¢ôÒ ²üÀÎõ Àðºò¾¢ø §¾º¢Â º¢ò¾ 
ÁÕòÐÅÁ¨ÉÂ¢ø ¾ì¸ º¢¸¢î¨º «Ç¢ì¸ôÀÎõ. 
­ó¾ ¬Ã¡öîº¢ìÌ ¾¡í¸û Å¢ÕôÀò¾¢ý §ÀÃ¢ø ¯ðÀÎõ Àðºò¾¢ø ¯ûÁÕó¾¡¸ Â¡¨É 
¦¿Õïº¢ø ÝÃ½õ -2 ¸¢Ã¡õ ¾ñ½£Õ¼ý 2 §Å¨Ç(¸¡¨Ä Á¡¨Ä) ¯½×ìÌô À¢ý ´Õ 
Áñ¼Äõ (48¿¡ð¸û) ¯ð¦¸¡ûÇ §ÅñÎõ. ¦ÅÇ¢ ÁÕó¾¡¸ Àò¾¢Â¡ §ÄÀÉõ 48 ¿¡ð¸ÙìÌ 
§¿¡ÔûÇ ­¼í¸Ç¢ø ¦ÅÇ¢§Â ¾¼Å §ÅñÎõ. ¦ÅÇ¢ §¿¡Â¡Ç÷¸û 7 ¿¡ð¸ÙìÌ ´ÕÓ¨È 
ÁÕòÐÅÁ¨ÉìÌ ÅÃ§ÅñÎõ. ¯û §¿¡Â¡Ç¢Â¡¸ ¾í¸ Å¢ÕôÀõ ¦¾Ã¢Å¢ìÌõ Àðºò¾¢ø 
§¿¡öìÌ ¾Ìó¾ §Â¡¸¡ºÉõ ÁüÚõ À¢Ã¡½Â¡Á ÀÂ¢üº¢¸ Ùõ ¸üÚò ¾ÃôÀÎõ 
­ó¾ ¬Ã¡öîº¢Â¢ø §¿¡Â¢ÉÃ¡¸ §º÷ó¾ À¢ÈÌ ¯í¸ÙìÌ Å¢ÕôÀõ ­ø¨Ä¦ÂÉ¢ø 
±ô§À¡Ð §ÅñÎÁ¡É¡Öõ Å¢Ä¸¢ ¦¸¡ûÇÄ¡õ 
­ó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ ÁüÈ Å¢ÀÃí¸ÙìÌõ §¿¡Â¢ý ¾ý¨Á ÀüÈ¢Ôõ Ó¾ý¨Á 
¬Ã¡öîº¢Â¡ÇÃ¡É ÁÕòÐÅ÷: ......................... (Àð¼ §Áü ÀÊôÀ¡Ç÷, º¢ÈôÒ ÁÕòÐÅ Ð¨È) 
«Ï¸×õ. ¨¸ô§Àº¢ ±ñ 9884444362 
§ÁÖõ  ­ó¾ ¬Ã¡öîº¢ìÌ IEC º¡ýÚ ¦ÀÈôÀðÎûÇÐ 
­ó¾ ÁÕóÐ º¢ÈôÀ¡¸ ¦ÅñÒûÇ¢ §¿¡öì¸¡¸ «í¸£¸Ã¢ôÀð¼ º¢ò¾ ÁÕòÐÅ áÄ¢ø 
ÜÈôÀðÎûÇÐ. ²ü¸É§Å ¯À§Â¡¸ò¾¢ø ¯ûÇ ­Ð §À¡ýÈ  ÁÕóÐ ­ÐÅ¨Ã 
§¿¡Â¡Ç¢¸Ç¢¼õ ±ó¾ Å¢¾ Àì¸ Å¢¨Ç×¸¨Ç ²üÀÎò¾Å¢ø¨Ä. §ÁÖõ ¯½× Ó¨ÈÂ¢ø 
ÁÕòÐÅÃ¡ø ÜÈôÀÎõ Àò¾¢Âõ  ¸¡ìÌÁ¡Ú «È¢×Úò¾ ÀÎ¸¢ÈÐ. 
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           NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON YAANAI NERUNJIL  CHOORANAM  
(INTERNAL MEDICINE) AND PATHIYAA LEBANAM (EXTERNAL  MEDICINE)  
FOR THE TREATMENT OF VENPULLI (VITILIGO). 
SERIAL NO: 
NAME OF THE ASANAM: 
Kiriya gnayiru vanakkam(kiriya pose of sun salutation) 
MEDITATIVE POSTURES: 
· Tamarai asanam    (  Padhmasanam  )   /   Sukhasanam 
· Mandi  uruthi asanam (vajrasanam) 
· Savaasanam 
NAME OF   PRANAYAMAM 
· Omkhara Pranayamam 
· NithiraiPranayamam 
· Mathiriga pranayamam 
 
  Day Date Morning Evening Day Date Morning Evening 
Day 1    Day25    
Day2    Day26    
Day3    Day27    
Day4    Day28    
Day5    Day29    
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Day6    Day30    
Day7    Day31    
Day8    Day32    
Day9    Day33    
Day10    Day34    
Day11    Day35    
Day12    Day36    
Day13    Day37    
Day14    Day38    
Day15    Day39    
Day16    Day40    
Day17    Day41    
Day18    Day42    
Day19    Day43    
Day20    Day44    
Day21    Day45    
Day22    Day46    
Day23    Day47    
Day24    Day48    
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              Signature of the HOD 
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